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Despite decades of research concerning the mechano-chemistry of the molecular motor myosin,
significant questions remain regarding the mechano-chemical coupling of actin binding, lever arm
rotation (the working stroke), and the release of inorganic phosphate. These processes are key to
myosin’s ability to produce force, and all occur within just a few milliseconds, making it difficult to
determine their properties. We have implemented and optimized an ultra-fast optical trapping technique
which is able to precisely (<100 >μs, <0.1 nm) observe the binding to and displacement of actin by myosin
while myosin experiences a controllable load. With this technique, we find that human β-cardiac myosin
initially interacts with actin in a short-lived state that has a lifetime of <1 ms but can support loads of > 4
pN. The working stroke of myosin occurs directly from this state at a rate of up to 5000 per second. This
stroke can be rapidly reversed under resisting loads until phosphate is released from the myosin. After
phosphate is released, high levels of free phosphate in solution (10 mM) can rebind to myosin, allowing
the stroke to once again be reversed. We observe that the coupling between the working stroke and
phosphate release can be disrupted by the addition of a small molecule drug, omecamtiv mecarbil (OM),
which binds directly to cardiac myosin. This drug speeds up phosphate release, but inhibits the working
stroke, diverting myosin off its canonical pathway and slowing detachment. We show that this slowed
detachment is responsible for the beneficial effects of the drug in patients. This work represents one of
the first direct, single molecule observations that the weak binding state of myosin is capable of
sustaining pN-sized forces and is the first direct observation of the working stroke rate as a function of
applied load. These findings provide strong evidence to place the working stroke before phosphate
release in cardiac myosin’s biochemical cycle.
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ABSTRACT
OPTICAL TRAPPING STUDIES OF THE MECHANO-CHEMICAL COUPLING OF
FORCE GENERATION AND PHOSPHATE RELEASE IN CARDIAC MYOSIN
Michael S. Woody
E. Michael Ostap and Yale E. Goldman
Despite decades of research concerning the mechano-chemistry of the molecular motor
myosin, significant questions remain regarding the mechano-chemical coupling of actin
binding, lever arm rotation (the working stroke), and the release of inorganic phosphate.
These processes are key to myosin’s ability to produce force, and all occur within just a
few milliseconds, making it difficult to determine their properties. We have implemented
and optimized an ultra-fast optical trapping technique which is able to precisely (<100
s, <0.1 nm) observe the binding to and displacement of actin by myosin while myosin
experiences a controllable load. With this technique, we find that human β-cardiac
myosin initially interacts with actin in a short-lived state that has a lifetime of <1 ms but
can support loads of > 4 pN. The working stroke of myosin occurs directly from this state
at a rate of up to 5000 s-1. This stroke can be rapidly reversed under resisting loads until
phosphate is released from the myosin. After phosphate is released, high levels of free
phosphate in solution (10 mM) can rebind to myosin, allowing the stroke to once again
be reversed. We observe that the coupling between the working stroke and phosphate
release can be disrupted by the addition of a small molecule drug, omecamtiv mecarbil
(OM), which binds directly to cardiac myosin. This drug speeds up phosphate release,
but inhibits the working stroke, diverting myosin off its canonical pathway and slowing
detachment. We show that this slowed detachment is responsible for the beneficial
effects of the drug in patients. This work represents one of the first direct, single
molecule observations that the weak binding state of myosin is capable of sustaining pNsized forces and is the first direct observation of the working stroke rate as a function of
applied load. These findings provide strong evidence to place the working stroke before
phosphate release in cardiac myosin’s biochemical cycle.
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CHAPTER 1 – Myosin’s Conversion of
Biochemical Energy into Mechanical Work
1.1. Motion in life
The kingdom of animals is well known for its members’ ability to move
themselves, but even much less complex forms of life, down to the single-celled amoeba
or bacterium, are able to propel themselves in a particular direction. While the
mechanism behind locomotion varies greatly across the kingdoms of life, in each case it
is powered by a class of proteins known as molecular motors, which act on the
nanometer scale to generate motion.
In many locomoting single-celled organisms, motility is powered by the whirling
motion of a long appendage known as a flagellum. These flagella are powered by the
molecular motor dynein. For more complex single cells, motion is primarily powered by
myosin molecular motors. This motor is behind the movement of both single-celled
organisms, such as amoebae, and individual cells within a larger organism that are
capable of their own directed motion. Myosin molecules interact with filamentous
structures called actin, which serve several purposes in cells, including acting as a type
of scaffolding to define the cell’s shape. Myosin binds to and then moves along an actin
filament by taking steps ranging from about 5 to 50 nm. Thousands of myosins working
together can create enough force and motion to move cells around through their
environment in a process known as cell motility.
Myosin is also the molecular motor which powers locomotion on the organismal
scale for animals, as it is the key component for powering contraction of muscle. Skeletal
and cardiac muscle (both types of striated muscle) are composed of connected arrays of
specialized, elongated cells called myocytes, which are able to shrink along their long
1

axis in concert, causing the muscle to shorten and perform work. Inside of each myocyte
are thousands of highly ordered sarcomeres, each of which can contract, leading to
shortening of the myocytes. Myosin II molecules are arranged into bi-polar “thick
filaments” inside of the sarcomeres. These thick filaments interdigitate with “thinfilaments” made up primarily of actin and regulatory proteins such as tropomyosin and
troponin. When the muscle is activated, the heads of the myosin molecules interact with
the actin in the thin filament to cause a relative motion between the thick and thin
filaments, leading to contraction of the sarcomere.1
This production of mechanical work requires the input of energy. This energy
comes from the food that organisms consume, where it is stored as biochemical energy
in sugars, fats, and proteins. The details of how this chemical energy is converted into
the motion of life, and in particular to the beating of the human heart, is one of the main
themes of the work presented here. The studies and conclusions presented here build
on a long history of scientific studies of the properties of muscles and how they produce
force. Long before the structure of the sarcomere was realized, biochemists were eager
to understand the source of this energy and how muscle could convert it to mechanical
work.

1.2. Early Studies of Mechanochemical Coupling in Muscle
Adenosine Triphosphate (ATP), now known by high school biology students as
the “energy currency” of biology, was first discovered by Karl Lohmann in 1929 by
examining extractions from liver and muscles.2,3 This high energy compound was quickly
proposed to be the energy source for the work done by muscles when Vladimir
Engelhardt discovered muscle ‘myosine’ was capable of hydrolysis of ATP in 1939.4
Szent-Gyorgyi went on to show that fibers extracted from muscle could be induced to

contract upon addition of ATP in 1943, providing further evidence that ATP was capable
of producing mechanical motion.5 Despite this and other similar experiments, by 1950,
A.V. Hill felt compelled to issue a “challenge to biochemists” to show conclusive
evidence that it was in fact the hydrolysis of ATP that directly powered contraction and
not any of the other high energy compounds present in muscle such as phosphocreatine.6

Figure 1.1 – Basic structure of the sarcomere, with the thin filament shown as horizontal solid black lines
connected to the z-disk and thick filaments as the four bipolar structures between the thin filaments.
Taken from Batters et al.1 under a Creative Commons License.

During this time when considerable work was being done by many in the field to
understand the structure of the sarcomere and the biochemistry of the muscle proteins
actin and myosin, Andrew Huxley published his seminal work, “Muscle Structure and
Theories of Contraction,”7 where he proposed a basic mechanism of muscle contraction
in which myosin and actin interact in interdigitating thick and thin filaments respectively.
He summarized and synthesized various works on the structure of the sarcomere from
electron microscopy and x-ray diffraction studies that described the basic geometry of
the sarcomere (Figure 1.1). In this structure, actin filaments are attached at the z-discs
on each end of the sarcomere with their barbed (or plus) ends facing the z-discs, with
bipolar myosin thick filaments arranged in the middle of the sarcomere. During

contraction, the actin filaments move toward the center of the sarcomere as there is a
relative motion of the myosin filaments toward the z-discs.
Huxley’s proposed mechanism for this motion was based on the cyclic interaction
between myosin and actin. He hypothesized that this involved association and
dissociation rates which depended on the relative position of myosin’s actin binding site
to the thick filament. In his model the myosin was more likely to bind to actin when the
myosin head was closer to the z-disc, and then was more likely to dissociate when the
myosin head was further from the z-disc. Assuming that these asymmetric rates exist,
his proposal was that Brownian motion of the filaments combined with this asymmetric
interaction would lead to directed motion between the filaments, causing contraction. He
postulated that the asymmetric rates which made this “Brownian ratchet” system work
were made possible by the energy input from a “high-energy phosphate compound.”
This basic idea of mechanical asymmetry arising from the input of biochemical energy
has persisted into contemporary thought of myosin’s mechanism of action, although the
Brownian ratchet model has been largely displaced by the “power stroke” model
described later.
In 1962, the “high-energy phosphate compound” was shown conclusively to be
ATP, as Dennis Cain and Robert E. Davies answered A.V. Hill’s “challenge” by
observing a decline in ATP in a contracting muscle after inhibiting creatine kinase. 8 With
the identity of the energy source verified, in vitro studies of purified myosin and actin with
ATP could now be accepted as physiologically relevant.
The foundational biochemical experiments of Lymn and Taylor showed that the
affinity of myosin for actin depended strongly on the identity of the nucleotide or
nucleotide hydrolysis products bound to myosin, where the affinity is much higher when
ADP or no nucleotide is bound, as compared to ATP or ADP-Pi.9 They also observed

that the release of inorganic phosphate (Pi) from myosin is greatly increased when
myosin interacts with actin.9 This basic biochemical cycle of myosin has since been built
up and expanded upon, as discussed below. However, there remain fundamental
questions about how this cycle of hydrolysis, actin binding, and product release is
related to the mechanical work performed by myosin.

1.3. Myosin’s Structure and Mechanochemistry
Today, there is a considerable amount known about the structure and
biochemistry of myosin and its interaction with actin. There are now over 26 classes of
myosins known. The myosin II isoforms found in muscle have been most extensively
studied. Myosin II is found as a homodimer of two polypeptides which form a long coiledcoiled domain at their C-termini known as LMM (light meromyosin). This distal end of
this coiled-coiled domain polymerizes with that of other myosin molecules in a striated
muscle to form the bipolar thick filament. At the “hinge” region, the coiled-coiled of each
myosin separates from the thick filament. The section from the hinge to the N-terminus
of the protein is known as HMM (heavy meromyosin). The LMM and HMM fragments of
the molecule can be separated through chymotrypsin digestion(Figure 1.2)10. The HMM
fragment can be further separated into sub fragment 1 (S1) and sub fragment 2 (S2)11.
The S1 region contains the myosin motor domain, consisting of the actin binding
domain, the nucleotide binding region, and the lever arm. The lever arm region is bound
by two separate proteins, the essential light chain and the regulatory light chain, which
serve to stabilize the lever arm region. The S2 region is composed of additional alpha
helical domains and serves to give space and flexibility between the thick filament (LMM
domain) and the myosin head (S1).1

Figure 1.2 Structure of Mysoin II showing the LMM, HMM, S2 and S1 regions of the molecule. Adapted
from Batters et al.1 under a Creative Commons License.

X-ray crystallography and, more recently, cryo-electron microscopy have
provided additional details about the structure of the myosin head12–14. The actin binding
site consists of two domains known as the upper 50 and lower 50 domains. The area
between these two domains is referred to as the actin binding site and contains a cleft
which can “close” when the two domains move closer to each other. This closed-cleft
state is associated with higher affinity for actin and corresponds to the strongly-bound
states of myosin.12,15,16 Whether the cleft is open or closed depends on the state of the
nucleotide that is bound in the nucleotide binding pocket of the motor domain.12,17,18
When ATP or ADP-Pi is present, the actin cleft is open and the myosin is in a weakbinding state, while when ADP or no nucleotide is present (apo or rigor state) myosin is
in a strong binding state. It still is not clear whether the closure of the cleft results in a
structural change that allows Pi to be released, or if the release of Pi allows the cleft to
close (or if they happen in concert), as discussed further below.12,19
In a similar way, the species bound to the nucleotide binding pocket is also
coupled to the conformation of the myosin lever arm. The lever arm is an alpha-helical
domain that is stabilized and stiffened by bound light chains and connects the catalytic
motor domain to the S2 domain and the thick filament.1 The lever arm is linked to the
motor domain through the converter, which allows allosteric communication between
nucleotide and the angular position of the lever arm with respect to a bound actin
filament.12 When ATP or ADP-Pi is bound, the lever arm is in the ‘pre-stroke’ position,

with its distal end angled closer to the plus end of the actin filament.20,21 When ADP or
no nucleotide is bound, the lever arm is in the post-stroke position, angled toward the
minus end of actin.13 Again, whether Pi release or the lever motion must occur first is still
under active debate and has significant implications for the mechano-chemical coupling
of the motor, as discussed at length in section 1.5. Because the presence of phosphate
strongly affects both the affinity of myosin for actin and the position of the lever arm, the
origin of the asymmetric rates as a function of the myosin’s head position proposed by
Huxley in 1957 can now be accounted for.

Figure 1.3. Mechanochemical cycle of myosin. Step five includes at least three steps: 1) Phosphate
release, 2) Transition from weakly to strongly bound, and 3) Lever arm rotation, known as the working
stroke.

The currently accepted biochemical cycle of myosin is shown in Figure 1.3.22,23
This cycle begins with myosin dissociated from actin in the post-stroke state with ATP
bound. ATP is hydrolyzed and the lever arm moves to the primed or pre-stroke state
(step 3). In this state, myosin’s actin binding cleft is open, leading to rapid associations
and dissociation between actin and myosin (step 4). In the literature, several important
processes are combined together and shown in step 5, including the release of
phosphate (the largest biochemical free energy change); the closure of the actin binding
cleft, putting myosin into a strongly bound state; and the conformational change leading
to lever arm rotation known as the working stroke. The reasons for why these steps are

often considered simultaneous and why this should be reconsidered are discussed in
section 1.5. These steps are followed by ADP release and another smaller conformation
change in the lever arm, referred to as the sub-step (step 6).24–26 Myosin is then waiting
in the apo or rigor state for ATP to bind (step 1), which will open the actin-binding cleft
and put myosin back into a weakly bound state, quickly leading to dissociation from actin
(step 2). This basic cycle is believed to be shared among all members of the myosin
super family; however, the rates and size of the mechanical motions vary between the
isoforms.22

1.4. Regulation of Myosin Mechano-chemistry
Individual steps of myosin’s mechano-chemical cycle have previously been
shown to be highly regulated by force applied to myosin. Which steps and the extent of
force-dependence varies widely between isoforms. For example, the rate of ADP release
(step 6) in myosin 1b and myosin II is slowed by the application of resisting load,24,26,27
while in myosin 1c it is the ATP binding rate (step 1) which is most strongly affected by
load.28 The sensitivity of the other attached states to load, particularly the processes
associated with step 5 in the scheme shown in Figure 1.3 have been difficult to study,
due to their short lifetime and the difficulty in conducting experiments which can apply
and/or measure loads on the time scales of these transitions.
In striated muscle (cardiac and skeletal), there is a significant amount of
regulation of myosin function via thin-filament proteins, which include actin-binding
proteins such as troponin and tropomyosin. When muscle is in its resting state and
myosin function is not needed, tropomyosin lies along the actin filament, blocking the
myosin binding site and preventing association (step 4, Figure 1.3). When the muscle is
activated, calcium enters the sarcomeres and binds to troponin, causing a shift in

tropomyosin’s position from a “blocked” to a “closed state” such that myosin is capable
of binding even though its binding site is not fully exposed (Figure 1.4)29. When myosin
binds to actin and enters a strongly bound state, the tropomyosin at that actin binding
site is displaced further to the “open state.” This displacement acts to cooperatively
activate nearby regions of the thin filament as more actin binding sites are exposed as
open states. This cooperative activation allows a very sharp response to calcium, which
plays a vital role in efficient contraction, especially in cardiac tissues, which undergo
calcium transients with each heartbeat.

Figure 1.4 Illustration of the three-state model of thin filament regulation. The myosin head is shown as a
shaded triangle, actin as an open circle, myosin binding sites as open triangles, and tropomyosin as a
shaded circle. Adapted from McKillop and Geeves, 199329 with permission.

In addition to thin filament activation, myosin in muscle can be regulated via
phosphorylation of its light chains or through changes to the structures of the thick
filament. New evidence suggests that the thick filament itself is mechano-sensitive, with
strain on the filament leading to more myosin heads being available to interact with
actin.30,31 This may be due to more heads being removed from the super-relaxed state,
which exhibits very low ATPase activity,32 and could be related to the “interacting heads
motif” where the myosin heads are folded onto the thick filament backbone.33 The extent
to which this regulation is important in the various muscle types is still under active
debate.30,34

1.5. Which Comes First, the Working Stroke or Phosphate Release?
While the majority of myosin’s cycle is well established, controversy remains
around the order and timing of the working stroke, transition from weak to strong binding,
and the phosphate (Pi) release step. In particular, the relationship between the
biochemical free energy change of Pi release and the mechanical work done by the
working stroke are of particular importance and interest. While many in the field believe
that phosphate release comes after the working stroke in skeletal muscle myosin II,
some controversy remains about this fact.35–38 In addition, there is evidence that for other
myosin isoforms, specifically the intracellular transport motor myosin V, the power
stroke comes after phosphate release.39 Not only is the placement and timing of
phosphate release from myosin debated, but it likely plays a vital role in the physiological
function of muscle, specifically in the heart. Recent studies have suggested that serum
phosphate levels may be effective indicators of heart problems,40–43 and it is known that
10 mM Pi in solution can cause up to 50% reduction in the force production of heart
muscle44. A wide variety of experimental techniques on various isoforms of myosin have
attempted to address the relationship between the working stroke and phosphate
release. A summary of a select few are presented below.

1.5.1.

A More Complex Cycle

In a 1980 study by JA Sleep and RL Hutton, skeletal muscle myosin was studied
using radiolabeled inorganic phosphate to determine the ability of the myosin motor
domain to bind to solution phosphate.45 They determined that actomyosin (the complex
of actin and myosin) that had been mixed with ADP was capable of binding ADP and
forming the AM-ADP state. However, this state was not able to bind phosphate from

solution. When they mixed ATP with actomyosin and allowed the biochemical cycle to
proceed, phosphate was capable of binding when the myosin was in an ADP state.

Figure 1.5 Scheme from Sleep's and Hutton's work showing two unique ADP states of actomyosin45

They postulated that two unique ADP-bound states exist: AM’-ADP, which is
produced from AM-ADP-Pi and is capable of binding solution phosphate and AM-ADP,
which is formed from actomyosin binding ADP from solution and cannot bind free
phosphate (Figure 1.5). The irreversibility of phosphate release from this AM-ADP state
suggested that there was a conformational difference between AM-ADP and AM’-ADP,
and weakly implied that the power stroke might be due to a transition between the two
AM-ADP states. If this were true, then phosphate release would precede the power
stroke. At the time, there was no evidence to show that this AM-ADP state was in fact
part of the normal biochemical cycle of myosin, but in light of more recent evidence, it is
possible that the conformational change from AM’-ADP to AM-ADP is the ~1 nm substroke of myosin that is associated with ADP release.25,26

1.5.2.

In Muscle Fibers

Five years later, in a result published by MG Hibberd et al. in Science, it was
shown that the force bearing state of myosin in muscle fibers was coupled to phosphate
release.46 In these experiments, the researchers took advantage of photo-activatable
ATP, which is inactive in solution until a laser pulse activates it. This allowed the study of
perturbations of the muscle fibers that were locked in the “rigor” state (strongly bound to
the actin with no nucleotide present). They found that after ATP activation, tension
decreased more rapidly when phosphate was present in the solution surrounding the

muscle fiber compared to when no phosphate was present. This decrease in tension
was explained as the reversal of the phosphate release step after ATP bound to myosin
and the biochemical cycle started. They also found that tension development of
activated muscle was faster in the presence of phosphate, due to the fact that the
observed rate of phosphate release is equal to the sum of the forward and reverse rates.
Since increased phosphate levels in solution would lead to a higher rate of rebinding of
phosphate, the observed rate for phosphate release would be sped up. This supports
the paper’s conclusion that phosphate release and the primary force bearing state of
myosin are tightly coupled and are part of a reversible reaction.
This work was built upon in 1992 by Dantzig et al. through the use of a photoactivatable phosphate molecule.47 This allowed perturbations of an actively cycling
muscle fiber with sudden increases in phosphate concentration. In these experiments,
muscle fibers were allowed to develop isometric tension before phosphate was released
into solution. The phosphate caused an expected decrease in tension as the population
of myosin was pushed back into states that were not capable of bearing force. The rate
of this relaxation in tension rose as the concentration of phosphate increased, but it
eventually reached a plateau where adding more phosphate had no additional effect on
the rate of tension decline.
If re-binding of phosphate to the AM-ADP state of the myosin simultaneously
caused a decrease in force, one would expect to see a linear dependence of the rate of
tension on phosphate decline. However, the saturation of the rate to a maximal velocity
indicates that there is an intermediate step that occurs between the rebinding of
phosphate and the decrease in tension. The maximal rate of tension decline would be
determined by the transition rate from this intermediate to a low-force state, which would
not depend on the phosphate concentration. This transition could be interpreted as the

reversal of the working stroke. The paper concludes that there is a force bearing state
that precedes phosphate release, as shown in Figure 1.6. There are two possible
interpretations of this transition from the AM-ADP-Pi state to the force bearing
intermediate AM’-ADP-Pi. It may be the transition from a weak binding state of
actomyosin to a strong binding state. The reversal of this would be expected to lead to
an overall decrease of tension in the muscle as observed. Otherwise, it may be the
conformational change responsible for the creation of force in the muscle, known today
as the working stroke.47 Thus it was established between this work and Sleep and
Hutton’s work that there are at least two separate AM-ADP-Pi states, and two AM-ADP
states.

Figure 1.6. Scheme from Dantzig et al. showing two force bearing states (indicated by F), including one
with bound phosphate47

This, and similar studies resulted in a well-accepted model that Pi in solution was
capable of inducing reversals and then fast detachments of myosin from a short-lived
state.48 However, these data have not been entirely convincing to the field, as some
authors maintain that phosphate release precedes the working stroke.12,37,49 The majority
of papers that use data from muscle fibers to justify the release of phosphate before the
stroke do so by extensive global modeling of the entire mechanochemical cycle in order
to explain data from multiple experimental protocols including tension, length and
temperature jumps.30,49–51 Because of the complexity of such models, these studies are at
risk of failing to convince skeptical readers that only the authors’ assumptions in the

proposed models can explain the data. It may be that there exists alternative
explanations and models which could describe the data sufficiently.

1.5.3. Biochemical and Optical Trapping Studies of Phosphate Release
A major stride was made in the study of phosphate release from myosin with the
development of a fluorescent probe for phosphate that was based on phosphate binding
protein (PBP). This probe greatly increases in fluorescence when it binds to phosphate
in solution.52 White et al. used the probe to show that phosphate release rate is fast (~70
s-1 ) compared to the hydrolysis step (~20 s-1) in isolated skeletal muscle myosin.53
While spectroscopy and other bulk measurements have been very useful for
studying myosin’s biochemical cycle, much is gained by using single molecule
techniques that allow individual myosin motors to be studied. In a three-bead optical
trapping assay, the force produced by single myosin molecules can be measured, and
forces can be applied to myosin as it interacts with an actin filament.54 In 2002, Baker et
al employed this technique to monitor the effect of phosphate in solution on the lifetimes
of attachments of single myosin molecules. With excess phosphate in solution, an
additional population of short-lived actomyosin interactions were detected, which
indicated that phosphate rebinding from solution could cause ‘premature’ detachment of
individual myosin molecules. However, the authors concluded that without the ability to
detect even shorter attachments (<3 ms), their data was unable to distinguish whether
the working stroke or Pi release occurred first. Their data suggested that there were
short-lived attached states that occurred before Pi release, but could not determine if the
stroke had occurred in one of these states.55
Optical trapping techniques were further advanced through the use of an
isometric feedback system, which holds the myosin molecule at a fixed position as it

tries to undergo the power stroke.56 However, due to inherent limitations of this type of
feedback, it is not possible to apply a load to the myosin before it has begun the working
stroke. However, Takagi et al. studied myosin under two conditions of feedback: fast
force loading and intermediate force loading with time constants of ~1 and 10 ms
respectively. They conclude that the fast loading condition is able to probe the
biochemical states which occur immediately after the working stroke, while the
intermediate feedback probes later stages of the mechano-chemical cycle. They see that
when they quickly load the myosin, there is a faster detachment of the protein from actin
than when it is loaded with force more slowly. This faster detachment under rapid
loading is attributed to the reversal of the working stroke, which can occur before
phosphate release, but which is nearly impossible after phosphate is released. After the
reversal of the working stroke, the motor was proposed to be in a weak binding state
with actin, allowing faster detachment. This leads them to support a model with the
power stroke occurring before phosphate release as shown in Figure 1.7.

Figure 1.7.Proposed detailed model of step 5 of Figure 1.3 with phosphate release occurring after the
power stroke. Takagi et al.35 believed their fast feedback system was able to reverse the power stroke
before the irreversible phosphate release step, leading to actin detachment, where the intermediate
feedback allowed phosphate to release to occur before force was applied.

Additional optical trapping studies were performed using small ensembles of
myosins interacting with a single actin filament in the presence and absence of solution
phosphate.57 In this work, it was necessary to use a computational model to examine
how effects on the biochemical cycle affected the force produced by a small number of

myosins working together. The authors found that Pi was able to induce fast
detachments of myosin and were able to explain this data using models where the
working stroke preceded phosphate release. Their data could be explained by either
myosin detaching upon phosphate binding from a post-stroke state, or after undergoing
a stroke reversal.58

1.5.4.

Controversy from Myosin V

The majority of the studies considered thus far have been performed with
skeletal myosin II. This is largely because myosin present in cells outside of muscles
only began to be intensely studied in the mid-1980s.59 Perhaps the most studied
unconventional myosin, myosin V, was only discovered in 1991.60 Since then, much
research has gone into understanding how the doubled headed motor can processively
transport cargos inside of cells. Myosin V differs from skeletal myosin not only in
structure and function, but, unsurprisingly, in the kinetics of the ATPase cycle.22,61 It has
even been suggested that this myosin, possibly along with others, may position the
power stroke at a different place in the biochemical cycle than myosin II does, as
suggested in the following study.
In 2005, Rosenfield and Sweeney39 studied the kinetics of myosin V with the aim
of understanding how it can walk processively as a dimer, i.e. that it can take hundreds
of steps along an actin filament without dissociating. They compared biochemical kinetic
measurements from two constructs of myosin V: a single headed construct and a twoheaded construct.39
The authors’ primary conclusion in the paper was that strain within myosin V
significantly slowed ADP release from the leading head and sped its release from the
trailing head with a 100-fold difference in rates. More pertinent to understanding

phosphate release, the authors used fluorescent phosphate binding protein to compare
the rate of phosphate release from the single and double headed constructs and found
very little difference. It would be expected via the energetics represented by Bell’s
Equation62 that the rate of the working stroke would be slowed if the leading head were
experiencing rearward strain. Thus, if the working stroke preceded phosphate release,
one would expect phosphate release to be slowed as well in the two-headed construct.
Their results support a model where phosphate release occurs prior to the working
stroke, and thus is unaffected by any strain slowing the working stroke (Figure 1.8).

Figure 1.8 Proposed detailed model of step 5 of Figure 1.3 with phosphate release occurring before the
power stroke, supported by the 2005 Rosenfeld and Sweeney paper. 39

Much of the other proposed evidence for phosphate release occurring before the
working stroke comes from structural studies.12,37,63,64 These works were done with
dictyostelium myosin II64, myosin V17, and myosin VI37, and were mainly based on
determining whether there is a pathway for phosphate to leave the nucleotide binding
site before the lever arm rotates. Early structural studies have shown that phosphate
release is blocked by ADP from leaving the nucleotide binding site, indicating that
phosphate leaves through a “back door”.65 There have been two main proposed
possibilities for the back door: 1) the movement of the structural element switch-I allows
Pi to dissociate, 2) switch-II moves to allow release. Arguments have been made
supporting both pathways.12 Initially it appears that switch-II movement would first
require the lever arm to undergo the working stroke; however, it has also been argued

that this may not be the case.12 In any case, the evidence presented in these studies is
based on possible structural states of the myosin, but it has been impossible to
determine which, if any, of these states are relevant for an actively cycling myosin.

1.5.5.

Potential Reconciliation

There are at least three possible ways to reconcile the myosin V data from
Rosenfeld and Sweeney with that of earlier studies in sarcomeric myosins suggesting
that the power stroke precedes phosphate release. The first is that myosin II and myosin
V have different mechanisms. While kinetic tuning is clearly different between various
myosin isoforms, a difference in the order of the basic mechano-biochemical cycle would
be surprising, although not inconceivable.
The relationship between the binding state of actomyosin and phosphate release
could provide a plausible explanation for why phosphate release might occur at different
points in muscle myosin and myosin V. For myosin V, it is very important for at least one
head to be bound to the actin at any given time so that the dimer does not dissociate
from the track. In this case, transitioning to a stronger binding state (via phosphate
release) before the power stroke may help to improve the processivity of the myosin. In
muscle however, hundreds of myosin molecules compose the thick filament that acts as
a unit, and it may be more efficient for each myosin head to stay weakly bound to actin
until it has completed its power stroke so that it does not hold back the motion of the
filament as other heads go through their cycle.
A second explanation is that the energy barrier for the working stroke is very
close to the pre-working stroke state. This would mean that the force dependence of this
step is very small, and the intramolecular strain present between the two heads would
have very little effect on the rate of the transition. The conclusion from Rosenfeld and

Sweeny placing phosphate release before the stroke assumed that the stroke would be
strongly force dependent. However, it is not required that the strain dependence of ADP
release and that of the working stroke are similar to each other.
The third possibility is that the working stroke does precede phosphate release,
but that the rate of the power stroke is fast enough so that it is not rate limiting, even
under load. This explanation is supported by some more recent work from several group
which have been made possible using novel spectroscopic and optical trapping
methods.

1.5.6.

Recent Studies

Such studies from Muretta et al. have used time resolved, transient, fluorescence
energy transfer (TR2FRET) to directly measure the rate of conformational change in the
motor domain, which the authors associated with the power stroke in several myosin
isoforms.67–70 They found the rate of this change to be greater than 200 s-1 in fast
skeletal myosin, significantly more than phosphate release measured at 37 s-1.70 Using
the same technique, a similar result was found for myosin V, which showed a stroke rate
of >250 s-1 compared to phosphate release rates at 97 s-1.67 Another 2013 study from
Capitanio et al.71 utilized a novel optical trapping technique to detect the time between
actin binding and the power stroke in fast skeletal myosin. They found that even under
3.2 pN of resistance, the power stroke occurred in under 0.5 ms, corresponding to a rate
of >2000 s-1.71 These recent results, especially measurements of myosin V’s rapid stroke
rate (fast enough not to be rate limiting), offer a plausible explanation for the
observations of Rosenfeld and Sweeney, which remain consistent with the power stroke
occurring before phosphate release.

While this recent evidence seems convincing that the results presented by
Rosenfeld and Sweeney may in fact be consistent with the power stroke occurring
before phosphate release, work from Caremani et al. makes the claim that phosphate
release is not tightly coupled to the working stroke at all.30,36 They based this conclusion
on isotonic (constant force) muscle fiber experiments where muscle fibers experienced a
perturbation through a rapid decrease in tension. They performed these experiments at
various free phosphate concentrations and fit the transient responses to a complex
model based on several assumptions. The large number of free parameters present in
their model makes it unsurprising that they are able to fit the data well. However, the
idea of the mechanics and biochemistry being potentially uncoupled has risen to higher
prominence since their work and has been used for interpreting various perturbations to
myosin’s typical function.23,58,68

1.5.7.

Unanswered Questions

In order to resolve this long-standing question in the field, a method that can
observe the transition from the pre-working stroke to post-working stroke state is
necessary. Although the FRET studies presented by Muretta et al showed that a
conformational change in the lever arm took place before phosphate release, these
measurements are unable to monitor the generation of force or actual displacement of
actin, and it could be argued that the structural change they characterized did not
correspond to the true working stroke. Current optical trapping techniques are able to
observe the size of the working stroke in single molecules, but until recently were not
able to measure the time between actin binding and the working stroke.71 We have
aimed to better understand the mechanical and biochemical transitions which occur
immediately upon actin association by performing experiments with added phosphate in

solution using the ultra-fast force clamp (UFFC) technique from Capitano et al.,71 and
measuring the length of time between actin binding and the power stroke. Such a
technique (described more fully in Chapter 2) allows the resolution of short-lived
attachments that precede the working stroke, which can provide more details about the
key interactions and kinetics of the conversion of biochemical energy into mechanical
work.
Human, beta-cardiac myosin is an ideal myosin isoform with which to perform
such experiments due to its previous characterization, close relationship with fastskeletal myosin, and its importance in human health and disease.

1.6. Cardiac Myosin
1.6.1. Biochemical and Mechanical Characterization
Beta-cardiac myosin is a member of the myosin II super family and is similar in
overall structure and function to skeletal myosin II. The polypeptide chain of beta-cardiac
myosin is the same as the myosin that is found in slow-twitch skeletal muscles fibers
(such as those found in the diaphragm), but the light chains that are expressed and bind
in the heart differ.72 This slow isoform of cardiac myosin (there also exists a faster
isoform) is the primary myosin found in the ventricles of humans and other large
mammals.73
Because of the vital role that the cardiac muscle plays, beta cardiac myosin is
one of the most well-characterized isoforms of myosin.74,75 There was early kinetic
characterization of the biochemical cycle of bovine cardiac myosin starting in 1984.76
More recently, porcine cardiac myosin77 and then human forms have been biochemically
characterized78 as recombinantly expressed human cardiac myosin can now be purified
for study.79,80 These studies have revealed that the biochemical cycle is very similar to

that of fast skeletal myosin, but the rates of key steps, specifically overall ATPase
activity and ADP release (this limits the time spent attached to actin) are ~10 fold
slower.78,81 This slower cycle is still much faster than many of the non-conventional
myosins such as myosin V82 or myosin I,22 and makes cardiac myosin a very suitable
isoform for studying the fast mechanical steps of a sarcomeric muscle myosin.
Optical trapping studies of beta cardiac myosin have established that, similar to
other myosins,25,83 it has a two-step working stroke, with an initial step of about 4 nm
followed by a 1.5 nm sub-step.26 The rate of this first step has not been measured
mechanically because it likely occurs within a few milliseconds of actin binding, but is
associated with Pi release. The second step has been measured to occur at around 5070s-1, which matches well with the measured ADP release rate.26,27,77 The ADP release
rate, and presumably its associated mechanical step, have been shown to be force
dependent, with resisting loads slowing the rate.27,84
Cardiac myosin has also been previously characterized with regard to whether
phosphate release occurs before or after the working stroke. Experiments with cardiac
muscle fibers and caged phosphate that mirrors those of Dantzig et al.47 discussed
above have yielded data consistent with Pi release occurring after the stroke.44 In
addition, experiments using FRET probes and time resolved spectroscopy like those
described above have been applied to cardiac myosin.68 However the results from these
studies have not been as convincing, since they report only a 25% slower rate for Pi
release than the lever arm motion (11.6 s-1 vs. 15.5 s-1), both of which are surprisingly
slower than similar measurements for myosin V.67,68 Thus, the question of when
phosphate is released is still an open question in cardiac myosin, and one that is of
relevant given the physiological and pathological function of cardiac myosin.

1.6.2.

Ischemia, Heart Failure, and Cardiac Therapeutics

In coronary artery disease, heart tissue can often experience a state of ischemia
when there is inadequate blood flow to the heart tissue. One effect of this is to inhibit the
production of ATP, and cause a buildup of various metabolites, including inorganic
phosphate.42,85,86 This accumulation of phosphate is one of the contributing factors to the
decrease in force production and cardiac output that occurs in these patients.46,47,87 Thus
the phosphate release step and its reversibility have health consequences for a large
portion of the population.
Because of the advances in the understanding of myosin and muscle biology,
myosin has recently become the target of drug discovery for the treatment of a variety of
muscle diseases, including heart failure. There is a large variety of causes and
presentations of heart failure, but in systolic heart failure, the heart is unable to pump
enough blood because of its inability to fully contract during systole. The existing
therapies for this disease have either targeted the signaling pathways upstream of
contraction (leading to off-target effects), or have sought to treat downstream symptoms.
88,89

The limitations of these treatments have spurred the development of a cardiac
myosin specific “activator”, called omecamtiv mecarbil (OM), which binds to cardiac
myosin directly and results in an increase in the force production and cardiac output in
patients.88,90 The original proposed mechanism for this action was that OM speeds up
the phosphate release step and thus leads to more myosins in a state in which they are
strongly bound to actin. However, subsequent studies observed seemingly inhibitory
effects of OM in various in vitro systems, calling the proposed mechanism into
question.77,91,92 Since the increase in the phosphate release rate has been verified by

multiple groups, this drug offers an interesting perturbation to probe how the phosphate
release step is coupled to force generation and how that coupling can be changed.
Since the phosphate release step of cardiac myosin has such a significant role in
several very common ailments yet is still not completely understood, cardiac myosin is
an ideal candidate for studies of how myosin efficiently uses the biochemical energy
expended by phosphate release to perform mechanical work.

CHAPTER 2 – Optical Trapping Methods for
Studying Myosin Motors

Portions of this chapter have been adapted from:
Electro-optic deflectors deliver advantages over acousto-optical deflectors in a high
resolution, ultra-fast force-clamp optical trap. Woody, M. S., Capitanio, M., Ostap, E. M.
& Goldman, Y. E. Opt. Express, OE 26, 11181–11193 (2018)
and
An ultra-fast EOD-based force-clamp detects rapid biomechanical transitions. Woody, M.
S., Capitanio, M., Ostap, E. M. & Goldman, Y. E. in 10347, 103470Q (International
Society for Optics and Photonics, 2017).
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2.1. Optical Trapping
Optical traps, also known as laser tweezers, can trap and exert forces on a
dielectric particle, such as a 0.2 – 2 µm spherical polymer bead, as a focused laser
beam passes through the object. These forces act to pull the particle toward the beam
center with a spring-like force proportional to the displacement of the bead from the trap
center. This phenomenon has been widely used in both biology and physics93 and the
Nobel prize was recently awarded to Arthur Ashkin in 2018 for his development of optical
trapping technologies.
There are two simple ways to consider how light is able to exert forces in an
optical trap: ray tracing and diffraction theory. The ray tracing explanation outlined is
instructive, even though it does not strictly apply when the diameters of the beads being
trapped are near or less than the wavelength of the laser.94

Figure 2.1 Ray diagram explanation of the restoring force on a bead in an optical trap. Original Caption:
“Qualitative view of the trapping of dielectric spheres. The refraction of a typical pair of rays a and b of
the trapping beam gives forces Fa and Fb whose vector sum F is always restoring for axial and transverse
displacements of the sphere from the trap focus f.”. Adapted from Ashkin, 199294 with permission
ℎ

Light has momentum, as given by the equation 𝑝 = 𝜆 , where h is Planck’s
constant and λ is the wavelength of the light. When a focused beam of light passes
through a sphere, it will reflect and refract at each interface. Each time the direction of

the light is changed by the sphere, the momentum of the light is changed. To cause this
change in momentum, the sphere must exert a force on the light, which, by Newton’s 3rd
law, implies that the light is exerting an equal and opposite force on the sphere. This
force is shown in Figure 2.1, for a highly focused beam for three situations: A) the bead
located below the focus of the beam, B) the bead located above the focus, and C) The
bead displaced horizontally from the focus. In each case, the net force on the bead is
directed to restore the bead to the trap’s center.
The phenomenon described by this classical optics explanation is also consistent
with more complex optical and even quantum mechanical treatments.95 An alternative,
yet simple, way to understand the origin of trapping forces comes from treating the bead,
and the atoms in the bead, as inducible dipoles. When the bead is present in the
focused gaussian-shaped beam, the electric field of the light induces a dipole in the
bead. The energy of this dipole is minimized when it is aligned with a strong electric field.
Since electric field is highest in the center of the beam, the gradient of the field will cause
the bead to move to the center position in order to minimize the energy of its dipole
moment. Because the oscillations of the electric field are slower than the typical
resonance frequency of the bead itself, the bead dipole remains aligned with the field as
it oscillates.
Practical measurements show that, regardless of explanation, beads in an optical
trap experience a stiffness in the transverse directions that can range from <0.01 to >1.0
pN/nm depending on bead size and laser power (with significantly less stiffness in the
longitudinal direction).93 This, powerful, simple, and easy to understand result, along
with the relatively simple optics needed to build a basic optical trap (High NA objectives,
a 1064nm laser, and a quadrant photodiode), has made this method very popular in the
scientific community and in teaching labs over the past few decades.

It is possible to measure the forces exerted on the beads in an optical trap by
either direct force detection using scattered light from the trapping beam or by
independently monitoring the displacement between the trap center and the bead center.
If this distance and the trap’s effective stiffness are known, the force on the bead is
readily determined through Hooke’s Law.96 Direct force measurements are carried out by
observing the interference pattern of the scattered light at the back focal plane of a
condenser lens positioned to collect the laser light that has passed through the trapped
particle.97 If displacement measurements are employed along with the trap stiffness, the
beads position can be monitored at low time resolution using a camera, or by observing
interference pattern of scattered light from a separate beam. The interference pattern
from either the trapping laser (direct force mode) or separate tracking beam
(displacement mode) has two important, but non-obvious properties. 1) It depends on
only the relative displacement of the bead from the beam waist and 2) the pattern shifts
in position linearly (over the relevant range), as the bead position changes. This pattern
is most often detected by a quadrant photodiode (QPD) which provides information with
a very high spatial and temporal resolution about the force on or position of the bead.
There have been a wide variety of experimental configurations of optical trapping
to study diverse biological systems. Figure 2.2 shows two general modes of optical
trapping. The most basic is the single trap, in which single beam waist is held in a
constant position (Figure 2.2a). A bead is often attached to a biological molecule of
interest in conditions in which it can produce force on the bead. As force is produced, the
bead is pulled from the trap center and the restoring force on the bead increases as the
excursion from the trap increases.98 Eventually the force may increase to the point
where the molecule can no longer advance, known as the stall force. This technique is
limited since the experimenter cannot directly control the forces being studied and the

observed force dependent directly on the displacement caused by the system of interest.
Feedback systems (described more fully below) can be applied to this single trap
geometry to allow precise control of the force during an experiment.

Figure 2.2 Two modes of optical trapping. a) Single bead with a single trap often used to study processive
motor proteins. b) Three bead assay with two trapped beads and one pedestal bead, often used to study
transient interaction including those from non-processive myosin motors. A designates the molecule of
interest on the pedestal bead and B shows the track on which the molecule can act. Adapted from
Capitanio et al. 2012 with permission.71

A more sophisticated method of optical trapping, known as a three bead assay
(Figure 2.2b), has been employed to study molecular motors that are not processive
(those that cannot take multiple steps on a track without detaching).54 Two optical traps
are used to hold a filament (B in Figure 2.2b, often actin or a microtubule) suspended
between two beads in order to position the filament over a third bead that contains the
motor being studied (A in Figure 2.2b). The motor transiently attaches to the filament
and may displace it before detaching. This geometry can also make use of feedback
system for more precise control, as discussed extensively below.

2.2. Optical Trapping Feedback Systems
Because the position of the bead and the force exerted on it typically follow a
linear relationship, it is useful to use a feedback mechanism to isolate the effects of force
and movement on the instrument and the biological system. Such feedback systems
operate to either hold the force or bead position constant. While there are many ways to
implement these types of feedback systems, they generally start by real-time monitoring

of the bead position or force. A feedback loop is used to control the position of the trap
with respect to the molecule of interest, which is often attached to the coverslip. Position
modulation can be accomplished either by moving the microscope stage or by
modulating the position of the trapping beam within the observation chamber using
various beam steering techniques (see 2.2.3).

2.2.1.

Optical Trap Force Clamps

In force clamp systems, the goal is to maintain a constant force on the system
being studied, even as motions in the system occur. There has been limited use of
“passive” force clamp systems to study changes in molecular extension in a dual beam
optical trap. This approach utilize the non-linear regime of trap stiffness when the bead is
displaced far from the trap to keep the force constant during small motions.99 However,
most force clamps are active, and maintaining a constant force is accomplished through
moving the stage or the traps such that the separation between the center of the trap
and the trapped bead is held constant. This type of system has been used to study the
properties of processive cytoskeletal motors under load, to see how force affects their
velocity or run lengths.98,100 In these systems, the feedback loop must be engaged after
the molecule of interest begins its interaction, otherwise the force applied to the bead will
quickly move the bead out of the desired area of the experiment. This has previously
limited the ability of studying short-lived, transient interactions with a force clamp system.
The ultra-fast force clamp system introduced by Marco Capitanio and coworkers in 2012
and described further in section 2.3, resolves this limitation.71

2.2.2.

Isometric Feedback or Position Clamps

Feedback mechanisms can also be used to maintain a constant position of the
trapped beads while monitoring changes in the force generated by the molecule being

studied. This position-clamp regime is also referred to as isometric feedback. One
application of this type of feedback used the three-bead geometry to study the force
dependence of non-processive myosin motors as they interact with actin filaments. In
such experiments, one bead is designated the transducer bead and the position signal
from this bead reports the position of the actin filament. The other bead, coupled to the
opposite end of the filament, is termed the motor bead, and its position is modulated to
maintain the position of the actin filament as reported by the transducer. When myosin
interacts with the actin filament and causes a displacement to be measured by the
transducer, the motor bead’s trap position is moved in the opposite direction by the
feedback loop, increasing the force on the motor bead until the filament is pulled back to
its original position.56
This system allows high forces to be exerted on the myosin (or other motor) with
relatively low trap stiffness. The size of the applied force depends primarily on the stroke
size of the molecule and its molecular stiffness. By recording the average force
experienced during an interaction and the duration of the interaction, it is possible to
probe the force dependence of the attachment lifetime. Such studies have been
performed for several myosin isoforms, and have revealed that various steps in the
biochemical cycle of myosin display vastly different force dependencies across
isoforms.23,24,28,84 The results from these isometric experiments agree well with results
from alternative methods used to determine force dependence of short-lived
interactions.27,101
The time that it takes for the feedback to respond to the displacement of the
filament determines which mecho-chemical steps can be probed by this method. For
example, Takagi et al. found that by using a short response time of the isometric
feedback loop of about 1 ms they were able to see examples of myosin’s working stroke

being reversed by the applied load.56 However, when the response time was lengthened,
they found that the stroke could no longer be reversed and had been ‘locked in’ by some
process.

2.2.3.

Beam Steering in Optical Trapping

The trap position can be controlled by altering the angular deflection of the
incoming beam at a point that is conjugate to the back focal plane of the microscope
objective. This method results in a change of the angle of entry into the objective and a
concomitant change in the trap position at the sample. The angular deflection can be
induced by using a mirror controlled by a piezo element, galvanometer, or stepper
motor. Mirror-based methods can offer a very large deflection range (up to 15 degrees)
but are limited by a relatively slow response time (>100 µs). Acousto-optical deflectors
(AODs) are widely used because of their fast response time (< 50 µs), and moderate
deflection angle, e.g. 30 mrad (1.7 degrees). Electro-optical deflectors (EODs) have a
smaller deflection range of only 3 mrad (0.17 degrees), but offer superior beam
transmission and more uniform modulation of the beam angle, along with a faster
response time (2 µs).102 Spatial light modulator have also been employed, which can
modulate the phase of the beam to produce multiple optical traps from one beam and to
vary the position of these traps.103 This approach is also limited by a slow response time,
on the order of several milliseconds. The characteristics of the beam positioning
approach combined with the resolution and response time of position/force detection and
the feedback electronics will determine the effectiveness and limitations of the feedback
system.

2.3. Ultra-fast Force-clamp Optical Trapping
In order to further investigate the rapid interactions that occur immediately after
myosin and actin associate, we have worked to implement and improve a force-clamp,
three-bead optical trap feedback system which can detect the timing, amplitude, and
force dependence of the myosin working stroke under constant, programmable load with
sub-millisecond resolution. Similar systems have previously been applied to the study of
myosin,71 DNA-binding proteins,104 and microtubule binding proteins.105

2.3.1.

Ultra-fast Force-clamp Concept

A dual beam, force-clamp optical trapping system described by Capitanio et al.71
is capable of independently maintaining a constant force on each bead in a bead-actinbead dumbbell while the dumbbell position changes within a spatial range of several
hundred nanometers. The system modulates the positions of the traps to maintain a
constant force on each bead as detected by backplane interferometry of the trapping
laser light scattered by the beads.
During an experiment, an actin dumbbell is brought close to a myosin molecule
on the surface of a pedestal bead affixed to a glass coverslip (Figure 2.3). The actin
dumbbell is pre-stretched by approximately 5 pN of tension (-Fpre and Fpre) from both
beads which limits the mechanical compliance of the assembly (Figure 2.3A). The
feedback system is activated and the force setpoint for the right bead is changed from
Fpre to Fpre + F (Figure 2.3B). The system quickly applies this excess force to the right
bead by moving the position of the trap, resulting in an unbalanced force on the
dumbbell assembly. The dumbbell then moves rightward at a constant velocity such that
the excess force applied to the right bead is balanced by the force of hydrodynamic drag
on the moving dumbbell. During this motion, the forces on both beads are maintained at

their constant setpoints (-Fpre and Fpre + F) by the feedback loops. The dumbbell
continues to travel at this constant velocity until the traps have moved a specified
distance (~100 nm), at which point the setpoint for each bead is triggered to change to Fpre - F and Fpre, switching the excess force to the left bead in the opposite direction, and
leading to a constant velocity in the opposite direction (Figure 2.3C).

Figure 2.3 Illustration of the sequence of events in the ultra-fast force clamp method. Changes between
each frame are highlighted in yellow. A) An actin dumbbell is held under pretension load by two optical
traps which can be independently controlled via force-feedback loops and beam steering devices (either
AODs or EODs). B). The setpoint of the feedback loop for one bead (right) is increased by F, which causes a
force to be exerted to the right, resulting in the motion of the dumbbell at a constant velocity (v) which
creates hydrodynamic drag on the dumbbell that matches the applied force, F. The feedback loops work
to maintain a constant force on both beads during the dumbbell’s motion. C) After a set excursion
distance, the force setpoints are changed for both beads, with the applied force, F, now being applied to
the left bead in the opposite direction. This results in motion of the dumbbell in the opposite direction.
D)This cycle repeats until the myosin interacts with the actin filament, at which point the force is quickly
transferred from hydrodynamic drag to the myosin molecule and the dumbbell’s motion stops within ~3050 microseconds. This allows precise detection of the attachment time and the ability to study myosin
under set loads from the beginning of its interaction with actin.

The applied force and direction of motion continue to alternate back and forth
until the myosin interacts with the actin filament, at which point the force of the
hydrodynamic drag is quickly (within ~10s of µs) transferred to the myosin molecule,

which becomes loaded with the excess force, F or -F. This transfer of force abruptly
stops the dumbbell’s motion, while the total forces on both beads are maintained
constant by the feedback system (Figure 2.3D). While the myosin interacts with actin,
the force applied to it is held constant, and the motion of the actin filament is recorded
from the position of the two traps. Thus, the force-producing displacement of the power
stroke can be observed under various pre-determined loads. When the myosin
dissociates from actin, the dumbbell continues its earlier motion, the excess force is
transferred back to hydrodynamic drag (Figure 2.3, panel B or C). In a single 30 s long
recording, the actin dumbbell switches its direction of travel thousands of times and
myosin attaches to actin in dozens of interactions, depending on the particular myosin
isoform and various experimental parameters.
This experimental approach conveys at least three main advantages over other
optical trapping techniques that have been used for examining biomolecular interactions
such as myosin with actin. First, very short interactions between myosin and actin can
be observed since these events can be detected after the experiment is completed by
analyzing the velocity of the actin dumbbell, whose motion stops and starts very quickly
and abruptly at the beginning and end of each interaction. This event detection method
allows events less than 1 millisecond to be identified, which is approximately an order of
magnitude improvement over the 5 - 10 ms limit for previous event detection methods
such as analysis of variance of the bead positions or covariance between the two
beads.71 Second, the moment of the beginning of the interaction between actin and
myosin can be localized to within 100 µs, and the subsequent power stroke can be
monitored to provide the precise timing between actin binding and force-bearing
displacements generated by the motor protein. Finally, this force-clamp system applies a
constant load to the actin-myosin interaction throughout the entire interaction, most

importantly before and during the stroke. This enables determination of the force
dependence of the primary power stroke, which has eluded previous studies.

2.3.2.

Ultra-fast Force-clamp Optical Trapping Implementation

To implement the ultra-fast force-clamp method, four key components are
required: 1) a stable dual beam optical trap setup, 2) high bandwidth force detection
electronics, 3) a high-speed feedback control system, and 4) low-latency, high precision
beam steering.
Our optical trap setup adopts many of the widely used practices for maintaining
mechanical stability and low optical fluctuations including a stiff, pneumatically isolated
optical table, high quality optical component mounts, isolated and limited acoustical
noise from instrument fans, and an enclosed beam path to minimize beam fluctuations
due to air currents. Additionally, to correct for sample drift, we use active 3-dimensional
stage-stabilization via a feedback loop and a nano-positioning piezo stage (Mad City
Labs, Inc.) to maintain the position of the myosin-adsorbed pedestal bead at the
coverslip.106
The response time of the force-clamp feedback loop must be very rapid (≤ 10 µs)
to investigate the myosin power stroke, as it must maintain constant forces on both
beads while the actin dumbbell is in motion. For a typical dumbbell made of two 500 nm
diameter polystyrene beads and a ~10 µm actin filament, a 2 pN applied force is
balanced by hydrodynamic drag at a dumbbell velocity of ~100 nm/ms. During 0.2 ms of
dumbbell motion at 100 nm/ms, the dumbbell travels 20 nm and, with trap stiffness equal
to 0.05 pN/nm, the force on the dumbbell would decrease by 1 pN if the trap position
were not updated. To stably maintain the mean force on the beads to within 10% of the
set points under these conditions, we found it necessary to keep the feedback loop

update rate less than 10 µs, which includes the time to 1) detect the instantaneous force
on the beads, 2) perform the feedback calculations, and 3) update the position of the
trapping beam. We optimized each of these three components of the setup to reach the
10 µs loop time.
The force on each bead is monitored by back-focal plane interferometry of the
1064 nm trapping laser on two silicon quadrant photodiodes (QPDs) with an active area
of 12.5 mm2 for each quadrant (JQ-50P, Electro Optical Components Inc.). The time
response of these QPDs for 1064 nm laser light is much slower than the 0.4 µs rise time
specified at 850 nm due to the increased penetration of the light through the depletion
layer of the detector, as has been previously described.107 To counter this effect, a
reverse bias voltage of 180 V is applied to the common cathode of the QPD. This is
greater than the rated bias voltage of 20 V but has not caused damage to the
photodiodes over several years of use and improves the response time at 1064 nm from
20 µs to approximately 1 µs. The custom-built amplifier circuit, which adds and
subtracts the signals from each quadrant detector, includes first order low-pass filters at
125 kHz, the Nyquist frequency for a 250 kHz acquisition rate, giving a rise time for the
force detection system of about 2 µs.
We utilize a National Instruments Multifunction I/O device (PXI-7851) equipped
with a Field Programmable Gate Array (FPGA) to perform the calculations, based on the
QPD signals and the force setpoint, to update the control signal for the beam deflectors.
This FPGA device digitizes analog input signals at up to 750 kHz, outputs analog control
signals at 1 MHz, and reads and writes digital registers at 40 MHz. The FPGA is
programmed in LabVIEW (National Instruments, Inc.) to perform the proportional or
integral feedback calculations and to automatically switch the setpoint of each trap to
reverse the direction of the dumbbell motion when the output signal reaches the limiting

excursion distance. The force set point, feedback gain, and excursion limits are easily
set within a custom-built LabVIEW virtual instrument (vi) which also controls data
acquisition, trap calibration, and other instrument functions. The feedback calculations
can operate up to 400 kHz, but in practice the feedback loop is operated at the same
rate as the data acquisition rate, 250 kHz, leading to the update time for the feedback
loop of 4 µs.
The control signal from the feedback calculations must move the position of the
beam in the sample chamber precisely and rapidly. Two methods of beam steering have
been utilized in our setup, acousto-optical deflectors (AODs) and electro optical
deflectors (EODs). Each of these deflector systems was optimized to reposition the
beam in less than 4 µs from the command signal input, allowing us to achieve the 10 µs
loop time (2 µs force detection + 4 µs feedback calculation + 4 µs beam steering).
This loop time is much faster than the trapped bead’s response time in solution
(~160 µs), as indicated from the power spectrum of bead displacement, which has a
corner frequency near 2 kHz. While it has previously been shown that a position-clamp
feedback loop running faster than the time response of the bead can increase the
effective trap stiffness,108 our feedback loop operates in the force-clamp mode. This
causes a decrease in the effective stiffness of the trap (since the trap follows the bead
rather than restraining it). The (reduced) effective stiffness in solution is not highly
relevant to the experiments as the primary interest is the dynamics of the actin filament
during interactions with myosin. In this situation, the effective stiffness of the entire
system becomes much greater than that of the trap, mostly due to the myosin’s stiffness
on the order of 1 pN/nm. Previous calculations have shown that this ultrafast system is
capable of detecting halting of the actin within 50 µs of myosin attachment under the

conditions of our experiments71 and subsequent displacements of the actin filament can
also be resolved within ~50 µs.

2.4. Acousto-optical Deflectors and Their Limitations
2.4.1.

Basic Principle and Response Time Limits

AODs contain a transparent crystal with a piezo-element at its end that produces
a radio frequency (RF) ultrasonic acoustic wave that travels across the crystal to the
incident optical beam. As laser light interacts with the compressions and rarefactions of
the acoustic waves, a portion of the beam energy (typically ~50-70%) is diffracted into a
deflected beam, where the wavelength of the ultrasonic waves sets the diffraction
angle109–111. Thus, the RF signal frequency modulates the diffraction angle of the beam.
By placing the AOD at a conjugate plane to the back focal plane (BFP) of the objective,
an angular change at the AOD produces a position change of the beam at the sample,
the focal plane of the objective.
The time response of a beam deflection system using AODs depends on the
response time of the RF frequency generator and the time for the ultrasonic wave to
travel across the optical beam. The RF generator used in our setup (64020-2002ADSDFS-A-2, Gooch and Housego/NEOS) accepts a 30-bit digital input to set the
frequency and has a response time of less than 250 ns.
The response time of the beam deflection after the RF signal changes depends
primarily on the speed of sound in the crystal and the size and position of the incident
beam relative to the piezo element. In our AODs (45035-3-6.5DEG-1.06 Gooch and
Housego/NEOS), the tellurium dioxide crystal has a sound velocity of 620 m/s112 and 1
cm length along its transverse axis. Thus, it takes ~16 µs for the acoustic wave with an
updated frequency to propagate across the entire crystal and about 10 µs for it to fill the

optical window. To minimize this delay, we reduce the beam diameter to ~2 mm and
position the beam very close to the piezo element. Reducing the beam size allows it to
be positioned to one side of the aperture without clipping and limits the time when it
encounters non-uniform wavelengths. With this approach, the response time of the AOD
beam steering system is reduced to 3 µs.

2.4.2.

Observed Artifacts in Feedback Experiments

While performing force-clamp experiments on myosin, we observed very rapid
(<1 ms) “jumps” in the trap position of 10 - 20 nm while the myosin was interacting with
the actin filament (Figure 2.4A). These jumps often were reversible, with the trap position
alternating between two positions many times during a single interaction lasting 10 ms
up to >100 ms. The sizes of the jumps varied between each interaction and experiment,
but within one actin-myosin binding event they were relatively constant in size and
frequency. To test whether these motions were an artifact caused by the feedback
system, we performed a control experiment replacing the myosin in the assay with
alpha-actinin, a non-catalytic actin binding protein that should not displace actin during
its interaction. In these experiments, we also observed fluctuations of our trap position
with a similar 10 - 20 nm deflection, strongly suggesting these were experimental
artifacts (Figure 2.4B). As an additional control, we centered the laser over a large 2.5
µm diameter bead firmly attached by nitrocellulose to the surface of the coverslip. We
engaged the force-clamp and observed the trap position. Similar fluctuations of the trap
position were observed depending on the initial AOD deflection (Figure 2.4C). Such
fluctuations severely compromise measuring the 5 - 10 nm actin displacements
expected to be produced by myosin.

Figure 2.4 A) Example of artifactual ~20 nm jumps in the dumbbell position during an interaction between
myosin and the actin filament while the force-clamp is engaged using AOD beam steering. Jumps are
marked by red arrows. B) A control experiment replacing myosin with alpha-actinin, which interacts with
actin but is not expected to cause displacements. Similar jumps of 15 nm are marked (red arrows). C)
Another control experiment placed the trapping laser over a pedestal bead stuck firmly to the surface and
engaged the force-clamp feedback. Although the time scale of the feedback loop was different here,
artifactual ~10 nm jumps of the trap position were observed.

2.4.3. Non-uniformities in AOD Beam Deflection Due to Standing Acoustic
Waves
We determined that the source of the artefactual jumps in trap position were due
to non-uniform deflection of the beam by the AODs. It was reported previously that
beams deflected by AODs can exhibit “wiggles”, which were shown to cause the position
of a trapped bead, as measured by an independent tracking laser, to move with quasiperiodic variations from a linear path when the AOD RF frequency was linearly swept.109
In our setup the force is directly measured via scattering of the trapping laser without an
independent position tracking beam. These non-linear effects present differently in this
situation. We measured the non-uniform deflection by sweeping the beam position in the
chamber, without a bead present, and monitored the differential QPD signal that usually
indicates the force in the sweeping direction. This signal should remain quite constant as
the beam position is swept, because the QPD is at a plane conjugate to the back focal
planes of the objective and condenser lenses, where positional displacements at the
sample are converted into angular changes. Periodic fluctuations corresponding to a ~20
nm period at the sample were recorded in the QPD signals as the beam was swept
(Figure 2.5A, red trace). This distance corresponds to a change of ~30 kHz in frequency

of the AOD RF signal input. Similar fluctuations in the total beam intensity were also
observed (Figure 2.5B, red). When we damped the intensity variation by a feedback
system controlling the RF signal amplitude (Figure 2.5B, blue), the fluctuations in the
QPD “force” signal remained (Figure 2.5A, blue). Over the entire 25 m range of the
AOD’s beam deflection at the sample, certain positions/RF frequencies exhibited smaller
or larger variations (Figure 2.5C).

Figure 2.5 A) Example of variations in the force signal observed with the AOD beam steering system as a
function of beam position. The y-axis shows the differential voltage from the QPD as the trap position
was scanned in the chamber without any trapped bead. Similar variations were seen when the bead was
present, but were visually masked by Brownian motions. The variations are shown without (red) and with
(blue) intensity-maintaining feedback. The two signals overlay nearly perfectly, and are displayed with an
offset for clarity. B) The total intensity of the light reaching the QPD also varies with a similar periodicity
(RF frequency in B corresponds directly to position plotted in panel A). Using an independent feedback
loop to maintain a constant total QPD illumination kept the light intensity at the QPD constant (B, blue),
but did not eliminate the variations in force signals. C) The standard deviations of the fluctuations over a
100 nm window were calculated over the entire 25 fm deflection range of the AOD. Some positions
(corresponding to particular RF frequencies) exhibited much larger variations in the recorded force signal
than the average. The y-axis scale in C is approximately in pN using typical experimental calibrations.

The periodicity of these fluctuations matches that expected from standing waves
in the crystal. Such a standing wave can arise from partial reflection of the acoustic wave
from the far face of the crystal which interferes with the original wave, leading to a small
amplitude of non-propagating nodes and internodes. The crystal is thus a weak
resonator (low quality factor, Q) with resonant peaks at frequencies giving integral

numbers of wavelengths in the crystal. The inverse of the round-trip time of the acoustic
wave in the crystal is approximately 32.2 µs, giving an expected periodicity of 31 kHz for
the applied RF signal, closely matching our observations. When the input RF frequency
was swept across 20 kHz of RF variation at a very high rate (1 sweep per ms or faster),
the pattern of the force signal variations was disrupted. At such fast RF update rates, the
frequency of the acoustic wave in the crystal does not remain constant long enough for
the reflected wave to interfere coherently and produce the standing wave.
Besides previously published reports of these deflection variations occurring in
several brands of AODs,109 we have also tested four brands of AODs of various models
and ages and have found that such non-linearities existed in all of them. Their
magnitude and spacing seemed to depend on many factors such as the model and
service age of deflector.
The effects of the standing waves could be visualized by imaging the beam at the
AOD crystal.111 We expanded the beam from its typical 2 mm diameter to about 4 mm
and projected an image of the 1064 nm light at the AOD crystal through neutral density
filters onto a CCD camera. The beam profile was recorded while linearly sweeping the
applied RF frequency 100 kHz over a period of 10 s, acquiring images at 10 frames per
second. We flattened the image and enhanced the contrast to better visualize changes
in the beam during the sweep. Large variations in the overall intensity of the beam as
well as localized fluctuations were detected. The overall fluctuations varied with a
periodicity of ~30 kHz, in agreement with the total QPD voltage fluctuations (Figure
2.6B). Wave-like variations are apparent that slowly move across the beam path as the
RF frequency changes, supporting the idea that standing waves are present (the ~35
MHz acoustic wave itself is not visible). If the intensity of each frame is scaled, so that
the total intensity of each frame is normalized, there are still local variations in the

intensity of the beam (Figure 2.6C). These fluctuations likely give rise to the artifactual
force signals we observed, even when the total intensity of the beam was held constant
by a feedback loop (Figure 2.5C). Variations in both the global and local intensities are
observed whether or not the images were flattened and contrast enhanced.

Figure 2.6. A) Snap shot from a video of a 1064 nm wavelength ~4 mm dia. beam at the face of the AOD
crystal. The applied RF signal was swept over a range of 100 kHz in 10 second period, corresponding to
about 75 nm of displacement at the microscope stage. The video rate is 10 frames per second. The
intensity of each frame has been normalized. Two regions of interest (ROI) were selected, shown in red
(ROI 1) and green (RO1 2). http://dx.doi.org/doi.number.goes.here. B) The original mean frame intensity
(blue) from the video of panel A shows an approximate periodicity of 25 kHz, corresponding to 20 nm at
the sample. The intensity-normalized video (orange) has a constant mean intensity, as expected. This
normalized video was used for analysis in panels C and D. C) The mean intensity in each ROI in the
normalized video shows pseudo-periodic fluctuations in its localized intensity with a similar period (25
kHz). The fluctuations in the different regions vary in amplitude and phase. D) The signal that would be
created from projecting the recorded images onto either a Quadrant Photodiode (QPD, blue) or a lateral
effect photodiode (LEP, red) were simulated to see if the variations mainly arose as fringes crossed the
quadrant boundary. The force signal varied for both types of detectors with similar periodicity, but with
somewhat different secondary characteristics.

We analyzed each frame of the video to simulate the signal that would be
generated by projecting the intensity-normalized image onto the quadrant photodiodes.
The plane of the AOD is conjugate to the QPD, so this simulated signal mimics the
conditions of Figure 2.5. Simulation of the QPD output was performed by dividing each
frame horizontally in half, summing the intensity from each half, and subtracting the two
sums. The simulation (Figure 2.6D) shows that the detected force signal on the
simulated QPD (red) fluctuates due to the regional variations in the light intensity at an

overall periodicity of 30 kHz, consistent with actual QPD recordings. Secondary,
apparently random variations in the calculated force signal are superimposed. To
investigate whether the observed deflections are due to the movement of fringes across
the centerline of the image (the simulated quadrant boundary of the QPD), we also
calculated the 1st moment of the image in the x dimension (blue), simulating the signal
from a lateral effect photodiode, which averages the beam position more faithfully than a
QPD. The overall variations remained, with only the smaller, secondary deflections
differing. This is consistent with observations using an actual lateral effect photodiode in
the experimental system that gave results very similar to the QPD (data not shown).

2.4.4.

Effect of Force Variations on Feedback Systems’ Response

To better understand how these variations in the detected force signal influence
force-clamp experiments, we performed Monte-Carlo simulations of a feedback system
acting to keep a constant force on a tethered bead undergoing Brownian motion (Figure
2.7). The detected error signal of the system was simulated by adding the error signal
arising from moving the trap relative to a fixed bead (yellow in panels A and C, the linear
force response of the trap) to the error signal arising solely from the non-linearities of the
AOD (blue), modeled as a sinusoid. The simulations were set to maintain zero load on
the bead (set point, purple lines in Figure 2.7A and C). Visualizing the observed error
signal of the system as a function of trap position under conditions similar to an
experiment (the sum of the yellow and blue curves, red in Figure 2.7A and C) shows that
there are multiple trap positions where the setpoint force would be observed (Figure
2.7C, intersections of red and purple lines). Brownian motions would cause the trap to
visit each of these positions while the feedback loop attempts to maintain a constant
force. The trap position is not stable at 0 nm, due to the reversed slope of the error

signal. However, the trap positions at -7 nm and +7 nm are stabilized by the feedback
loop. This was observed in the simulations of the trap position over time, where rapid
transitions between these stable positions were observed (Figure 2.7B).

Figure 2.7 A) Simulated error signals for a trapped bead undergoing Brownian motion. The total measured
error signal as a function of trap position (red) includes the Hookean (linear) trap potential (yellow) and
the imposed variations from the AOD (blue) modeled as a sinusoidal curve. Due to the influence of the
AOD force variations, there are two possible trap positions (-7 nm and +7 nm) where the force will be
stabilized at the set point (zero error signal, purple). B) Simulated trap positions for the potential in A
using parameters similar to our experiments. The trap position quickly jumps between the values where
the total measured force is equal to the set point (horizontal dashed lines show intercepts of red and
purple curves from A. C) A reduction in the amplitude of the variations and doubling of their spacing
changes the landscape of the measured error response (red), effectively reducing the loop gain. D)
Simulated trap positions from the potentials in C show that large jumps are no longer observed, but the
small AOD variations introduce added noise. E) A comparison of the simulated trap positions with the low
levels of non-linearity shown in Panel C (blue histogram) compared with simulated positions without nonlinearities (pink histogram). F) Simulated trap positions under feedback when only the trap’s potential is
present and non-linearities are absent.

The probability, timing, and size of these jumps depend on many of the
simulation parameters, including the relative position between the bead and the peaks of
the force variations. This situation, combined with the fact that the real non-linearities
vary considerably in their positions and amplitude across the AOD deflection range,
explains why the size and frequency of the jumps we observed in the experiments varied
widely among myosin binding events. We simulated a “better” AOD, where the

variations had half the amplitude and twice the spacing as found in our system (Figure
2.7C, D). This combination did not exhibit the drastic jumps in position because the
observed error signal crossed zero only once, but its sensitivity became lower (Figure
2.7C, red,), effectively reducing the loop gain and leading to increased noise in the trap
position (Figure 2.7D, E, blue), as compared to a simulation without any superimposed
AOD non-linearities (Figure 2.7E, F, pink).

2.5. Advantages of Electro-optical Deflectors
2.5.1. Principles, Time Response, and Previous Use of Electro-optical
Deflectors
An electro-optical crystal generates a linear refractive index gradient proportional
to an applied electric field. This gradient causes light propagating in it to be deflected
from its straight path through the crystal. When zero voltage is applied, the beam passes
straight through the device, simplifying alignment, and when the field is applied, all of the
light (except for small portions that are reflected or scattered) is deflected the same
amount. Because there is no traveling acoustic wave as is in an AOD, the response time
of an EOD is mainly limited by the driver applying the high voltage signal to the device,
which acts as a capacitive load. Our EODs (LTA-4 crystal, Conoptics) and high voltage
driver (Model 412, Conoptics) have a combined response time of about 1 µs, well within
the 4 µs requirement to maintain a total loop time <10 µs. This same EOD system has
previously been shown to work well in optical trap feedback systems, and not to exhibit
the non-linearities in deflection that are found in AODs.109

2.5.2.

Implementation of Ultra-fast Force Clamp with EODs

The reduced angular displacement of the EODs and the location of the effective
center of the deflection within the EOD device required special consideration in the

optical path design. EODs can deflect the beam up to 3 milliradians peak-to-peak, which
is ~10-fold less than the AODs. In our system this corresponds to several hundred
nanometers of trap translation at the sample, which is sufficient for our feedback
experiments. However, to form actin dumbbells from filaments of various lengths that are
pre-tensioned to 5 pN, >3 µm of beam travel is required. This is accomplished via a
remote-controlled gimbal mounted mirror (PM1 in Figure 2.8) placed at another plane
conjugate to the back focal plane (BFP) of the objective. Angular changes at this mirror
produce displacement at the sample.

Figure 2.8 A) Schematic of the optical trap setup including EODs. Dashed blue lines indicate conjugate
planes. L7 is necessary to create a conjugate plane at Picomotor Mirror 1 (PM1) to properly control the
position of EOD B’s beam relative to EOD A’s beam. A similar lens is included after EOD A to maintain
homogeneity between the beam paths. HWP A is necessary to rotate the polarization of the incoming
light to horizontal as required for deflection. A pair of lenses in front of each EOD (L4-L6, and L3-L5) acts
to reduce the beam diameter during transit through the EOD crystals. The layout was like that used with
the AODs, however without the lenses described above and slightly different positions of half waveplates
and other lenses. PBS: Polarizing Beam Splitter, M: Mirror, L: Lens, HV Amp: High voltage amplifier.

The center of deflection of the EOD, which needs to be conjugate to the BFP of
the objective, is located approximately 2 centimeters inside the 10 cm EOD device, as
measured from the exit aperture. To ensure both this center of deflection and the mirror
are conjugate to each other, a short focal length relay lens is used to image the center of
rotation of the EOD onto the mirror as a 4f relay system. While only one of the traps is

manipulated by this conjugate mirror, both traps contain corresponding relay lenses (L6
and L7 in Figure 2.8) to produce similar beam characteristics once they are recombined.

2.5.3.

Visualizing the Myosin Working Stroke with EOD-based Feedback

When the beam is carefully aligned inside the EODs, and all the conjugate
planes are properly positioned, the response of the QPD force signals as the beam
position is moved over a range of 700 nm is smooth (Figure 2.9A). The EODs do not
exhibit the variations and non-linearities detected from the AODs. It should be noted that
in our case, when the beam was larger or slightly misaligned so that even a small
amount of its power (1% - 5%) struck the edges of the 2 mm diameter crystals and/or
their electrodes, the effective position of beam imaged at the QPD was unstable.

Figure 2.9 A) Characterization of the deflection of the EODs as a function of trap position (green) shows a
uniform detected force signal on the QPD. The corresponding signal using AODs from Figure 2.5 is shown
offset at the same scale. B) An enlarged view of the EOD data from Panel A shows that there are no
detectable “wiggles” in the deflection of the beam by the EOD. C) The actin dumbbell’s position is shown
for the beginning of a single interaction between cardiac myosin and actin using the EOD-based forceclamp system. Red dashed lines guide the eye to the dumbbell’s motions. The dumbbell is traveling at a
constant velocity under feedback before it quickly stops at t = 1 ms. There is one clear displacement of
~10 nm at 2 ms and no other large fluctuations. A similar figure for the AOD-based system is shown in
Figure 2.4A without the initial motion of the filament at a constant velocity

The improvements in beam steering from the EODs enable experiments on
myosin to be accomplished without the artifactual jumps which had previously foiled

analyzing myosin’s power stroke. When we use the force clamp system with EODs, we
can observe the position of the actin dumbbell smoothing traveling under the feedback
system and coming to an abrupt and precise stop when the myosin interacts with actin.
In some of these interactions, we can clearly see single ~10 nm displacements of the
actin filament within a few milliseconds of binding, as expected for the cardiac myosin
isoform under study. The position of the dumbbell does not exhibit the fluctuations seen
in Figure 2.4A, and thus the power stroke of the myosin can be properly characterized.

2.6. Realtime Drift and Slope Correction
Although the EODs can provide a very flat ‘slope’ for the force as a function of
trap position when properly aligned (as shown in Figure 2.9A and B), there were still two
challenges with obtaining consistently accurate force measurements with this system.
The first was low-frequency (on the order of seconds) drift in the force signals
from each bead in the absence of load. This type of drift often is attributed to thermal
fluctuations.113 Despite our best efforts to reduce these types of fluctuations by enclosing
our beam paths, ensuring mechanical stability and isolation of all components, etc., we
still observed fluctuations that were up to 0.25 pN during a 30 second recording and
could exceed several pN over the course of an hour-long experiment.
The second challenge was that the slope of the force signal vs. trap position
(referred to as the EOD slope), was not consistently flat from day to day or even over the
course of an experiment. This could be related to small drifts in the positions of optical
components from the thermal drift issues above. Despite substantial efforts to stabilize
this slope, it would vary from one day to the next by up to 0.01 pN/nm, requiring
repeated realignment of key components each day to eliminate.

These fluctuations, although small by some standards, prevent the ultra-fast
feedback system from working effectively. In order to apply a 1.5 pN load to the actin,
each bead experiences a load 0.75 pN. An error due to 0.25 pN of signal drift, or more
substantially, up to 2 pN of error from the EOD slope over a 200 nm excursion distance,
make consistent measurements in this force regime impossible.

Figure 2.10 UFFC Realtime Drift and EOD slope correction (DSC) system. a) Relative unbound velocities of
one trap under 1.5 pN applied load from multiple sequential traces over 12 minutes without the real time
corrections (red) shows a 20% change in the velocity, while the DSC system results in <3% change in
velocity over the same period. b) Distributions of velocities from single traces when 1.5 pN of load are
applied (traces are from different days). The distribution without DSC is broader and has a lower unbound
velocity (red) than the DSC enabled trace (blue). c) Approximately 25 ms of raw force signals and position
signals when the DSC is engaged with a force set point of 4.5 pN. An upper and lower pause are indicated.
The equations to the right show the calculations to obtain the values plotted in d). d) Calculated drift and
EOD slope values for both traps over the full 30 second trace of c. e) The estimated real force and position
traces from the data in c with the pauses removed for further analysis.

The thermal drifts result in errors in the average applied forces which can be
seen by examining the mean velocity of the filament across multiple traces (Figure

2.10a, red) and the EOD slope results in a widening and reduction in the mean of the
velocity distributions (Figure 2.10b, red), leading to decreased experimental deadtimes.
To resolve these challenges and obtain accurate and reliable force signals, we
utilized a real time drift and slope correction (DSC) system which periodically pauses the
feedback system during an experiment to probe the true “zero load” (F0) signal values.
When the feedback system is paused, the trap positions are no longer updated and (if
no myosin interaction is occurring) the only force on the beads is from the pretension
applied to the filament. The force signals observed during each pause can be used to
re-zero the system and calculate the setpoint in the feedback system, by adding the
applied force to the recorded F0 level.
We implemented this system on the FPGA feedback controller such that every
20 ms the feedback signal pauses twice, first when the trap position reaches the top of
the set excursion distance, and then again when the trap position is at the bottom of the
set excursion (Figure 2.10c). Each pause lasts 3 ms, and the force signal from the last
2.5 ms (to allow time for the signal to settle) are averaged for each bead to provide an
estimate of the F0 signal. The estimates from the past 20 pauses are used in the
calculation of the setpoint signal. Using the estimates from either the top or bottom of the
excursion allows correction of the slow thermal drifts. Additionally, by using both the top
and bottom F0 values and the known excursion distance, the value of the EOD slope can
be calculated (Figure 2.10). This slope value can then be used in the FPGA to update
the setpoint value as the trap positions change in order to account for the slope in the
force signals. Examples of the drift offset and the calculated slope value over a 30
second trace are shown in Figure 2.10d.
When the data are analyzed after experiments, the recorded force signals can be
transformed into the actual force signals by using a similar algorithm in the analysis

software that was used in real time on the FPGA (Figure 2.10e) . When detecting and
characterizing binding events, only the forces and positions of the traps when the
feedback was not paused are processed.
This system has resulted in much greater reliability and consistency within and
across experiments. The mean velocities of actin motion no long drift over the course of
an experiment and the width of the velocity distributions are reduced (Figure 2.10 a,b,
blue). This allows experiments to be performed at lower forces with better experimental
deadtimes.

2.7. Conclusions
We have shown that using AODs for beam steering in a ultra-fast force clamp
optical trap system, where force is directly measured by deflections of the trapping laser,
can cause serious artifacts in the output signals. This builds on a previous report of a
similar effect in a system using a separate position tracking laser. While it was not
immediately obvious how the quasi-periodic variations in the deflected beam would
cause jumps in the feedback control signals, a combination of control experiments and
simulations, showed that they are the cause. The simulations emphasize that key
parameters such as the spacing and amplitude of the force non-linearities and the
stiffness of the trap have considerable qualitative and quantitative effects on a force
feedback system.
Thus, for some researchers using similar feedback systems with AODs, it is
possible such variations may introduce spurious and difficult to trace noise into their
experimental data. AOD devices are designed to reduce standing waves by including an
absorptive material on the crystal opposite of the piezo element, but it seems that the
specific design of the device and its service age may influence the amount of reflections.

For high precision force feedback experiments, researchers are recommended to test
their systems to check that deflection variations from standing waves do not lead to
artifacts in their experiments. Even if the effects do not manifest as large jumps in trap
positions, smaller non-linearities may be adding additional noise to a system, as shown
in Figure 2.7. If such effects are found, changes to experimental or device parameters,
or the use of EODs for beam steering may be advisable.
We have found that using EODs for beam steering has reduced the noise and
spurious jumps in our feedback signals which were masking the myosin power stroke
phenomenon we set out to study. Although their deflection range is smaller than AODs,
their faster time response and uniform deflection makes EODs more reliable for high
speed, high precision experiments requiring precise beam control. The drift and slope
correction (DSC) system allows for consistently accurate force measurements to be
made, which is imperative for the use of the ultra-fast force clamp system to operate at
low loads.

CHAPTER 3 – Ultra-fast Optical Trapping
Studies Show Myosin’s Rapid Working Stroke
Occurs Before Phosphate Release
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3.1. Abstract
Cardiac myosin is the molecular motor that powers contraction in the heart, using
energy stored in ATP to perform work as it displaces actin filaments. Key steps in
myosin’s mechanochemical cycle occur very rapidly after actin association, including
force generation and phosphate (Pi) release. We employed an ultra-fast force-clamp
optical trap to probe these processes under constant loads. We observe an initial, shortlived actomyosin state which can sustain loads of up to 4.5 pN for hundreds of
microseconds. We show that the observed rate of the working stroke could exceed 5000
s-1 at near physiological loads (3 pN). Free Pi in solution does not affect this rate but
allows the working stroke to be reversed. Thee data provide further evidence that the
working stroke occurs before Pi release in -cardiac myosin II. Overall, this study
provides the first direct mechanical measurements of myosin’s initial interaction with
actin and the steps leading to force production.

3.2. Introduction
Myosin is a cytoskeletal motor that uses metabolic energy stored in ATP to do
mechanical work. This process underlies muscle contraction, cell motility, and
intracellular transport. In muscle, myosin causes displacements of actin filaments
connected to work against an external load. The majority of the mechanical work done
by myosin is performed in the working stroke, the rotation of myosin’s lever arm domain,
which occurs soon after actin binding and is closely associated with the release of
inorganic phosphate (Pi), a product of ATP hydrolysis. Understanding the connections
between the formation of a force-bearing actin-bound state, the biochemical step of Pi
release, and the mechanical action of the working stroke are fundamental to
understanding energy transduction.

Figure 3.1 Myosin Biochemical Model and UFFC Example Traces a) Currently accepted mechano-chemical
model of acto-myosin interaction. Inset: Two possible models of when phosphate may be released during
myosin’s biochemical cycle. b) Applied forces from the ultra-fast force clamp feedback system set to apply
3.75 pN of load. Dashed line indicates zero force. c) Position of the actin filament as reported by the trap
position while being subject to the forces applied in b). Dashed boxes indicate regions containing myosin
binding events presented in panels d), and e). d) and e) The force on and position of the actin filament
during a myosin binding event under hindering (positive) load. f) Expanded section of panel f showing the
binding (red triangle) and dissociation (blue triangle) can be distinguished by the change in slope of the
position trace. g) Further expanded view of f) showing a displacement (green triangle) of approximately
10 nm occurring within about 1 ms of actin binding (red triangle).

Although substantial physiological and biophysical experiments have provided
key details associated with these transitions,114,115,46,116,47,44,117,56,69,118,68,37 controversy
remains regarding the order of the force-generating conformational transitions and
whether the free energy change from phosphate release precedes or follows the
working stroke (Figure 3.1a). Strengthening of the actomyosin bond due to

conformational changes in myosin and actin, tilting of the lever arm, and Pi release all
occur within milliseconds of initial actin binding, making the mechanochemical steps
difficult to resolve by commonly available biophysical measurements.
To detect the rapid sequence of events between actin binding and the working
stroke, we examined the interactions of recombinant human beta-cardiac myosin
(MHY7) with actin using the three-bead optical trapping geometry, where a bead-actinbead “dumbbell” assembly is brought near to a single myosin molecule attached to a
pedestal bead.54 We employed an ultra-fast force clamp (UFFC) which can resolve the
onset of actin-myosin binding events to within less than 100 microseconds and filament
motions at sub-nm resolution.71 Unlike standard optical trapping techniques which
typically have temporal resolutions > 10 ms, UFFC allows observation of the initial
myosin working stroke which can occur within 1 ms of actin binding.

3.3. Results
3.3.1.

Duration of Actomyosin Interactions Observed Under Load

UFFC uses a feedback loop to maintain a constant force on an actin filament
dumbbell by rapid (µs) control of the trapping laser position (Figure 3.1b). The net force
applied to the filament and two beads causes them to move through the assay solution
at a constant velocity set by the bead size and water viscosity (Figure 3.1c). When a
surface-attached myosin binds to actin and becomes loaded with the applied force, the
filament motion stops within ~50 µs (Figure 3.1d - g). Displacement of the actin filament
caused by myosin’s working stroke is monitored during the interaction, which ends when
myosin dissociates, allowing the actin filament to resume motion under the applied force
(Figure 3.1f). The beginning and end of each actomyosin interaction are detected by
examining the velocity of the optical traps as they respond to the feedback system,

dropping to zero when myosin binds and increasing again when myosin releases the
actin (Figure 3.1f). When the working stroke displaces the filament toward its pointed
end, the beads and the traps move a corresponding amount to maintain a constant force
(Figure 3.1g).
We applied this system to explore actomyosin kinetics and displacements in the
presence of 1.5 - 4.5 pN mechanical loads in directions along the long-axis of the actin
filament that hinder or assist the stroke. The duration of the events, and the timing and
size of filament displacements during interactions were examined in the presence and
absence of 10 mM Pi to determine the relationship between actin binding, the working
stroke, and Pi release.
To distinguish brief, reversible actomyosin attachments from longer attachments
when myosins complete the ATPase cycle, most experiments were performed at a low
(1 M), rate-limiting MgATP concentration. Under both assisting and hindering
directions, the distributions of event durations span a range from less than 1 ms to
greater than 1 s (Figure 3.2a-e). The actomyosin events with durations less than 10 ms,
which represent up to 50% of the observed interactions, have not been observed
previously with standard optical trapping techniques because their durations are below
the minimum detectable length (deadtime).71
The very wide distributions of actomyosin event durations were best described by
the linear combination of at least two exponential components, which we quantified
using maximum likelihood estimation via the software package MEMLET.119

Figure 3.2 Kinetics of actomyosin dissociation under load. a) Cumulative distributions functions of
actomyosin attachment durations at 1 uM ATP under assisting loads (solid lines) on a semi-log plot. Best
fits from the loglikelihood ratio test are shown for each data set (dashed lines). Low-load data from nonfeedback experiments shown in grey with a single exponential fit. Inset shows the same data on a linear
scale. b-e) Comparison of cumulative distribution functions for durations under hindering loads with no
added phosphate (light solid lines) to 10 mM added phosphate (dark solid lines). f) Fitted rates from the
multiexponential function which describe the data with no added phosphate (solid symbols) and 10 mM
added Pi (open symbols). Positive forces resist the motion of the myosin working stroke. Blue symbols
give the slowest of the fitted rates (ks), red the fastest rates (kf), and green the intermediate rate (kint)
when three rates were statistically justified. Black symbols are the single rate fitted to the non-feedback
data from the same molecules. Error bars represent 68% confidence intervals from 500 rounds of
bootstrapping. g) Fraction of observed interactions that were rapid (Af+Aint) from the multicomponent
exponential fits to the data for no added Pi (blue) and 10 mM added P (red). Error bars give the 68%
confidence intervals from 500 rounds of bootstrapping. h) Relative fraction of rapid events for 10 mM
added Pi compared to control, calculated by dividing (Af+Aint) at 10 mM Pi by (Af+Aint) at 0 mM Pi. Error
bars give 90% confidence intervals from 500 rounds of bootstrapping. N molecules ranges from 5-8, and n
events from 784 to 1502 (See Table 3.1 for details).

For forces >2.25 pN, three exponential components were necessary to obtain an
adequate fit (Figure 3.2a,f, Figure 3.3). This result contrasts with the distribution of
durations observed with lower time-resolution, non-feedback measurements performed
on the same myosin molecules, which are well-described by a single, slow rate of
detachment (grey and black, Figure 3.2a).
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7
4
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3

267
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Table 3.1 – Number of molecules and events in the current study

The higher detachment rates, kf (the fastest rate, Figure 3.2f, red) and kint (the
intermediate rate, green), are more than 10-fold faster than the slowest detachment rate,

ks (blue). kf increases from 1x103 s-1 at low loads to up to 3-6 x103 s-1 with increasing
hindering or assisting forces.

Figure 3.3 Fits to attachment durations. a) Data from Figure 2a plotted with other potential fits, showing
that for forces >2.25 pN a triple exponential fit was required. b) The amplitudes (relative fraction) of each
fitted rate kf (Af, red), kint(Aint, green), and ks(As, blue) for data with 0 (dark bars) and 10 mM (light bars)
added Pi. c) Plot of the corrected cumulative distribution functions for 0 mM P i and hindering loads taking
into account that events are missed by the experimental deadtime (see Methods). Dashes lines show fits
to the data and extrapolate back to the graph origin (not shown). d) Similar plot to b, but showing the
corrected amplitudes based on the experimental deadtime. The fast amplitude (red) is considerably larger
for each force than in panel b because the majority of the events that are missed detached at this fastest
rate. Error bars are 68% confidence intervals from 500 rounds of bootstrapping for all panels.

Events which detach at kf composed 10 - 40% (Af) of all observed interactions
(Figure 3.3, Figure 3.4). The events which detach at the intermediate rate make up a
small fraction of observed interactions (Aint = 10 - 20%, Figure 3.3) and detach at a rate,

kint = 102 – 103 s-1. This rate has an asymmetric force dependence about zero force,
increasing from -3.75 pN to +4.5 pN (Figure 3.4).

Figure 3.4 Force dependence of fast and intermediate detachments at 0 mM P i and 1M ATP. a) Bell
equation fits for kf were performed separately for assisting (negative) and hindering loads (positive). For
assisting loads k0 = 579 s-1, d=-1.47 nm, and for hindering loads k0 = 354 s-1, d=-2.54 nm. b) The fit for ki
was performed on positive and negative data but excluded the point at -4.5 pN. k0 = 256 s-1, d=-1.18 nm.

The rate ks, which is 6 - 8 s1 at 1 M MgATP (consistent with the measured ATP
binding rate),77 increases to 10 - 70s-1 in the presence of 1 mM MgATP (Figure 3.5). This
observation is consistent with ADP release limiting the detachment rate at saturating
ATP and indicates this population (As) represents motors that have completed the
ATPase cycle (Figure 3.1a).23,26,27,77,101
The actin attachments described by kf are much shorter than expected for
molecules that undergo the full, multi-step biochemical reaction while attached to actin
that ends with ATP-induced detachment (Figure 3.1a). These fast detaching interactions
do not become faster when MgATP concentration is raised to 1 mM (Figure 3.5), further
supporting the suggestion that they detach before completing the ATPase cycle. As
shown below, these states do not undergo a working stroke, and are likely the short-

lived states described in the physiological and biochemical literature as “weak-binding”
states9,114,117.

Figure 3.5 Kinetics of detachment at saturating ATP (1mM MgATP). a) Fitted detachment rates kf (red),
kint(green), and ks(blue) shown for 1 M ATP (closed circles, same data as in Fig. 2f) and 1 mM ATP (open
diamonds). Zero load rates (black) are from the non-feedback experiments. The kf does not vary at higher
ATP concentration, while ks is faster and force dependent. b) ks at 1mM ATP with a fit to the Bell equation,
yielding a distance parameter of 1.1 nm. The fitted unloaded rate (k0 = 31.5 s-1) is slightly less than some
previous measurements (50-70 s-1), which may be at least partially due to the mixing of the slow and
intermediate phases in the fits. This mixing may also be responsible for the slight difference in kint for 1
M vs 1mM ATP under resisting loads

The fraction of rapid events detaching at kf or kint (Af + Aint) increases with
assisting and hindering forces (Figure 3.2g, h). Although this effect may be partially due
to reduced deadtimes at higher forces (x-axis intercepts in panels a – e, see Methods), it
also may indicate that higher forces are more likely to pull motor domains off of actin
before they can complete their cycle.

3.3.2.

Observation of Myosin’s Rapid Working Stroke

Individual myosin working stroke displacements were observed shortly after the
linear motion of the actin stopped when myosin attached (Figure 3.6a). Upon binding, 5
– 10 nm displacements were observed in many traces. However, displacements were
not readily apparent in all traces, and were rarely seen in interactions with durations

below 5 ms (Figure 3.6a, bottom example). These short duration interactions likely
represent myosins that detach before producing a working stroke (see below).
Attempts to objectively quantify these traces using step finding algorithms,
hidden Markov chains, or Bayesian non-parametric analysis proved unsatisfactory due
to the amplitude and frequency characteristics of the random signal fluctuations.

Figure 3.6 Visualization of the myosin working stroke dynamics under hindering load. a) Example traces of
the position of the actin filament (as reported by the leading trap position) during individual acto-myosin
interactions under 3.75 pN of hindering load. Red triangles indicate approximately where myosin binds to
actin, stopping the motion of the filament under feedback. Green triangles indicate where positive
displacements occur which may correspond to the myosin working stroke, and blue triangles show a
dissociation event. The top two examples show the beginnings of long events with potential working
strokes. The third example is a short event (<1 ms) where there is not a clear displacement observed. b)
Ensemble averages of all events from 0 added Pi data at 1.5, 3, and 4.5 pN hindering load. Dashed box
shows region is expanded in panel c). d) Ensemble averages of events shorter than 5 ms only, where the
observed step is seen to be greatly reduced for forces above 1.5 pN. e) Ensemble averages of only events
lasting longer than 15 ms f) Total measured step for events longer than 15 ms as a function of applied
load with a linear fit, giving an estimate of the stiffness of the myosin lever arm of 2.3 pN/nm. g)
Expanded view of boxed area of e) showing a similar initial displacement across forces.

Therefore, ensemble averaging of individual interactions was used to determine
the average time and amplitude of the myosin working stroke at forces that hindered the
stroke. Interactions were aligned at their detected start times and averaged forward in
time (Figure 3.6b, c). Event displacements were extended in time from their last
interacting positions to generate groups with equal durations that could be averaged.83

Figure 3.7 Quantification of total observed displacement from ensembles as a function of the minimum
event duration included in the ensembles (e.g. the data points at x=10 ms indicates the average
displacement when only events that are longer than 10 ms are included in the ensemble average).
Displacement is normalized to the largest displacement observed for that force. As more events are
excluded (increasing x-axis), the total observed displacement rises, until it nearly reaches it maximum
when x=15 ms. This result is justification of why events longer than 15 ms were analyzed separately.

The sizes of the average displacements were highly force dependent, decreasing
with increasing force (Figure 3.6b, c). At forces >1.5pN interactions with durations <5 ms
showed suppressed displacements (Figure 3.6d). When short events were excluded
from the ensemble averages, the average displacement increased as the minimum
event duration increased from 0 to 15 ms (Figure 3.6e, Figure 3.7). Average
displacement of events >15 ms decreased linearly with increasing hindering load (Figure
3.6f). If the load-dependence of displacement for interactions >15 ms is due to

compliance within the myosin and/or actin-bead attachment,120 then we estimate the
stiffness of the motor to be 2.3 pN/nm or greater from the linear fit to the data points in
Figure 3.6f. This value is at the upper end of previous estimates.121,122

Figure 3.8 Kinetics of the initial working stroke displacement. a) and b) Ensembles averages from events
longer than 25 ms with the size of the initial displacements normalized. a) without added Pi and b) with
10 mM added Pi for 1.5 pN to 3.75 pN hindering loads. c) Quantification of the observed stroke rate
(kstroke, diamonds) from the 20% to 80% rise-time of the signals in a) and b). The rates kf from Figure 2f are
plotted as red circles for comparison with the stroke rates

Strikingly, ensemble averages show that the myosin working stroke occurs within
5 ms of actin binding, without a detectable time lag at forces >1.5 pN (Figure 3.6g,
Figure 3.8). In Figure 3.8a, the traces are normalized to the amplitude of the initial stroke
for visual comparison of their rates. Estimates of the stroke rate from the 20 - 80% rise
time (assuming an exponential shape, see Methods) yielded rate constants (kstroke) of
700 to 5,250 s-1, that increase with force from 1.5 pN to 3 pN and then plateau (Figure
3.8c, diamonds). The apparent kstroke decreased at 4.5 pN, but the quantitation here is
less reliable (See Figure 3.9). These observed rate constants are likely the sum of the
rate for proceeding forward (performing the stroke, Figure 3.1a, k+5) and rate for
reversing actomyosin attachment (Figure 3.1a, k-4).

A slower 1 – 1.5 nm further displacement (Figure 3.6b, e) observed in the
ensemble averages was completed in 50 - 100 ms. The amplitude and time-scale of this
slower displacement are consistent with the second phase of the myosin working stroke,
previously associated with ADP release.23,25,26

Figure 3.9 Limitations in quantifying 4.5pN initial stroke rates. a). In the absence of phosphate, the
normalized 4.5pN data shows noise characteristics which makes it difficult to reliably use the 20-80% rise
time measurement, but this method was most reliable for the other forces studied. An exponential
function (red) fit to the data from 0.18 ms to 1 ms gives a rate of the stroke, kstroke = 4740 s-1, as compared
to the rate from the 20-80% rise time of 3600 s-1 (Figure 3.8c). b) With 10 mM added Pi, the total stroke is
very small and thus the noise in the normalized trace is quite large, making quantification difficult. An
exponential fit from 0.2 ms to 0.63 ms (red) gives a kstroke = 3490 s-1, similar to the estimated 3570 s-1 from
the 20-80% rise time (Figure 3.8c).

3.3.3.

Effects of Pi on Actomyosin Attachments and Displacement Dynamics

The addition of phosphate to contracting demembranated muscle fibers results in
a decrease in active force due to the redistribution of myosin states44,46,116. To probe the
effect of phosphate on myosin at the single molecule level, we performed UFFC
experiments in the presence of 10 mM free Pi. Adding phosphate did not substantially
change the rates of the kf or kint over the range of probed forces (Figure 3.2f, open red
and green symbols); however, their combined amplitudes (Af+Aint) increased in 10 mM Pi
at loads <3pN, suggesting an increase in the fraction of events that detach from weakbinding states (Figure 3.2 b, c, g, h). The ratio of Af+Aint at 10 mM Pi to Af+Aint at 0 Pi

shows there is up to a 50% increase in the number of these rapid detachments (Figure
3.2h). ks decreased about two-fold at 10 mM Pi and 1 M MgATP (Figure 3.2f) in both
the UFFC and non-feedback experiments, which is consistent with weak competition
between Pi and ATP for binding at the active site, as previously proposed123.

Figure 3.10 Possible effects of free Pi on displacements. a) Schematic for the working stroke occurring
before Pi release and the expected effect of P i of causing increased and delayed stroke reversals. b)
Schematic of Pi release occurring before the working stroke and the expected effect of solution P i on
idealized displacement traces predicting a delay in the working stroke from P i being able to rebind and
then dissociate again from a pre-stroke state.

The presence of 10 mM free Pi did not affect the rates of the ensemble
displacements for events longer than 25 ms (Figure 3.8b and open vs. closed diamonds
in panel c). This result strongly implicates a mechanism in which Pi release occurs after
the working stroke, as a delay in the stroke kinetics would have been observed with 10
mM Pi if Pi release and rebinding occurred before the working stroke. (Figure 3.10).
Comparing the rate of the stroke to the fastest rate of detachment, kf, from the event
duration data (circles, Figure 3.8c), shows that the average stroke rate, up through 3.75
pN, is greater than or equal to the fastest phase of detachments. This result implies that
molecules in the earliest state resolved in our experiment either perform a stroke or
detach, and that Pi release (or any other substantial intermediate step) does not occur
between attachment and the stroke.

Figure 3.11 Effect of added Pi on reversals of the working stroke displacement. a) Example traces of
displacements in individual interactions under 3pN of load with 10 mM Pi present with possible stroke
reversals (open green triangles) highlighted. b) Ensemble averages of events longer than 25 ms at 1.5 pN
(blue), 3 pN (red), and 4.5 pN (green) with 0 (light colored lines) and 10 mM added Pi (dark lines). Data at
the various forces are offset by 2 nm for readability. c) Expanded view of the boxed region in b) showing
the initial stroke and dip. Triangles indicate the detected maximum initial displacement, and circles
indicate the location and timing of the maximum ‘dip’ in the signal as described in the Methods using a
moving average. d) Quantification of the relative total displacement for events longer than 25ms with
10mM added Pi compared to that with no added Pi. d) Quantification of the relative size of the dip for 10
mM vs 0 mM added Pi. e) Comparison of the time between the maximum initial displacement and
minimum of the dip for no added Pi (blue) and 10 mM added Pi (red). g) Simulated ensembles averages
from the model described in the text and methods with Pi release occurring after the working stroke. h)
Expanded view of the boxed region in g) showing the simulated dip in the displacement. Inset shows a
simplified view of the working stroke-first model used in simulations.

Many individual displacement records acquired in the presence of 10 mM Pi
showed reversals in the working stroke to the pre-stroke level (Figure 3.11a). However,
the individual recordings are variable, and reversals cannot be reliably identified among
the Brownian fluctuations. Thus, the dynamic features of the displacements were
objectively quantified via ensemble averaging (Figure 3.8 and Figure 3.11b-c).

Figure 3.12 Simulations of the effect of free phosphate on ensembles averages. The scheme in a) shows
the rates and pathways used in the simulations of the ensembles shown in Fig. 3.11 g,h in the main text.
When a rate of 100 s-1 was used for rebinding of myosin-ADP-Pi to actin (small black up arrow near red),
the estimated biochemically measured Pi release rate is 18 s-1, in agreement with the literature (see
Supplementary Note 1).68,77 b) and c) Examples of 8 (out of 3000) individual traces simulated using the
above pathway with added Gaussian noise to aid visualization. Averages of these (and other) traces are
shown in the main text Fig. 3.11 g and h. b) Traces simulated with no Pi rebinding and c) simulated with Pi
rebinding at 400 per second, showing more reversals of the stroke, especially those occurring later in the
cycle.

The average displacement traces decreased after the peak of the initial working
stroke in the presence of 10 mM Pi (Figure 3.11c, dark colors). We tabulated the total
displacement, the size of any declines occurring after the initial positive displacement,
and the time to reach the minimum of this dip (Figure 3.11d-f). Total displacement was
reduced (Figure 3.11d), and the size of the dip was increased by Pi at all forces above
1.5 pN hindering load (panel e). The changes in total displacement and the amplitude of
dip are both greater at higher hindering loads, and the time to reach the minimum of this

dip is considerably increased by the presence of 10 mM Pi (panel f). These results are
consistent with a model in which Pi is released after the working stroke and then may
rebind and cause reversal of the stroke (Figure 3.10). We performed simulations of
individual actomyosin interactions using a kinetic model with these features (Figure
3.12). Ensemble averages of these interactions recapitulate the observed effects of Pi.

3.4. Discussion
The time resolution afforded by the UFFC system has allowed us to gain novel
insights into dynamics of cardiac myosin’s initial states following actin attachment and
the working stroke. We resolved a short-lived state that is capable of bearing loads up to
4.5 pN and obtained the first estimates of the delay between myosin attachment to actin
and the working stroke as a function of applied load from single molecule
measurements. We also observed the effects of free phosphate on these events. The
results allow us to characterize the order and properties of the rapid processes which
follow cardiac myosin’s association with actin and lead to force generation. Based on the
experimental results discussed below, we propose a model (Figure 3.13) in which an
early actomyosin state that is short-lived but nevertheless is capable of bearing load
leads promptly to the working stroke and concomitant strong binding, which is then
followed by slower Pi release.

3.4.1. Short lived States are Stereo-Specific, Open-cleft, Pre-stroke, and Pibound
Our UFFC experiments reveal short-lived interactions which detach before
myosin completes its biochemical cycle via ATP binding. The short-lived state detected
in this study can stop the motion of an actin filament and maintain forces of up to 4.5 pN
for hundreds of microseconds. In earlier publications, a weak-binding state of myosin

has been described in several ways, and we considered whether the observed shortlived interactions may be in such a weak-binding state.

Figure 3.13 Proposed model with short-lived, weakly-bound attachments directly preceding the working
stroke, which is followed by phosphate release and potential phosphate rebinding. Ranges of rates are
estimates of the rate at zero load (lowest value) to 4.5 pN of hindering load (highest values).

An electrostatic, non-stereospecific interaction between actin and myosin has
been called a weak-binding state in which the myosin head experiences significant
orientation fluctuations relative to actin. 15,124–131 The dissociation rate of the short-lived
state found here (kf) is substantially more force dependent under hindering loads as
compared to assisting loads (Figure 3.2f, Figure 3.4) and as mentioned above it can
briefly support loads. These characteristics suggest that the actomyosin bond in this
state is stereo-specific and not a highly disordered interaction.
Weak-binding has also been used describe a conformation of the myosin head in
which a cleft in the actin binding interface is open and is usually associated with ATP or
ADP-Pi bound myosin12,20. This cleft-open state has been proposed to be the initial
stereospecific interaction between actin and myosin which can rapidly dissociate from
actin unless a relatively slow isomerization leads to ‘strong binding’.15,125,127,128,132–134 The

short-lived states we observed are estimated to dissociate at ~500 s-1 in unloaded
conditions, fairly close to the measured ~950 s-1 dissociation rate of actomyosin after
actin cleft opening induced by ATP binding77. Comparing this to the <0.1 s-1 dissociation
rates measured for known cleft-closed states23, our short-lived state’s lifetime suggests
that myosin is in an open-cleft conformation.
Actin-activated Pi release is dependent on a stereo-specific interaction between
actin and myosin. If Pi were released prior to the observed short-lived state, there would
have to exist an additional stereo-specific state that is too rapid to observe. Based on
the estimated rate of dissociation from an open-cleft state of 950 s-1 given above, such a
state is highly unlikely. Thus, our short-lived state is likely to be a stereospecific, actincleft-open state with Pi bound.

3.4.2.

The Working Stroke and Cleft Closure Occur before Pi is released

The model in Figure 3.13 which places the working stroke before Pi release is
supported by the rapid observed rate of the stroke (kstroke) and the similarity between
kstroke and kf (Figure 3.8), as well as the observations of increased and delayed reversals
in the presence of free Pi (Figure 3.11), as discussed further below.
Ensemble averages of actin displacement during actomyosin events show that
there is no appreciable working stroke during the short-lived interactions when time
resolution is optimal (forces >1.5 pN, Figure 3.6d). The working stroke appears to
immediately follow this short-lived state, as the observed rate of the working stroke
(kstroke, diamonds in Figure 3.8c) is greater than or equal to the rate of detachment from
the short-lived state (kf, circles in Figure 3.8c). kstroke, surprisingly, shows an increased
rate with larger forces in the direction that should hinder the working stroke. If the stroke
immediately follows the short-lived state, this result can be readily explained by the slip-

bond behavior of kf, as the observed kstroke (≈ k+5 + k-4) should increase when k-4
increases. If a significant intermediate process existed between the short-lived state and
the stroke, it would have to occur at >10,000 s-1 to obtain the observed value of kstroke
(Figure 3.14).

Figure 3.14 Simulations of the initial ensemble displacement for single (blue) vs. multistep (red, yellow,
green) processes occurring between actin binding and the working stroke compared to the observed data
for 3pN (black). Only the single process at 5000 s-1 (blue) or a multistep process with one rate being
≥10,000 s-1 (red and yellow) exhibit a similar rapid displacement like that observed (black), indicating that
if two processes occur after binding but before the stroke is completed, one of them must be extremely
fast.

In addition, if Pi release and rebinding were to occur before the stroke, kstroke
would be slowed by Pi rebinding when it is present in solution (Figure 3.10). The lack of
effect from 10 mM Pi on kstroke (Figure 3.8c, compare open and closed diamonds) is thus
further evidence that Pi release and rebinding do not occur before the working stroke.
Biochemical estimates of the Pi release rate for cardiac myosin in solution range
from 11.6 to 17 s-1, 68,77 which is much slower than the observed stroke rate. The
biochemical measurements estimate the microscopic rate of Pi release, while our
measurements are observed rates including competing processes (such as detachment)
from the same states. If Pi release were to happen before, or simultaneously with, the

stroke at a rate of 17 s-1, less than 0.4 - 4% (high load to zero load) of the molecules
occupying the short-lived state would produce a the stroke, the rest detaching at ≥ 500 –
5000 s-1. The event duration data show that >10 - 40% (high - low load) of interactions
proceed through the entire biochemical cycle (Figure 3.2g, Figure 3.3). This comparison
thus again supports models in which Pi is released after the working stroke and prevents
reversal of the stroke and cleft re-opening unless Pi rebinds.

3.4.3.

The Stroke is Reversible and Reservals are More Common with Free Pi

It has been previously suggested that myosin’s actin-binding cleft closure, and a
corresponding increase in actin affinity, is tightly coupled to the working stroke12,19,135,
and our data support this hypothesis. If the binding interface cleft remained open after
the stroke, a significant fraction of short-lived events would be expected to show a
displacement of actin. Under conditions when the time resolution was optimal (forces
≥3pN), negligible displacement was observed in short-lived events (Figure 3.6d).
The data provide evidence that the working stroke and cleft closure are both
reversible. The kint detachment rate without added Pi showed an asymmetric force
dependence about zero load (Figure 3.2f, green, Figure 3.4), consistent with a forcedependent rate for the reversal of the working stroke followed immediately by
detachment from the short-lived, pre-stroke state. Evidence of these reversals appeared
in the ensemble averages of displacement both with and without free Pi (Figure 3.6c,e
and Figure 3.11b,c) as a dip in the displacement that occurred within a few milliseconds
after the initial stroke.
An increase in the fraction of rapidly detaching events was observed with 10 mM
added Pi at low forces (Figure 3.2g,h). This result is consistent with previous single
molecule observations55,57, and with the scheme of Figure 3.13 in which Pi rebinding

allows more stroke reversals which can lead to premature detachments. At higher
forces, it is likely that the increased fraction of direct detachments from the short-lived
state (at rate kf) may mask the effects of Pi on attachment durations. Ensemble averages
of the long events (>25 ms) show that added Pi leads to a larger and more delayed dip in
the displacement (Figure 3.11 c – f), consistent with the scheme of Figure 3.13 in which
Pi rebinding allows reversals to occur both more often and later in the attachment (Figure
3.10). The decreased displacement in the presence of 10 mM Pi compared to control
(Figure 3.11d) is consistent with myosin detaching from a pre-stroke conformation after a
delayed reversal of the working stroke.
It should be noted that for this model to quantitatively describe the ensemble
average data (Figure 3.11g, h), the lifetime of the pre-stroke state following a reversal
was approximately 1 ms under load (Figure 3.12), which is longer than the estimated
300 s lifetime of the initial pre-stroke state under load. This might suggest that after Pi
is released, the Pi rebinding does not cause the actin cleft to reopen fully, even if it does
allow power stroke reversal. Additional studies and modeling will be required to test this
speculation, but it has been suggested previously that Pi rebinding may induce
transitions off of the canonical pathway.57
The model in Figure 3.13 can explain all our observations. In this model,
electrostatically mediated interactions between actin and myosin transition to the shortlived, stereo-specific state detected in our study. In this state, myosin can briefly bear
force with an open actin binding cleft and Pi bound. The working stroke of myosin occurs
directly from this state and the closure of the cleft is tightly coupled to the stroke. Both
the stroke and cleft-closure can be reversed under zero load, with a rate (kint) that

increases with hindering load. Phosphate release occurs after the stroke and rebinding
of phosphate allows reversals of the stroke.

3.4.4.

Relation to Previous Work

The scheme of Figure 3.13 is fully consistent with a previously proposed model
developed from muscle fiber experiments for skeletal myosin II.47 That model included a
force bearing state followed by reversible force generation (the working stroke) and then
phosphate release.47 Similar studies on cardiac fibers showed this model also is
applicable to cardiac myosin.44 More recent studies of the rate of the working stroke in
skeletal69 and cardiac68 myosin II, and myosin V67 using FRET probes and time-resolved
fluorescence have found evidence of a conformational change in the motor domain,
likely a rotation of the lever arm, that precedes phosphate release. The data from
previous experiments on fast-skeletal myosin with the UFFC system support that the
model of Figure 3.13 also applies to this myosin isoform71. The present data provide the
most direct evidence for this ordering of events after actin attachment in cardiac muscle
myosin.
High resolution crystal structures of myosin have been used to suggest that
phosphate can be released before the stroke occurs12,37. In addition, some models of
contraction developed to explain a wide variety of muscle fiber data have suggested that
phosphate release and the working stroke are not tightly coupled.118,136 While our data
cannot exclude that Pi may occasionally be released before the stroke, if this occurred
more than 20% of the time, there would be a discernable delay in the stroke rate in the
presence of Pi which not was observed (Figure 3.8). The possibility remains that other
myosin isoforms, such as myosin V and VI, may proceed through actin binding, the

working stroke, and phosphate release with a different mechanism or in different
orders.12,37,39 Studies are needed to clarify the mechanism in those systems.

3.5. Methods
3.5.1.

Protein Purification and Source

A heavy-mero myosin (HMM) construct of human -cardiac myosin (MHY7) was
expressed in C2C12 myoblasts and purified as previously described80. The light chains
are composed of those constitutively expressed in the mouse myoblasts, which are
similar to those found in humans in sequence.

3.5.2.

Experimental Protocol

Experiments were conducted in flow cells constructed and prepared as
previously described23. All assay solutions were composed of 60 mM MOPs, 10 mM
DTT, 1 mM EGTA, 1 mM MgCl2, and 1 mg/mL BSA. The calculated ionic strength of the
experimental solutions was held constant across ATP and Pi conditions. Experiments
without added Pi contained 25 mM KCl, consistent with previous optical trapping
experiments on cardiac myosin performed in our lab, giving a final ionic strength of
approximately 31 mM for the 1M MgATP experiments. Buffers with 10 mM added
phosphate were made from KHPO4, which was pH adjusted to 7.0 with KOH, which
added approximately 17 mM potassium ions. An extra 1 mM MgCl2 was added to the
10mM Pi buffer to maintain approximately 1 mM free MgCl2 due to the coordination
between Pi and MgCl2. This resulted in the final 10 mM Pi buffer having a calculated 32
mM ionic strength. Experiments conducted with 1 mM MgATP contained 16 mM KCl to
maintain the ionic strength at 31 mM.
Myosin was added to nitrocellulose-coated chambers and allowed to
nonspecifically attach to 2.5 m silica pedestal beads on the surface before the

chambers were blocked with 1 mg/mL BSA as previously described23. The concentration
of myosin was such that only about 1 out of 10 locations tested showed interactions
between myosin and actin, to obtain single molecule conditions. The final assay solution
was added which contained pM concentrations of 10 - 15% biotinylated (Cytoskeleton)
actin from rabbit skeletal muscle stabilized by rhodamine phalloidin, followed by ~3
microliters of the final assay solution containing 5 ng mL-1 500 nm diameter beads
(PolySciences) coated nonspecifically with neutravidin (ThermoFisher).
Experiments were performed with trap stiffnesses of 0.06 -0.08 pN/nm and 4-5.5
pN of pretension was applied to the actin dumbbells. When a myosin molecule was
found on a pedestal bead, a stage stabilization system was engaged137,138 and nonfeedback data was acquired to determine the step size and directionality of the
filament23. The ultra-fast feedback system was engaged, and 5 - 10 minutes of data
were taken for each value of applied force. Because of sporadic filament breakage, not
every molecule produced data at each force.

3.5.3.

Optical Trapping Implementation

The optical trapping setup used in these experiments has been described
previously in detail in Chapter 2,139 including many optimizations to increase the update
speed of the feedback loop to less than 8 s. Briefly, polarization-split 1064 nm beams
are steered by two 1D electro-optical deflectors (EODs, Conoptics, Inc.) into a 60x water
immersion objective (Nikon). The scattered laser light from the chamber is collected by
an oil immersion condenser and projected onto two quadrant photodiodes conjugate to
the back focal plane of the condenser for direct force detection.140 The feedback loop
and data acquisition occurred at 250 kHz using a National Instruments Field
Programmable Gate Array controlled by custom LabVIEW virtual instruments.

Experiments were conducted otherwise as previously described71,137 with applied
forces ranging from 1.5 pN to 4.5 pN in directions toward both ends of the actin filament
with excursions of the trap of 200 nm before the applied force was switched. In order to
eliminate any effects that tension on the actin filament might have on myosin’s
interaction, forces were distributed between the two beads such that the pretension on
the filament was constant even as the applied force changed (Supplementary Figure 9).
The force signals and feedback output signals were digitized at 250 kHz through a 125
kHz anti-aliasing filter. The positions of the traps were determined from the EOD driving
signals and optical calibration measurements of bead displacements.
We added a novel real-time drift and slope correction (DSC) system to our UFFC
software to achieve more stable and accurate forces despite thermal drifts and related
variations in the force signals. This system is described fully in Section 2.6 and Figure
2.10. In brief, the feedback system is paused intermittently (for 2 ms at 10 ms intervals)
to probe for drifts in the force signals. The amount of detected drift is used to correct the
setpoints of the feedback loops to maintain accurate forces.

3.5.4.

Data Analysis

Event Detection
Events were detected using a modified version of software written in Matlab
(Mathworks, Natick, MA) used previously for UFFC experiments71. Briefly, the velocity of
the traps is calculated and smoothed using a 160-800 s width Gaussian filter, and a
threshold is determined for distinguishing periods when the trap motion has stopped that
balances false binding and false unbinding events. The amount of smoothing is set so
that the number of false events is estimated to be <1% of all detected events based on
statistical estimates141. The smoothing varies with the applied force but is constant

across experimental conditions. Because higher loads cause faster motion of the actin,
less smoothing is required and shorter events can be detected at higher loads. Small
corrections are applied to the start- and end-times of the events to account for delay
based on the Gaussian filter, as previously described.71 The estimated uncertainty of the
localization of binding time (σt) also can be calculated and ranged from 500

s at 1.5 pN

to <60 microseconds at 4.5 pN applied load. From each data trace, a theoretical
minimum detectable event length (deadtime) was calculated based on the velocity
distributions and the threshold value as previously described.71 Events were designated
as occurring either during hindering or assisting load based on the direction of actin
motion when binding occurred and the polarity of the actin as determined by initial nonfeedback experiments.

Duration Analysis
For a given force, all events which were shorter than the largest calculated
deadtime for traces recorded at that force were excluded from the analysis. The
deadtimes, set to be constant across different biochemical conditions, were 2.7, 1.25,
0.73, 0.65, and 0.5 ms for forces 1.5, 2.25, 3, 3.75, and 4.5 pN respectively. Events from
molecules at the same magnitudes and directions of force were pooled for each given
condition (e.g. forces, [MgATP], [Pi]). Parameters for deadtime corrected single, double,
and triple exponential distributions were estimated in MEMLET119 for each data set and
the log-likelihood ratio test was used with a p-value cutoff of 0.05 to determine if the
triple and/or double exponential distributions were statistically justified. Each molecule
contributed equally to the fitted values as described prevoiusly23, although this did not
lead to considerable differences compared to the fits weighted by the number of
interactions. The observed amplitudes of each phase are reported as well as the

deadtime corrected amplitudes (Supplementary Figure 1), which consider how many
events are likely missed due to the experimental deadtime and assuming exponential
duration components.119

Ensemble Averaging
Ensemble averages were carried out as have been described previously23. The
beginnings of the events were aligned based on their detected time of binding from the
crossing of the smoothed velocity trace through the detection threshold as previously
described71. The trap position for the leading bead (the bead with the higher magnitude
of force applied) was taken as the position of the actin filament, as there is less influence
of non-linear end compliance on this more highly loaded bead. The extension point was
taken to be the displacement at time t (uncertainty of binding time) before the detected
end of the event, meaning this value was used in the averages for all time points longer
than the actual event duration. The value of t depends on the smoothing of the velocity
for event detection, and thus was smaller (more accurate) for larger forces. The average
value of t varied from 0.5 ms for 1.5 pN to ~72 s for 4.5 pN. Ensembles were weighted
such that each molecule contributed equally to the final average.

Quantifications of Ensemble Averages
Quantification of the ensemble average was done programmatically to ensure
objectivity, using the parameters reported below which were adjusted by eye to
accurately represent the trace characteristics.
The minimum position of the ensemble average within the first millisecond of
detected actin binding was set to be zero displacement. The size of the initial
displacement was calculated from the raw (unfiltered) ensemble averages by finding the
time (tintit) when the ensemble average reached its maximum within the first 1.2 ms

following the minimum position, with the exception of the 1.5 pN data which was
searched over the first 5 ms. The minimum and maximum positions were used to
normalize the displacements to range from 0 to 1, as plotted in Figure 3.8a, b. The time,
t20-80, for the normalized signal to cross from 0.2 to 0.8 was determined, and this time
was converted to a rate constant (k) assuming a single exponential process: k = (ln(0.8)ln(0.2)) / t20-80% .
For quantification of the dip size and time, the initial stroke size was determined
by averaging 100 s on either side of tinit. The location and position of the dip were
determined by taking a 1 ms moving average of the ensemble and finding the minimum
point between tinit and 15 ms after the detected binding time. The size and timing of the
dip are reported as the difference between the time and displacement of initial stroke
and the minimum dip respectively. The total displacement is quantified as an average
over the last 200 s of the ensemble average.

3.5.5.

Modeling

Simulations of individual traces were performed using a Monte-Carlo based
method142 using the rates and transitions given in Supplementary Fig. 7. For each
simulated state (i), and for each transition out of that state (𝑖 → 𝑗) , times, 𝑡𝑖→𝑗 , were
randomly selected from an exponential distribution based on the transition rate (𝑘𝑖→𝑗 ).
The shortest 𝑡𝑖→𝑗 was used as the lifetime of the state i and the transition associated with
that time was used to assign the next state (j). This method leads to the expected results
that the flux through a transition (𝐴𝑖→𝑗 ) will be the rate of that transition 𝑘𝑖→𝑗 divided by
the sum of all rates exiting the current state (𝑘𝑠𝑢𝑚 = ∑𝑗 𝑘𝑖→𝑗 ). The effective rate of the
transition will be 𝑘𝑠𝑢𝑚 . Once all states were assigned for a given simulated interaction
(the last state is always a detached state), a position value was assigned to each state

based on the mechanical properties of the states. The simulated position values were
drawn for each interaction from a Gaussian distribution with a 0.1 nm standard deviation
from their set mean value. The position trace before the initial interaction was a constant
slope with a velocity similar to what is observed in the data for the simulated applied
force. Upon initial binding, an exponential function was used to simulated stretching of
the myosin under the applied load using a linear stiffness of 2 pN/nm. 3000 interactions
were simulated, and the interactions lasting longer than a 25 ms cutoff were included for
averaging with the same routine used for the data analysis.

CHAPTER 4 – Omecamtiv Mecarbil Decouples
Cardiac Myosin’s Working Stroke from Phosphate
Release While Activating Muscle

This chapter has been adapted from:
Positive cardiac inotrope omecamtiv mecarbil activates muscle despite suppressing the
myosin working stroke. Michael S. Woody, Michael J. Greenberg, Bipasha Barua,
Donald A. Winkelmann, Yale E. Goldman & E. Michael Ostap Nature Communications 9,
3838 (2018).
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4.1. Abstract
Omecamtiv mecarbil (OM) is a positive cardiac inotrope in phase-3 clinical trials
for treatment of heart failure. Although initially described as a direct myosin activator,
subsequent studies are at odds with this description and do not explain OM-mediated
increases in cardiac performance. Here we show, via single-molecule, biophysical
experiments on cardiac myosin, that OM suppresses myosin’s working stroke and
prolongs actomyosin attachment 5-fold, which explains inhibitory actions of the drug
observed in vitro. OM also causes the actin detachment rate to become independent of
both applied load and ATP concentration. Surprisingly, increased myocardial force
output in the presence of OM can be explained by cooperative thin filament activation by
OM-inhibited myosin molecules. Selective suppression of myosin is an unanticipated
route to muscle activation that may guide future development of therapeutic drugs.

4.2. Introduction
Omecamtiv mecarbil (OM) is a positive cardiac inotropic agent that increases
cardiac performance in failing hearts, as measured by left ventricular fractional
shortening and ejection fraction, in both animal models88 and humans.90,143,144 OM was
initially described as a direct binder and activator of -cardiac myosin (MYH7), the
molecular motor responsible for powering contraction.88 The drug has generated great
excitement, since a pharmaceutical that directly improves myosin activity holds the
promise of avoiding side effects that can occur with drugs that target calcium signaling or
other upstream regulators of contraction.145
Myosin activation by OM was proposed to be the result of an increase in the
actin-activated rate of phosphate release (Figure 4.1, step 5) without changing the rate
of ADP release (Figure 4.1, step 6).88 This kinetic modification is expected to increase

the fraction of the ATPase cycle in which myosins are bound to actin in a force-bearing
state (i.e., increasing the duty ratio), resulting in higher force production without affecting
the rate of shortening.88 Subsequent studies confirmed that OM increases the rate of
phosphate release;68,77 however, it was also shown that OM inhibits the velocity of actin
gliding in the in vitro motility assay at all concentrations tested77,80,91,92 and reduces the
rate of tension development and relaxation in myocytes at micromolar
concentrations.88,91,146–148 These phenomena, along with observations of decreased
isometric force in fully activated cardiomyocytes,34,146 are inconsistent with the originally
proposed model for OM-activation of myosin in muscle.

Figure 4.1 Biochemical Cycle of Cardiac Myosin . Omecamtiv Mecarbil has been shown to increase the
rate of phosphate release (step 5) and bias the ATP hydrolysis step (step 3) towards the post-hydrolysis
M·ADP·Pi state, which is proposed to cause myosin to enter the strong binding states (red underline)
more rapidly. Other biochemical steps have been previously shown through stop-flow biochemical
experiments to be nearly unchanged by the presence of OM. Inset: Example optical trapping trace of the
position (median filtered with 0.4 ms window) of an actin filament during one interaction with a single
myosin molecule reproduced from Figure 4.2b. The step size and attachment duration of these
interactions can be measured as shown.

To better understand the molecular mechanisms by which OM increases
contractility, we utilize single molecule optical trapping to directly measure the effects of
OM on the working stroke size and attachment lifetime of individual recombinantexpressed, human β-cardiac myosin molecules. We find that OM suppresses the myosin
working stroke and prolongs the actin attachment lifetime at physiological ATP

concentrations and at therapeutic OM concentrations. Simulations of the ensemble
behavior of myosins in the presence of OM provide information on the molecular
mechanism of OM and how this drug can increase force production in hearts, while also
inhibiting cardiomyocyte force production under high calcium and/or high OM
concentrations and inhibiting in vitro actin gliding velocity. The results also point to a
mode of muscle activation by the selective modulation of a sub-population of myosin
molecules.

4.3. Previous studies of Omecamtiv Mecarbil’s Mechanism
There have been multiple studies of the effects of OM on cardiac myosin utilizing
in vitro methods to elucidate the mechanism of the drug’s action. The initial report of the
drug showed that actin-activated phosphate release (Figure 4.1, step 5) was increased,
while the rate-limiting step for detachment, ADP-release (Figure 4.1, step 6), was
unchanged.88 The authors suggested that this caused a large portion of myosin heads
to reside in a strongly-bound, force generating state leading to increased force
production.88 Later, more comprehensive, biochemical characterization of the effects of
OM supported these initial results, while also indicating that the hydrolysis equilibrium
was shifted towards post-hydrolysis in the presence of the drug, with no other significant
alterations of key biochemical rates.77
Surprisingly, the velocity of actin motion by cardiac myosin measured in the in
vitro motility assay has been shown by several groups to be dramatically decreased
nearly 20-fold in the presence of OM.77,80,91,92 The biochemical measurements cannot
explain this result, as the rate of motility is believed to be due to the attachment lifetime
and the step size of myosin. The rates of ADP release and ATP binding, which typically
set the overall attachment lifetime, were measured to be unchanged by OM, and the

step size cannot be directly measured through biochemical experiments. A study utilizing
time-resolved FRET measurements suggest that there may be an inhibition of the
myosin power stroke in the presence of OM, but these measurements could not describe
the size of the power stroke, and only indicated its delay.69 Single-turnover stopped
flow experiments have also suggested that an intermediate step in myosin’s biochemical
cycle preceding detachment may be slowed by OM, possibly affecting the attachment
lifetime.91 Besides these possibilities, the groups that have observed inhibited motility
have suggested that OM may act to dramatically increase the force sensitivity of myosin,
causing its attachment lifetime to be significantly increased when it is placed under load,
leading to reduced velocities, but this change in force dependence has yet to be directly
observed.
Structural studies of myosin bound to OM have shown multiple possible binding
sites63,80, all of which reside near the converter domain, the region that acts to transduce
structural changes from the ATP-binding site and actin-binding site to the level arm. One
of the crystal structures indicates that OM may bind to an ADP-bound myosin state,80
implying that force-sensitivity may be altered by OM as the ADP release step has been
shown to be the primary force-sensitive transition in cardiac myosin.26 Another possible
structure shows OM bound to a pre-power stroke state,63 implying the drug could
possibly affect and inhibit the power stroke itself, as suggested by the time-resolved
FRET data mentioned above.
Despite in vitro results which suggest that OM can inhibit cardiac myosin, it has
been shown that OM can increase ejection fraction and stroke volume in dogs88 and
humans,90,143 and can lead to increased force production and increased calcium
sensitivity in permeabilized cardiomyocytes.34,146,148 However, these and other studies
have also shown that at concentrations of the drug above approximately 250 nM there is

a reduction in force production and a marked decreased in the kinetics of both force
development and relaxation.34,146–149 Nagy et al. have shown that at saturating calcium
concentrations, OM inhibits isometric force in rat cardiomyocytes at all concentrations.146
They also showed at intermediate calcium (pCa 6), there is a bell-shaped response of
isometric force to OM, with concentrations of the drug above 1 µM leading to decreased
force production.146 This is consistent with observations in human trials where some
adverse events attributed to “excessive prolongation of ejection time” resulting in
patients where plasma concentrations of OM exceeded 1200 ng/mL (3.1 µM)90.
It is apparent that the proper concentration of OM is vital and that concentrations
above the therapeutic range (~250 ng/mL plasma concentration, 620 nM) can cause
adverse effects in patients. However, the cause of these adverse effects and in vitro
motility inhibition have yet to be explained. We sought to answer the key outstanding
questions about the effect of OM on the attachment duration, step size, and force
dependence of β-cardiac myosin using single molecule optical trapping. This technique
allows us to directly measure each of these key parameters of single myosin molecules
as a function of OM. We then use a simple quantitative model to show how the single
molecule results explain the inhibition of motility and the biphasic response of isometric
force in cardiomyocytes, providing an important update to the mechanism of action of
this auspicious drug.

4.4. Results
4.4.1.

OM Reduces the Size of Myosin’s Working Stroke

We kinetically and mechanically characterized the interaction of a recombinant,
human -cardiac heavy-meromyosin (HMM) construct with actin in the presence and
absence of OM using single-molecule, optical trapping. In this assay, a single actin

filament suspended between two optically-trapped polystyrene beads (known as an actin
dumbbell) is brought into proximity with a single myosin molecule adsorbed to a pedestal
bead which is anchored to the coverslip surface24,54. Single myosin molecules bind and
displace the dumbbell when it is near the pedestal, and binding events are detected by
analysis of the covariance of the bead position fluctuations150,151 (see 4.7 Methods).
Binding events as short as 16 ms can be detected, and the displacement of the
dumbbell by the myosin working stroke is determined with sub-nanometer resolution
(Figure 4.1, inset).
In the absence of OM, we observed directional displacements of the actin
filament consistent with previous measurements (Figure 4.2a,b). Full length porcine cardiac myosin has been shown to have a working stroke composed of two sub-steps,
where an initial displacement associated with the release of phosphate (4.7 nm) is
followed by a second displacement associated with ADP release (1.9 nm).26 By
averaging ensembles of single molecule interactions aligned at their beginnings and
ends, we also resolved a two-step working stroke for human -cardiac myosin at low
MgATP concentrations (200 nM MgATP,

Figure 4.3). The initial displacement of 4.2 ± 0.4 nm (standard error of the mean,
sample sizes located in Table 4.1) is followed by a second displacement of 1.5 ± 0.3 nm,

resulting in a 5.7 ± 0.3 nm total working stroke (

Figure 4.3). At a near-physiological MgATP concentration of 4 mM we observe a
total working stroke of 5.4 ± 0.2 nm, but we do not fully resolve the second displacement
due to the rapid binding of ATP and subsequent detachment of myosin (~500 s-1)77
immediately following the second displacement.

Figure 4.2 The Effect of OM on Myosin Working Stroke Size (a) Example trace of the position of one bead
during several interactions of cardiac myosin with actin in the absence of OM (blue). The covariance of the
two beads’ positions is shown in black and was used to determine when a binding event occurred, as
indicated by the dark horizontal lines above the position trace. (b) An expanded section of the data inside
the dashed box in (a), where two clear interactions can be visualized. (c) and (d) Example trace similar to
that in (a) and (b), but with 10 M OM present. The interactions are more difficult to distinguish in the
position trace (red) but are clear from the covariance (black). Position traces in (a)-(d) are median filtered
with a 0.4 ms window. (e) Binding events were synchronized at their starts and averaged forward in time
to show the average stroke size observed in the presence of OM ranging from 0 to 10 M. Average stroke
size decreases with increasing OM concentration. (f) The average observed stroke size was decreased by
OM in a dose dependent manner. Error bars give the standard deviation of the mean step sizes from each
molecule observed. N-values are presented in Table 4.1.

Figure 4.3 Ensemble Averages of Myosin Working Stroke at 200 nM MgATP
The ensemble averages83 with a 0.4 ms median filter applied in the absence of drug (blue) show a total
step size of 5.7 nm with an initial displacement of 4.2 nm followed by a 1.5 nm sub step, consistent with
previous results26. The rate constant of the forward ensemble average (left) is 71.2 s-1, consistent with the
rate of ADP release77. The rate constant of the reverse average (right), 1.15 s-1, is close to the observed
detachment rate and rate of ATP binding at 200 nM MgATP77, which is to be expected at limiting ATP
concentrations. In the presence of 10 M OM (red), it is difficult to ensure proper alignment of the
forward averages, so extracting information about the size and kinetics of the sub step is less reliable, but
the total observed step is less than 0.5 nm, as is also the case at saturating MgATP. 600 events were
averaged for the control case and 709 for the 10 M OM case. Vertical dashed lines show the detected
starts and ends of the events.

In the presence of a high OM concentration (10 M), myosin attachments to actin
were clearly resolved via a decrease in the covariance signal (Figure 4.2c, d). Strikingly,
however, there was no clearly discernable working stroke observed (Figure 4.2e). The
average observed step size was 0.4 ± 0.2 nm, and never exceeded 0.75 nm for any
individual myosin molecule. The optical trap stiffness (0.06-0.08 pN/nm) was much lower
than the stiffness of the myosin (0.5-2 pN/nm121,122,152) nearly identical in the absence
and presence of OM, so it is unlikely that the working stoke was suppressed by the small
mechanical resistance imposed by the trap (~ 0.5 pN for a 5.5 nm displacement).
Over a range of OM concentrations (0, 50 nM, 100 nM, 200 nM, 500 nM, 10 M),
the calculated average size of the working strokes decreased from 5.4 ± 0.2 nm to 0.4 ±
0.2 nm in an OM concentration-dependent manner, with an EC50 of 101 ± 25 nM (Figure

4.2f). This EC50 is near the clinically relevant plasma concentration of OM of 100-600
nM153.
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We hypothesize that when OM is bound to myosin it completely inhibits the
working stroke, and the probability of OM being bound to myosin during an interaction
varies with OM concentration (e.g. at the EC50 concentration, half of the observed
actomyosin interactions occur with OM bound to myosin and had a suppressed working
stroke, while the other half of interactions exhibited a full working stroke). We tested this
hypothesis by assuming a model where the distributions of the individual step sizes were
described by the linear combination of two Gaussian distributions, each with its own
mean step size. We performed a MLE global fit across all observed OM concentrations
in the software MEMLET (6)119 to determine if the best-fit parameters from this model
were consistent with our hypothesis (See 0 Methods).

Figure 4.4 Stroke Size Distributions at Saturating [ATP]
Stroke size distributions are shown for OM concentrations ranging from 0 to 10 µM (blue histograms). A
single Gaussian distribution was fit to each dataset individually (black curves), and a 2 component
Gaussian distribution was fit globally to all datasets, where the mean and standard deviations of the
distributions were constrained to be shared among the datasets. The double Gaussian global fit is shown
in solid red, and the large and small dashed curves show the contributions from the two separate
components. One component had a mean of 0.18 nm (large dashed red) and the other of 5.46 nm (small
dashed red). With increasing concentration of OM, the overall distribution shifts leftward toward zero and
the contribution of the component with a stroke of 0.18 nm increases. Figure 4.5a plots the fraction of
events with the 5.46 nm stroke vs. OM concentration. Table 4.1gives the number of observations and
Table 4.3 lists all fitted parameters.

Figure 4.5 Proportions of Events with 5.5 nm Stroke and Rate ka as a Function of [OM]
(a) The fraction of interactions with a 5.46 nm step obtained from the global fitting of step size
distributions is plotted against OM concentration. The dose dependent inhibition has an EC 50 of 88 ± 31
nM (s.e.m.). (b) The data from panel a is replotted in red, alongside the fraction of events which dissociate
at rate ka (the rate observed in the absence of OM, black) which show an IC50 of 96 ± 27 nM. The close
resemblance of these two curves supports the idea that OM acts in one way both to inhibit the step size
and to prolong attachment duration when it is bound to myosin. The green plot shows the deadtime
corrected fraction of events detaching at ka, which takes into account that more events from this
population are undetected due to the experimental deadtime compared to events that detach at the
slower rate kb (see 4.6.1 Deadtime Correction and Adjusted EC50). This correction shifts the EC50 to 164 ±
42 nM. Error bars show the 95% confidence intervals obtained via bootstrapping.
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Table 4.2 Stroke Size Distributions Fitted Parameters at Saturating [ATP]

The step sizes and widths of the two distributions were shared across all OM
concentrations, while the relative proportion of each population could vary. The best-fit
parameters to this model gave two populations with working strokes of 5.46 nm and 0.18
nm. The fraction of events with a mean working stroke of 5.46 nm decreased from 100%
to 8.8% as the OM concentration increased from 0 to 10 M with an apparent EC50 of
87.5 nM ± 31 nM (Figure 4.4 and Figure 4.5, Table 4.2) which agrees with the EC50 for
the average step size of 101 ± 25 nM. This result is consistent with a model in which
myosin performs it full working stroke when OM is not bound but has virtually no net
displacement when OM is bound, and the proportion of interactions that occur with OM
is bound depends on the OM concentration.

4.4.2.

OM Prolongs Myosin Attachment Durations at Physiological ATP

Actin bound durations were well-described by single exponential functions at all
MgATP concentrations studied in the absence of OM, as indicated by the log-likelihood

ratio test performed in MEMLET(6)119 (Figure 4.7,

Figure 4.8 and Table 4.3). The rates of detachment were linearly related to
[MgATP] at low concentrations (0.2 – 10 M, Figure 4.6e), yielding an apparent secondorder rate constant for MgATP binding and detachment (3.0 ± 0.14 M-1s-1), which is
consistent with biochemical measurements77. At saturating ATP (4 mM MgATP), the
mean detachment rate of 47.7 s-1 (43.2 - 51.9 s-1 95% CI, Figure 4.6a) is consistent with

ADP release limiting the rate of actin detachment as predicted by biochemical
experiments and shown previously26,27,77,154.

Figure 4.6 Actin Attachment Durations as a Function of OM Concentration. (a) Cumulative distributions of
the actomyosin attachment durations (solid lines) at 4 mM MgATP. Without OM, the attachment
durations are well described by a single exponential distribution (dotted blue line); however, at 100 nM
and 10 M OM, double exponential distributions were required (yellow and red dashed lines). Inset: 100
nM OM durations on logarithmic x-scale, highlighting the two phases of detachment. (b) Concentrationdependent effect of OM prolonging the mean observed attachment duration (black) at 4 mM MgATP.
Black error bars show the standard deviation of the mean durations from each molecule. Red squares
show the expected duration calculated from the global fit to durations. (c) The fraction of events which
were found to detach at ka, (black), or at the OM-associated rate (kb, red) from the durations global fit as a
function of OM concentration. (d) Observed step size linearly correlates with the fraction of events which
detach at the OM-associated rate, kb. Vertical error bars are the standard deviation of the mean step from
each molecule studied. (e) Detachment rates at 10 M OM as a function of MgATP concentration. Rate k a
(blue) was proportional to MgATP concentration at low ATP concentrations. Rate k b (red) was only
observed in the presence of the drug and was independent of the ATP concentration at all concentrations
studied. Unless otherwise noted, error bars from all panels show the 95% confidence intervals obtained
via bootstrapping. N-values are presented in Table 4.1.

Figure 4.7 Distributions and Fits of the Kinetics of Detachment at Saturating [ATP]. Cumulative density
functions are shown for each OM concentration at saturating MgATP concentration on a semi-log scale
(black). MLE Fits to a single exponential distribution only provide a good fit for the control data (a).
Double exponential distributions fitted via MLE to each dataset individually (red) provide a much better
fit. The global double exponential distribution (blue) forces all the of datasets to share the same two rates
but allows the proportion of events detaching at those rates to vary between datasets at different [OM].
These global fits provide nearly as good of a fit to all the datasets compared to the individual fits. The
global fit requires 8 free parameters (2 rates and 6 amplitudes) to fit all datasets, whereas 18 free
parameters are required for the separate double exponential fits. The number of observations are given
in Table 4.1 and p-values from the log-likelihood ratio test of MEMLET(6) are given in Table 4.3.

Figure 4.8 Distributions and Fits of the Kinetics of Detachment at Sub-saturating [ATP]. Cumulative density
distributions (black) of attachment durations at sub-saturating ATP concentrations for 0 and 10 M OM
(left and right columns respectively) on a semi-log axis. Note the x-axis is scaled differently for the 200 nM
MgATP data (a and b). Single exponential distributions fit well to the data without OM (log-likelihood ratio
test119 for double exponential yielded p = 0.29, 0.44, and 0.43 for 200 nm, 1 M, and 10 M MgATP
respectively), but double exponential distributions are required to describe the 10 M OM data,
especially at 200 nM and 10 M MgATP (log-likelihood ratio test119 for double exponential yielded p < 1e15, = 0.023, and = 1.26e-12, for 200 nm, 1 M, and 10 M MgATP respectively). At 1 M MgATP, the rate
of ATP induced dissociation (5 per second) and OM-associated dissociation (10 per second) are so close,
they become difficult to distinguish visually. The number of observations is given in Table 4.1.
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High concentrations of OM (10 M) decreased the actin-detachment rate 5-fold
to 9.4 s-1 (8.6 – 10.3 s-1 95% CI), as calculated by a single-exponential fit. As the OM
concentration varied from 0 to 10 M, the mean observed attachment duration was
prolonged with an EC50 of 114 ± 38 nM (Figure 4.6b, and 4.6.1 Deadtime Correction
and Adjusted EC50).
The durations of attachment with OM present were not well-described by single
exponential distributions but were best fit by two-component exponential functions as
determined by log-likelihood ratio testing119 (Figure 4.6a, inset, Figure 4.7, Table 4.3). At
saturating ATP and at all OM concentrations studied, the rate of the faster phase (ka) is
similar to the detachment rate of myosin in the absence of OM and the rate of the slow
phase (kb) is similar to the detachment rate in the presence of 10 M OM (Figure 4.7,
Table 4.3). A global fit of a double exponential distribution was performed for the 0 – 10
M OM datasets simultaneously with rates ka and kb being shared between the data sets.
Only the relative proportion of events which dissociated at each rate was allowed to vary
between OM concentrations119. This procedure yielded two common rates similar to
those observed at the 0 M and 10 M OM concentrations (ka = 52 s-1 and kb = 9.4 s-1),
and the relative fraction of events dissociating at rate kb increased monotonically with
increasing OM concentration with an EC50 of 114 ± 28 nM (Figure 4.6c). This supports

the idea that the concentration of OM affects the likelihood that myosin will be bound to
OM when it binds to actin, and that when OM is bound, the rate of detachment of myosin
is changed from ka to kb.
The proportions of events detaching at the OM-associated rate, kb, show a
linear relationship with the observed working stroke sizes (Figure 4.6d). The observed
stroke size decreased as more events detached at rate kb. This relationship supports a
model in which both the stroke size is suppressed and the detachment rate is changed
when OM is bound to myosin.

4.4.3.

Detachment of OM-Bound Myosin is Independent of ATP Binding

At low ATP concentrations (≤ 10 M), where the actomyosin dissociation rate is
dependent on the ATP concentration, the kinetics of actomyosin dissociation with OM

present were again best described by two-component exponential distributions (

Figure 4.8). One of the observed rates (kb) was near 10 s-1 for all MgATP
concentrations studied (Figure 4.6e, red squares). The other rate (ka) varied with ATP
concentration and was consistent with the previously measured second order rate
constant of 3.0 M -1 s-1 for ATP binding to actomyosin77. At MgATP concentrations ≤1
M MgATP, the ATP-dependent rate of detachment was slower than the OM-associated
10 s-1 detachment rate, while at MgATP concentrations ≥10 M, ATP-induced

dissociation was faster than 10 s-1 (Figure 4.6e). Detachments with rates ka and kb were
consistently observed under the same conditions in a single experiment from the same
molecule. This result indicates that after OM-bound M·ADP·Pi binds to actin and enters a
strongly bound state (step 5; Figure 4.1), its subsequent actin dissociation is not through
ATP binding to AM (step 1; Figure 4.1). Additionally, the dissociation at rate kb is not due
to OM-induced dissociation of the M or M·ADP states from actin, as stopped-flow
biochemical experiments indicate that these dissociation rates are substantially slower
than kb and not affected by OM (4.6.2 Stopped-flow Experiments Show OM Does Not
Speed Detachment from the Canonical AM-ADP or AM state., Figure 4.9, Table 4.4).
Taken together these results indicate that cycling, OM-bound myosin does not pass
through the canonical rigor state that requires ATP binding for detachment, but rather
follows a non-canonical pathway.

Figure 4.9 Dissociation of Myosin from Actin from Nucleotide-free or ADP-bound States. (a) Normalized
fluorescence transient increases of pyrene actin during the dissociation of rigor (nucleotide-free or apo)
myosin from pyrene actin in the absence of OM (blue curve) and in the presence of 10 µM OM (red curve)
as obtained from stopped-flow biochemical experiments. The data were fitted by a single exponential rise
plus a constant slope (necessary likely due to the long duration of the experiment, black). The rate of
detachment, was very slow, as expected (0.0054 s-1), and was unchanged by OM. (b) We also observed

the rate of dissociation of M-ADP from pyrene actin (blue, see Methods), which was faster than rigor, but
still very slow (0.015 s-1) and also nearly unchanged by the presence of OM (red, 0.012 s-1). See Table 4.4
for all rates.

AM->M + DMSO
AM->M + 10 µM OM
AM·ADP->M·ADP + DMSO
AM·ADP->M·ADP + 10 µM OM

Rate Constant (s-1)

Uncertainty from fit (s-1)

0.0054
0.0052
0.015
0.012

0.000009
0.000009
0.000105
0.000093

Table 4.4 ATP independent dissociation rates from stopped flow experiments

4.4.4.

Force Dependence of Detachment Rate is Reduced by OM

To probe the force dependence of the attachment lifetime of cardiac myosin, we
used an isometric feedback technique151 previously used to determine the force
dependence of various myosin isoforms.24,26,28 This technique applies a load onto the
myosin molecule by varying the position of one of the optical traps to maintain a constant
position of the bead in the opposite trap. This acts to maintain the actin filament (which is
inside the feedback loop) in a nearly constant position, allowing myosin to exert an
isometric force while it interacts with actin. The value of the applied load is determined
by the distribution of myosin binding positions along the actin and the magnitude of the
working stroke. In the absence of OM, myosin was able to maintain isometric forces
ranging from -1 pN to +7 pN (Figure 4.10a), while in the presence of 10 M OM, the
observed forces ranged between -8 pN to +8 pN (Figure 4.10b). There was no apparent
bias to the direction of the applied forces with OM present, even within a single
molecule’s interactions with a single actin filament. The force distribution in the presence
of OM is likely due to stochastic binding along the actin filament due to Brownian Motion
unbiased by a working stroke, supporting the result given earlier (Figure 4.2) that OM
suppresses the working stroke.

The force-dependence of the actin-detachment rate can be quantified by fitting
the Bell equation62 to the attachment durations without binning using Maximum
Likelihood Estimation119:
𝑘(𝐅) = 𝑘0 e

−𝐅∙𝒅
(
)
𝑘B 𝑇 ,

4.1

where k0 is the rate of detachment in the absence of applied load, F is the
applied force, d is the distance to the force-dependent transition state and a measure of
the degree of force dependence, kB is Boltzmann’s constant, and T is temperature.
Binned detachment rates as a function of force and the results of fitting Eq. 4.4.1 to the
data are shown in Figure 4.10c. In the absence of OM, we found that the distance
parameter (d) was 1.3 nm (1.19-1.49 nm 95% CI), with k0 = 89 s-1 (72.9-109 s-1 95%
CI), consistent with previous measurements for β-cardiac myosin.26,27 However, in the
presence of 10 M OM, there was no appreciable change in the detachment rate as a
function of load (Figure 4d). A log-likelihood-ratio statistical test119 also indicates that
fitting the Bell model to the data is not justified over a force-independent single
exponential distribution (p = 0.62). This reduction in force dependence and prolonged
attachment lifetime by OM is similar to recently published results using an alternative
optical trapping method.101

Figure 4.10 Force Dependence of Detachment is Reduced by OM. (a) and (b) Example traces of force on
the motor bead (blue, red) with the trap’s isometric feedback system engaged. Events, as detected by
covariance, are indicated by dark lines above the force traces. (a) In the absence of OM (blue), forces are
predominantly in the positive direction (myosin is under resisting load) (b) In the presence of 10 M OM
(red), forces are generated in both directions. (c) The observed detachment rates in the absence of 0 OM
(blue) and at 10 M OM (red) as a function of applied load are shown as circles at the average force and
rate of 20 events sorted by force. Green and yellow lines show the detachment rate calculated from
Equation 1 and parameters from the MLE fit in the absence of and presence of 10 M OM, respectively,
with 95% confidence intervals shown as shaded grey areas. Data are composed of 665 and 583 binding
events from 3 and 4 molecules for the absence of OM and 10 M OM respectively. (d) Distance parameter
estimates for the control (no OM) and 10 M OM data from all observed molecules (closed circles) are
shown with 95% confidence intervals from bootstrapping and the estimated distance parameters from
individual molecules (open circles).

4.4.5.

Simulation of Myosin Ensemble Behavior in the Presence of OM

We carried out simulations to determine whether the results we observed in the
optical trapping assay could explain the effect of OM on the actin gliding rate in the in
vitro motility assay77,80,91,92 and on the calcium-dependence of contractile function of
cardiomyocytes.34,146 We used a simple, two-state model of the actomyosin cycle along
with cooperative activation of the thin filament as simulated by Walcott et al.

155,156

(See 0

Methods). This model was used to test whether the effects of OM on attachment rate,
detachment rate, step size, and force dependence would alter gliding velocity and
isometric force as a function of OM and calcium. We utilized parameter values from the
literature77,121,156 combined with the detachment rate, stroke size, and force dependence
measured in our experiments in the presence and absence of OM (Table 4.5). We tested
six possible models of OM’s effects Figure 4.11a, Figure 4.12), including one where only
the phosphate release rate was increased (Malik Model). All other models also included
this increase in phosphate release rate, but varied in the size of the stroke, the
detachment rate, and/or the force dependence of detachment rate. The model utilizing
the parameters measured in this work for step size, force dependence, and attachment
duration is referred to as the Stroke Eliminated, Prolonged Time of Attachment (SEPTA)
Model.

Simulations of unloaded velocity, using an OM binding affinity of 100 nM, showed
that the SEPTA model (Figure 4.11b, red) which includes a decreased step size and
decreased detachment rate was able to fully account for the drastic reduction in actin
gliding velocity we and others80,91,92 observe in vitro (Figure 4.11b, black circles). It is
also possible to simulate a drastic reduction in the motility rate by decreasing the
working stroke size without changing the detachment rate (Figure 4.12, SE model,
green). The Malik Model, the previously proposed mechanism of action for OM88, did not
decrease the velocity (Figure 4.11b, Malik, blue). It had previously been suggested that
the slowed motility could be due to increased force dependence of myosin detachment
in the presence of the drug,68,77,91 but a 10-fold increase in the distance parameter, d,
corresponding to a greatly increased force sensitivity of detachment could not reproduce
the observed suppression of the gliding velocity by OM in the in vitro motility assay
(Figure 4.12, brown).
Description

Parameter

Value

Source

Attachment Rate without OM (Pi rate)

f

17 s-1

Liu et al.77

Attachment Rate with OM (Pi rate)

fOM

Model dep*

Liu et al.77

Detachment Rate without OM

g

89 s-1

This work

Detachment Rate with OM

gOM

Model dep*

This work

Stroke size without OM

s

5.5 nm

This work

Stroke size with OM

sOM

Model dep*

This work

Distance Parameter for Detachment without OM

d

1.3 nm

This work

Distance Parameter for Detachment with OM

dOM

Model dep*

This work

Affinity of myosin for OM (motility)

OM KD Motile

0.1 M-1

This work

Affinity of myosin for OM (cardio myocyte)

OM KD Myocyte

1.2 M-1

Kampourakis et al.33

Stiffness of myosin

kmyo

0.5 pN/nm

Kaya et al.121

Coupling constant for thin filament activation **

C=L/mspace

11

Longyear et al.156

*

Scaling of rate f for off-state of thin filament

εmin

0.0005

***

Scaling of rate f for on-state of thin filament

εmax

0.5

Longyear et al.156

Affinity of Calcium for thin filament regulation

Ca KD

2 µM-1

Kobayashi et al.157

See Figure 4.12A for values

**

This constant was used for simulations of motility assays and cellular-scale simulations in Longyear et.
al., (2017) although it may not directly correspond to the cooperative unit in a native thin filament.
***

Adjusted to fit Nagy et al.146 at 0 µM OM
Table 4.5 Parameter Values for Simulations

Figure 4.11 Simulations of OM’s Effect on in vitro Actin Gliding Velocity and Isometric Force of Muscle
Preparations. (a) Summary of parameters used in models in panels (b)-(e). (b) Comparison of gliding
filament velocity for the protein used in this study (open triangles) and from Swenson et al.91 (closed
circles) to simulated data from the various model parameter sets (colored lines as in (a)). The Stroke
Eliminated, Prolonged Time of Attachment (SEPTA) Model (red), with parameters from the single

molecule measurements, fully accounts for the observed marked decrease in vitro velocity as a function
of OM concentration. Motility error bars are standard deviations of velocities from individual filaments (n
of filaments= 92 - 6709). (c) Comparison of simulated, normalized, isometric forces at an intermediate
calcium concentration (15% activation, lines colored as in (a)) and results from Nagy et. al11 who reported
a bell-shaped force response of permeabilized myocardial trabeculae as a function of OM (black circles).
The SEPTA model (red) shows a similar biphasic shape. (d) Active force data reproduced from Nagy et. al.
as a function of pCa (-log [Ca2+]) at 0, 100 nM and 1 M OM. (e) Simulated isometric force at 0 OM (grey
line), and using the SEPTA model at 100 nM (red dashed line) and 1 M OM (red, solid line) for
comparison with the experimental data in (d). The SEPTA model recapitulates the leftward shift in the
pCa-tension curve (calcium sensitization) and decreased force production at fully activating [Ca2+]

Figure 4.12 Motility Rate and Isometric Force Simulations with Alternative Models
Simulations of OM’s effect on gliding velocity and isometric force with additional models included for
comparison to Figure 4.11 of the main text. (a) Summary of parameters used in models in panels (b)-(e).
(b) Comparison of gliding filament velocity for the protein used in this study (open triangles) and from
Swenson et al.91 (closed circles) to simulated data from the various model parameter sets (colored lines as

in (a)). Only the Stroke Eliminated, Prolonged Time of Attachment (SEPTA) model, with parameters from
the single molecule measurements, fully accounts for the observed marked decrease of in vitro velocity as
a function of OM concentration. Motility error bars are standard deviations of velocities from individual
filaments (n of filaments= 92 - 6709). (c) Comparison of simulated, normalized, isometric forces at an
intermediate calcium concentration (15% activation, lines colored as in (a)) and results from Nagy et. al
(2015) who reported a bell-shaped curve of force development for permeabilized myocardial trabeculae
as a function of OM (black circles). Only the SEPTA model (red) produces a similar biphasic shape. (d)
Active force data reproduced from Nagy et. al. as a function of pCa (-log [Ca2+]) at 0, 100 nM and 1 µM
OM. (e) Simulated isometric force at 0 (grey line), 100 nM (dashed lines, colors as in (a)), and 1 µM OM
(solid lines) for comparison with the experimental data in (d). Only the SEPTA model (red dashed and solid
curves) recapitulates the measured leftward shift in the pCa-tension curve (calcium sensitization) and
decreased force production at fully activating [Ca2+].

Experimental measurements using isolated and permeabilized cardiomyocytes
have shown a biphasic effect of the OM concentration on isometric force production, with
force enhancement peaking at intermediate calcium concentrations.34,146 The SEPTA
model reproduced this biphasic force response in simulations (Figure 4.11c, red).
Simulations using other parameter variations were able to predict an increase in force
production with increasing OM, but only when the working stroke was inhibited did the
force decrease at high simulated OM concentrations (Figure 4.12, SEPTA, SE Models).
SEPTA also was the only one of the six combinations tested that reproduced the
inhibition of force by OM at high calcium concentrations (pCa 4.75) and the increased
calcium sensitivity reported by Nagy et. al and others,9,11,13,14 who demonstrated a
leftward shift in the pCa-tension curve (Figure 4.11d,e). While the in vitro motility assay
simulations used a dissociation constant for OM (Kd) of 100 nM, which is consistent with
our optical trapping data, in the simulations of myocyte isometric force, Kd for OM was
set to 1.2 µM. This value is consistent with the observed effects of the drug in the same
type of muscle preparations (permeabilized rat trabeculae) used in Nagy et al. (2015)
and as discussed in 4.6.3.

4.5. Discussion
OM is not a direct activator of myosin, and its inhibitory effects on motility seem
counterintuitive for a drug that improves myocardial function in heart failure. Our single
molecule results provide a revised mechanism of action of this interesting
pharmaceutical that explains results from a variety of biochemical, structural, and
physiological experiments.
Our optical trapping studies indicate that OM binding to myosin has two main
effects. First, it inhibits the size of the working stroke more than 10-fold, from 5.4 nm to
less than 0.4 nm. Secondly, actomyosin attachment duration is prolonged at
physiological ATP concentrations by 5-fold, and detachment becomes independent of
both ATP concentration and force applied to the myosin. The OM effect on both the
working stroke and attachment duration occur with an EC50 of ~100 nM. A simple model
predicts that prolonged attachments lead to increased force production in muscle due to
thin-filament activation (see below), while the inhibited step size explains the 30-fold
reduction of gliding velocity in vitro and decreased force production in cardiomyocytes
observed under either high OM concentrations or at all OM concentrations for fullyactivating calcium concentrations.
Our discovery of the OM-induced decrease of the myosin working stroke size
clarifies the findings of previous studies. Biochemical and structural studies
demonstrated that OM stabilizes the pre-powerstroke ADP·Pi state6,31. Transient-timeresolved distance measurements utilizing fluorescence resonance energy transfer
suggest that the rate of a conformational change that correlates with myosin’s working
stroke is drastically reduced by OM7, leading to the possibility that myosin detaches from
actin before the power stroke occurs. Additionally, molecular dynamics studies of

cardiac myosin bound to OM suggest that movement of the myosin lever arm relative to
the myosin motor domain may be inhibited by OM.32 Recently reported in-situ studies
also have shown evidence that the stroke may be reduced by OM in muscle fibers.33
Biochemical kinetic experiments have suggested that OM does not affect the
actomyosin detachment rate during cycling,77,88 which is at odds with our findings.
However, studies of tension development and relaxation rates of cardiac muscle
preparations have indicated that detachment may be slowed by OM.146,147,158 The
previous biochemical conclusions77,88 were based on the measurement of the rate of
ADP release (the step that limits the rate of actin detachment at physiological ATP) from
an AM·ADP complex formed by adding ADP to the rigor, AM complex in isolated
actomyosin77,88,91 Our results indicate that the step that limits actin detachment is not
accessible by simply adding ADP, but occurs earlier in the cycle and may not be on the
conventional ATPase pathway (Figure 4.13). Interestingly, a single-turnover, stoppedflow study showed the rate of ADP release was slowed by OM when myosin proceeded
through its cycle from the M·ADP·Pi state.91 However, the authors of this study
concluded that the actin-bound, ADP-isomerization step (AM’·ADP -> AM·ADP) found on
the canonical ATPase pathway was affected by OM. This interpretation is inconsistent
with data presented here (Figure 4.6e) since their model would include a normal working
stroke displacement and an actin detachment rate that would be slowed by low MgATP
concentrations.

Figure 4.13 Model of OM’s Effect on Cardiac Myosin. 1) OM increases the rate of entry into strong
binding as previously measured by phosphate release rates, but the force generating power stroke is
inhibited. 2) Myosin remains strongly bound to actin (red bar), contributing to increased thin filament
activation at intermediate calcium concentrations. 3) OM disrupts the typical pathway of myosin, causing
it to pass through an ADP or apo (nucleotide-free) state with its lever arm still in the pre-power stroke
position. 4) Myosin detaches from actin without needing to bind ATP. ATP binding must occur before the
cycle can start again.

In contrast, our experiments suggest that myosin detaches from actin from an
ADP bound or apo state off the typical pathway, since we observe that myosin does not
undergo a working stroke while attached to actin. This finding is consistent with the lack
of force dependence of actin detachment rate in the presence of OM (Figure 4.10).
Forces that resist the myosin working stroke have been shown to slow the ADP
isomerization or ADP release step.19,25 As the working stroke does not occur in the
presence of OM, the post-stroke state preceding force-sensitive ADP release is never
populated, and the kinetic step that limits detachment is thus not force dependent.
Our SEPTA (Stroke Eliminated, Prolonged Time of Attachment) model
reproduced the biphasic effect of isometric force production on OM concentration in
cardiomyocytes (Figure 4.11). Models that included increased phosphate release rates
and and/or prolonged actin attachment resulted in monotonic increases in force with
increasing OM (Figure 4.11c). The force increase is expected, since increasing the
phosphate release rate and decreasing the actin detachment rate lead to a higher duty

ratio, with more myosins dwelling in the strongly-bound states. However, increasing
phosphate release (Figure 4.11, Malik Model) and/or prolonging the time attached
(Figure 4.12, PTA Model) alone does not account for the experimentally observed
decreases in force at high OM concentrations or at fully activating calcium
concentrations (Figure 4.12c, e). An OM-induced decrease in the working stroke does
account for these effects. Although not modeled in our simulations, OM’s proposed
effect on thick filament activation also could result in monotonically increasing force
production with OM concentration.34 While thick filament activation alone cannot explain
OM’s biphasic effect on force production, it may explain the observed decrease in the
Hill coefficient for the isometric force pCa curves which is not reproduced in our
simulations.
Our simulations suggest that the experimentally observed increase in
cardiomyocyte force production in the presence of sub-micromolar OM concentrations is
due to prolonged actin attachment increasing thin filament activation. OM-bound
myosins do not produce a power stroke and cannot generate force, so experimentally
observed increases in force must be due to the increased recruitment of drug-free
myosin. OM-bound myosin activates the thin-filament regulatory system allowing the
cooperative binding of fully functioning myosin.29 A similar effect on thin filament
activation has previously been shown in low ATP conditions, where the actin-attachment
duration of myosin to the thin filament is increased.159,160 At high concentrations of the
drug, when a majority of myosin heads are bound to OM, force is inhibited at all calcium
concentrations, since OM-bound myosin does not perform its working stroke. A
prediction of the SEPTA model, that is seen experimentally,34,146,148 is that OM does not
increase force production at calcium concentrations that fully activate the thin filament,
and increasing OM concentrations inhibit force. The maximal force at intermediate

calcium (15% activation) is developed when approximately 30% of myosin heads are
bound to OM in the conditions of our simulation (Figure 4.14).
The observed effects on working stroke and attachment duration occur at OM
concentrations lower than the therapeutic plasma concentration of OM in patients of
approximately 100-600 nM,143,144,153 making these observations relevant to therapeutic
applications of the drug (See 4.6.3).
Our single molecule, optical trapping experiments have revealed that at
concentrations relevant to therapeutic treatment of patients, OM acts to suppress
cardiac myosin’s working stroke and to prolong the time of actin attachment. These
effects intuitively seem at odds with the positive results of the clinical trials which showed
increased cardiac output from patients treated with the drug. However, our findings can
account for the previously unexplained inhibition of the gliding velocity in vitro and force
production in cardiomyocytes under saturating calcium and/or high OM concentrations.

Figure 4.14 Isometric Force as a Fraction of Myosin Bound to OM. The (a) normalized and (b) nonnormalized isometric force developed at pCa 6.4-5.8 in simulations utilizing the SEPTA parameters from
the table in Figure 4.11A plotted as a function of the fraction of myosin bound to OM. The bell-shaped
response to force reaches a maximum between 15-35% of myosin bound to OM. In the simulations, pCa
6.4, 6.2, 6.0, and 5.8 correspond to 14%, 25%, 40%, and 63% of full activation respectively in the absence
of OM.

The previous hypothesis that motility was inhibited by increased force sensitivity
of the myosin detachment rate has been shown to be unlikely, both by direct
measurement of the force dependence (Figure 4.10) and our modeling results (Figure
4.12). Our simulations show that the increased attachment lifetime of a small population
of non-force generating myosin molecules is sufficient to explain the calcium
sensitization effect observed in cardiomyocytes and is the likely explanation for the
physiological benefits seen in clinical trials. The concentration of OM in patients has
been shown clinically to be crucial, as doses of OM above the therapeutic level slow
relaxation to the point where ischemia or adverse reactions may occur.90 This knowledge
helps to resolve the apparent inconsistencies observed in the wide variety of
experiments and applications that have used this promising drug.
This study provides an example of how the perturbation of myosin by a drug can
affect more than the kinetic rate constants of its biochemical cycle. To fully characterize
a mutation or drug’s effect on myosin, the possibility of off-pathway states being induced
by the perturbation should be considered. In addition, the observed modulations of
myosin function can cause unexpected functional alterations in the more complex,
integrated muscle cell system. Targeted drug development for alleviating functional
deficits can benefit from screening for biochemical alterations of myosin’s cycle and
testing for biophysical effects, and also taking account of the indirect actions that emerge
when they are assembled into the full biological environment.
The uncoupling of the myosin working stroke from phosphate release in the
presence of this drug provides an interesting example of the disruption between the
biochemistry and mechanical output of the motor. It will be important to study other
perturbations, such as mutations in myosin which cause similar disruptions.

4.6. Additional Notes
4.6.1.

Deadtime Correction and Adjusted EC50

The minimum detectable event in the experiments, derived from the window size
used to calculate the covariance of the two beads, ranged from 16-30 ms depending on
experimental conditions. As described previously119, when two components of a kinetic
process are observed with a deadtime, more events from the component with the faster
process are undetected due to the deadtime as compared to those from the slower
process. For example, in our data at 10 µM MgATP with no OM, we might expect the
distribution of durations to be described the sum of two exponentials since the ADP
release rate (~50 s-1) is close the ATP binding rate (~30 s-1). However, because of the 20
ms deadtime for detecting events from the bead covariance, the lag-phase expected
from the ~50 s-1 ADP release rate is not observed, and the data are well fitted by a
single exponential corresponding to the ATP binding rate.
In other cases, when fitting to a double exponential distribution is statistically
justified (from the likelihood ratio test), this bias can lead to the fractional amplitude of
the slow phase being over-estimated. The amplitudes of the phases presented in the
main text (Figure 4.6 C, D) show the observed amplitudes, without correction for the
deadtime in order to simplify comparison with the step size data, for which no such
correction can be made. When a correction for the deadtime is applied, the fraction of
events occurring at rate ka shifts, as shown in Figure 4.5b (green curve), and the fitted
EC50 increases from 96 ± 27 nM to 164 ± 42 nM. This may represent a more accurate
estimate of the EC50 if the assumed model of two, single exponential components is
correct. The proportion of steps with step size of 5.46 nm from the global fit (Figure 4.5b,
red) more closely resembles the observed amplitude of ka (Figure 4.5b, black), which is
to be expected according to our model since myosin not bound to OM shows the 5.46

nm step and detaches more rapidly and thus the full step events are also more likely to
be missed.

4.6.2. Stopped-flow Experiments Show OM Does Not Speed Detachment
from the Canonical AM-ADP or AM state.
Since OM causes actomyosin dissociation at a rate independent of ATP
concentration we sought to determine which biochemical state of myosin precedes this
detachment. We performed stopped flow experiments using pyrene actin to measure the
dissociation rate of actin-bound porcine cardiac myosin (S1) in the presence and
absence of OM and with no nucleotide present (apo-myosin) or with MgADP. The
detachment rates for both apo and ADP states were quite slow (<0.1 s-1) in agreement
with previously reported values for bovine cardiac myosin76 and were unaffected by the
presence of 10 µM OM (Figure 4.9; Table 4.4). It is important to note that the ADP state
in this study (AM·ADP) is that which is accessible via binding of ADP to the nucleotidefree (rigor) myosin molecule, and is not the AM’·ADP state that immediately follows
phosphate release45. These data suggest that the OM-associated detachment we
observe in the optical trapping experiments does not come from the canonical rigor or
AM·ADP states.

4.6.3.

Affinities and EC50 of OM for in vitro vs. Cardiomyocyte Experiments

The effective concentration yielding a 50% effect (EC50) for OM varies by an
order of magnitude between various reported experiments. Actin gliding assays using
bovine or human β-cardiac myosin have EC50’s ranging from 50 to 200 nM 77,80,91,92. The
EC50’s measured in our optical trapping experiments fall within this range. However,
inhibition of steady-state ATPase activity has been measured to have an EC50 of 500 nM
for the same protein that exhibited an EC50 of 100 nM for gliding velocity91. In addition,

the ATPase inhibition EC50 for permeabilized rat trabeculae has been reported as 1.2
M33. The source of OM and preparation of stock solutions in this rat trabeculae study
were the same as that used in our optical trapping and in vitro motility experiments. We
used 1.2 M as the affinity for our cardiomyocyte simulations (Figure 4.11 and Figure
4.12 C, E) since this rat trabeculae preparation was similar to that used in the Nagy et.
al. experiments146.
The difference in the EC50 values may be explained either as isoform differences,
differential affinity for nucleotide states of the myosin, or a combination of the two. Rat
trabeculae contain a combination of α- and β-cardiac myosin, with 40-70% being αcardiac myosin161. The affinity of OM for rat α- and β-cardiac myosin have not been
measured, offering a possible explanation for the difference in observed affinities in the
rat cardiomyocyte experiments versus the in vitro experiments using purified, human βcardiac myosin. In addition, the trabeculae structure might contain hydrophobic pockets
that could act as competitive binding sites for OM, which may cause a decrease in the
observed EC50 of the drug as compared to the simplified in vitro systems which lack
these hydrophobic pockets.
The affinity of OM for cardiac myosin has been directly measured via isothermal
titration calorimetry for bovine cardiac myosin and ranges from 0.29 to 5.3 µM depending
on the nucleotide state of myosin63. The tightest affinity was for an ADP·Pi analog,
ADP·VO4. Although the primary steady-state biochemical state for cardiac myosin in
muscle is expected to be an ATP or ADP·Pi state, the relative population of the states, or
the partition among other myosin states (e.g. the super-relaxed (SRX) state32) may affect
the effective affinity of the drug. In addition, if OM only tightly binds to the ADP·Pi state,
high actin concentrations may act as a type of competitive inhibitor to drug binding as

myosin in the ADP·Pi state could either bind to OM or quickly bind to actin. Thus, the
highly ordered sarcomere structure which positions actin close to myosin (creating a
very large effective concentration), may serve to reduce the EC50 for the drug.
If the therapeutic plasma concentration of 100 - 600 nM is also present inside
cardiomyocytes, it would result in approximately 50-80% of myosin bound to the drug
based on our experimentally determined EC50 of 100 nM. This high percentage of drugbound myosin would likely drastically reduce force production; however, it is not clear
what is the internal concentration of the drug in patient cardiomyocytes. If the effective
affinity of the drug was 1.2 M, 200-600 nM OM would result in 15-30% of myosin being
bound, consistent with increasing isometric force production at near physiological
calcium levels due to thin filament cooperative activation (Figure 4.14).

4.7. Methods
4.7.1.

Protein Purification, in vitro Gliding Assays

An heavy mero myosin (HMM) construct of human β-cardiac myosin (MYH7) was
expressed in C2C12 myoblasts and purified.80. Actin gliding assays were performed
using fluorescently labeled actin filaments at 32°C80. Omecamtiv mecarbil was obtained
from Selleck Chemical (S2623) and a 10 mM stock solution was prepared in DMSO and
stored at -80 C.

4.7.2.

Optical Trapping Assay

Optical trapping assays were performed at room temperature (20±1°C). Flow cell
chambers were constructed using double-sided tape and vacuum grease26,162. The
surface of the coverslip was coated with a 0.1% nitrocellulose solution (EMS) mixed with
2.5 m diameter silica pedestal beads (Polysciences). The main assay buffer (AB)
contained 25 mM KCl, 60 mM MOPS, 1 mM DTT, 1 mM MgCl2, and 1 mM EGTA.

Cardiac myosin in myosin buffer (AB with 300 mM KCl) was incubated in the 20-30 L
chamber for 30 s to non-specially adhere to the nitrocellulose coated surface, before
being washed out with additional myosin buffer. The concentration of myosin, ranging
from 0.02 to 0.1 g/mL, was adjusted each day so that only 1 out of 5-10 locations
tested showed interaction with the actin filament. The chamber was blocked with 2
incubations of 1 mg/mL BSA each lasting 3 minutes. The experimental solution was
added to the flow cell containing MgATP, either 0.1% DMSO for control experiments or
OM (in DMSO with a final DMSO concentration of 0.1% for all conditions), 0.1-0.2 nM
actin filaments composed of 10% biotin actin (Cytoskeleton) and 90% unlabeled rabbit
skeletal actin prepared from cryoground rabbit back muscle (Pel-Freeze)163 and
stabilized by rhodamine labeled phalloidin (Sigma) and an oxygen scavenging system of
approximately 3 mg/mL glucose, and glucose oxidase catalase. For ATP concentrations
≤ 10 M, the concentration of a freshly made 1 mM MgATP stock solution was verified
spectroscopically each day. Polystyrene beads with a diameter of 500 nm
(Polysciences) were prepared by incubating approximately 0.40 ng of beads with 10 L
of 5 mg/mL neutravidin solution (Thermo) in water overnight at room temperature before
washing 4 times with AB via centrifugation. Four microliters of a solution containing
approximately 5 ng/mL neutravidin-coated beads, MgATP, and either 0.1% DMSO or
OM was added to the chamber before it was sealed with vacuum grease.
Experiments were performed on a dual-beam optical trapping setup137 which
utilizes a 1064 nm laser for trapping and direct force detection using quadrant
photodiodes (JQ-50P, Electro Optical Components Inc.) and a custom-built amplifier.
The two beams were produced and controlled by splitting the laser by polarization and
passing each beam through a 1-D electro-optical deflector (LTA4-Crystal, Conoptics),

which could deflect the beam based on input from a high voltage source (Conoptics,
Model 420 Amplifier). Data acquisition, feedback calculations, and beam position control
output utilized a LabVIEW Multi-function I/O device with built-in FPGA (PXI-7851) and
custom-built virtual instruments (LabVIEW). Data acquisition and digital feedback
calculations occurred at 250 kHz.
The microscope utilized a Nikon Plan Apo 60x water immersion objective (NA
1.2) and a Nikon HNA Oil condenser lens (NA 1.4). One bead was trapped in each of the
two 1064nm beams, with a trap stiffness of 0.06 -0.08 pN/nm, calculated via the power
spectrum of the beads’ positions164. An actin filament 5-10 m long was attached at each
end to the two beads. The position of one bead was adjusted (using a servo-controlled
mirror that was positioned conjugate to the back focal of the objective) to stretch the
actin filament under 4-6 pN of pretension, reducing the effects of the non-linear
compliance of the bead-actin linkage. Pedestal beads were tested by moving the actin
filament close and observing whether any reductions in variance of the measured force
signals occurred. When interactions were detected, a piezo-electric stage (Mad City
Labs) was used to fine tune the position to maximize the number of interactions per
second. A feedback system using an image of the pedestal bead and the nanopositioning stage was used to stabilize the stage position.138,139 For a given molecule, the
position of the stage was slightly shifted along the axis of the filament by 6-12 nm
between some data acquisition traces to reduce inhomogeneity of the accessibility of the
actin attachment zones152.
The isometric feedback experiments24,26,28,56 were conducted using a digital
feedback loop and EODs to steer the beam position. Briefly, a feedback loop held the
position of one of the beads (referred to as the transducer) constant by modulating the

position of the other trap, known as the motor trap. Since the actin filament is between
the two beads and is inside the feedback loop, its position was maintained continuously,
allowing the myosin to develop isometric force during its interaction with actin. The
excursion of the motor trap was limited to 100-125 nm (corresponding to approximately
6-10 pN) to prevent entering the non-linear force regime due to the bead being pulled
too far from the trap center. The response time of the feedback loop during myosin
interactions was approximately 15-20 ms.

4.7.3.

Optical Trap Data Analysis

Optical Trap data were analyzed by calculating the covariance of the force signal
from the two beads with a window of 8-15 ms.24,26,28 The covariance signal from a 30 s
recording was fit to a double gaussian distribution, with the mean of the high covariance
value peak representing when myosin was detached and the lower covariance value
indicating attachment to actin. Events were selected by determining when the
covariance signal passed from the detached value to the attached value and back to the
detached level. The time of the binding event start and end were refined by examining
the point when the covariance crossed a threshold calculated to minimize the overlap
between the distributions of bound and unbound covariance values.24,28 The duration of
the event was calculated from these values of the start and end of each event. The total
stroke size of the event was found by averaging 1 ms of the actin displacement of both
beads 4-10 ms prior to dissociation and subtracting the baseline displacement of the
actin position calculated by the average of a 1 ms window 4 ms after the detected end of
the event. Depending on experimental conditions (dumbbell length, stiffness of beadactin linkages, etc) events shorter than 16-30 ms (16 ms for saturating ATP and up to 30
ms for [ATP] < 4 mM) could not be reliably detected and were eliminated from the

analysis. This deadtime was determined by taking the size of the covariance window and
multiplying it by a factor of 2. Ensemble averaging was performed by aligning the starts
of each event and averaging the signals24,26,28,83 and were weighted such that each
molecule contributed equally to the average.
Events from data acquired utilizing isometric feedback were also analyzed by
examining the covariance signal, which clearly decreased during actomyosin
interactions. While the feedback loop was engaged, we also observed transient (<5 ms)
rises in the covariance signal in the middle of interactions that were plainly not
associated with detachment but were more likely due to a small conformation change in
the myosin which causes both beads to move together simultaneously. These transients
in the covariance signal were recorded as detachment events by the initial analysis, but
a second pass through the data eliminated these detachments by removing detected
unbound events which both lasted less than 2 times the covariance calculation window
and were not associated with a return of the motor bead force to the baseline. The
average force during an interaction was calculated by averaging the force on the motor
bead starting 2 ms after detected attachment through 2 ms before detachment. The
baseline force on the motor bead 4 ms after detachment was subtracted from this
average force.

4.7.4.

Attachment Duration and Step Size Parameter Estimation

Detachment rates and mean step sizes were calculated using MEMLET(6),119 a
MATLAB based program which utilized maximum likelihood estimation to perform
parameter estimation without the need for binning. For each set of conditions, parameter
estimation was performed on data combined from multiple molecules (estimates from
individual molecules yielded similar results to the combined datasets). Because the

number of recorded events from each molecule varied due to non-biologically relevant
experimental conditions (age of chamber, precise positioning of the actin filament,
number of data traces recorded by the user), for each condition, the data was weighted
such that the data from each molecule counted equally in the parameter estimation
process. The multidimensional fitting capability of MEMLET was used to include weights
for each duration or step size, and each weight included as an exponential factor acting
on the total probability density function (PDF) describing the distribution before the log of
the PDF was minimized.119 The weights were calculated such that the sum of all weights
was equal to the number of total points being fit, so that the estimated log-likelihood
would be consistent with unweighted fitting results. Duration data were fit to either single
exponential or double exponential PDF with weights, while step size data was fit to a
weighted double Gaussian distribution in MEMLET119 (v 1.3). Log-likelihood ratio testing
was performed using MEMLET to test for the significance of a two-component fit over a
single-component. Only molecules which had greater than 75 binding events were
analyzed.
Global fitting was performed on the step size distribution data to
determine the parameters for a two-component gaussian model. In this weighted global
fit, data from each OM concentration contributed equally to the parameter estimation,
and data from each molecule contributed equally within a given OM concentration.
Unweighted fitting produced similar results to this weighted approach. In the global fit,
the means and standard deviations were shared between all datasets, but the relative
amplitude of the two components could vary. Using a double Gaussian distribution to fit
each condition individually was not statistically justified over a single component, as
measured by the log-likelihood ratio test. Simulations showed however that this would be
expected even if two populations of events were present with the distributions obtained

via global fitting. This is because the relative size of the standard deviations of the step
size distributions (approximately 7-8 nm) is large compared to the expected difference
between the mean step sizes (~0 nm and ~5.5 nm), and even several thousand
simulated event measurements was not enough for 2 components to be statistically
justified.
Weighting of molecules and conditions for the event duration global fit was
performed as described above for the step size global fit.

4.7.5.

Fitted Parameter Calculations and Reported Uncertainties

Calculations of the effective concentration leading to 50% of the observed effect
(EC50) were performed in Prism v 7.03 (GraphPad Software). Three parameters were
used in the model (Min, Max, EC50), and the standard error of mean was reported for
EC50. Uncertainties in step size measurements are reported as standard errors of the
mean, calculated from the step size distributions. Uncertainties for rates, proportions of
events, and distance parameters are given as 95% confidence intervals calculated via
200-500 rounds of bootstrapping,119 corresponding to approximately twice the expected
standard error of the mean.

4.7.6.

Stopped Flow Experiments

Transient kinetic experiments were performed with pyrene labeled actin filaments
using a stopped-flow instrument (Applied Photophysics).81 Porcine cardiac myosin was
prepared from cryoground pig heart ventricles (PelFreeze)165 and was then digested by
chymotrypsin to isolate the S1 fragment.166 Experiments were performed using the same
assay buffer (AB) as used in the trapping experiments at room temperature (20 °C). All
solutions contained a total of 0.1% DMSO. For AM·ADP dissociation experiments, 1 M
myosin S1 was incubated with 2 mM MgADP and 1 M pyrene labeled F-actin before

being rapidly mixed with a solution containing 76 M unlabeled F-actin, 2 mM MgADP,
and 0.02 units/mL apyrase. The pyrene fluorescence transient was fit to a single
exponential function plus a linear function (to account for drift over the long acquisition
time). The rigor myosin dissociation experiments were conducted in a similar manner but
without MgADP and apyrase.

4.7.7.

Simulations

A Monte Carlo simulation using a modified Gillespie method142 was utilized to
relate the single molecule biochemical and mechanical measurements to previous
results from in-vitro motility assays80,91 and permeabilized cardiomyocyte assays34,146. To
keep the model simple, we only included two states of the myosin, bound and unbound
to actin, and ATP hydrolysis was ignored. A single thin-filament from half a sarcomere
was modeled, where 75 myosin molecules spaced 14.3nm apart (coming from 3 thick
filaments) could interact continuously with the infinitely stiff thin filament. Cooperative
activation arising from strong binding of myosin heads to the thin filament was modeled
by allowing heads near an already bound myosin head to exhibit the maximal on rate
(εmax·f), with an exponential decrease of the on rate as distance from the bound head
increased156. Because the kinetics of OM binding to myosin has not been studied, we did
not allow the exchange of OM with the myosin heads, but set the proportion of myosin
with OM bound based the simulated concentration of OM and using a KD of 100 nM for
motility simulations and 1.2 M for cardiomyocyte simulations. Measured phosphate
release rates from solution were used for the attachment rates to an undecorated actin
filament. Model parameters were taken from the literature when possible, with only one
parameter (εmin) being adjusted to fit experimental control data (Table 4.5). At each
concentration of OM and calcium, 1000 steps of the simulation were run 1000 times. For

the cardiomyocyte simulations, the actin position was held constant (to simulate
isometric conditions) and the average force produced during the last half of the
simulations was recorded. To simulate motility assay results, the simulations were run
without any actin regulation and the total distance the actin filament traveled divided by
the simulation time was used as the measured velocity. For the OM titration curves
(Figure 4.11c, Figure 4.12c), the simulations displayed were run at pCa 6.4 since this
was when the simulated force was approximately 15% activated at zero OM, as it was
far pCa 6.0 in Nagy et al146. Forces for Figure 4.11c-d and Figure 4.12c-d were scaled
to match the data from Nagy et al by first subtracting the simulated force at 0 OM at pCa
9 (simulated passive force), then multiplying by a constant factor set to scale the force
produced at pCa 4.75 (with no OM) in the simulations to that measured by Nagy et. al
under the same conditions. This same constant factor (0.306) was used across all
parameters, OM concentrations, and pCA values.

CHAPTER 5 – Conclusions
5.1. Summary of Findings
This dissertation presents new insights into the chemo-mechanical coupling of
force production in myosin. This has been made possible by advances in optical trapping
technology that allow single molecule studies of the rapid processes which occur
immediately after actin and myosin’s interaction. These observations allow submillisecond and sub-nanometer resolution of the myosin interaction with actin under a
controllable load. The studies presented here using the ultra-fast force-clamp (UFFC)
technique have yielded some of the most direct evidence to date that myosin undergoes
its working stroke prior to the release of phosphate. The UFFC allows us to observe the
initial short-lived, force bearing state of actomyosin, which we find immediately precedes
the working stroke. We have observed that the rate of the working stroke under load is
very rapid (>1000 s-1) and is unchanged by the presence of free phosphate in solution.
These results strongly support that myosin initially displaces an actin filament via its
working stroke before the biochemical energy is expended when Pi is released. We have
also shown that this sequence of events can be disrupted by perturbations, such as the
small molecule drug, omecamtiv mecarbil (OM). We have shown that while OM speeds
up the rate of Pi release, it appears to completely inhibit the working stroke. This is a
direct observation of decoupling of the biochemical and mechanical cycles of myosin.
These methods and results may significantly impact the interpretation of existing
experimental observations and will help guide future studies of not only cardiac myosin,
but other isoforms of myosin and other motor proteins.

5.2. Implications for the Field of Muscle Contraction
Although previous works have presented evidence to support that the working
stroke occurs before Pi release in sarcomeric myosins (some of which is summarized in
Section 1.5), the majority of these studies have relied on either FRET-based
measurements of myosin’s unloaded working stroke,68–70 or significant kinetic modelling
of data from muscle fibers perturbed by solution phosphate.46,47 Since these
measurements are somewhat indirect, the field has not been entirely convinced, leading
some to develop models of muscle contraction placing Pi release before the
stroke.36,49,167 Because of the myriad of factors which can play a role in force
development in muscle tissue, or even isolated muscle fibers, models of this behavior
must include many parameters,36,118 most of which cannot be reliably and independently
estimated.
The reductionist approach presented in this dissertation seeks to better
understand muscle contraction by studying the most basic components of force
generation (myosin, actin, and ATP) in isolation. Characterizing how single molecules of
myosin produce displacement of actin while experiencing near-physiological loads
provides constraints on possible mechano-chemical schemes and parameters for
modeling functioning muscle. Only one other single molecule study of myosin II has
attempted to determine the order of the stroke and Pi release to our knowledge,151 and
the present work is the first to do so under constant loads. Our study provides
compelling evidence for the stroke-first model from data which does not have added Pi in
solution (although we also provide additional support with data including added Pi). This
helps to address the valid concern that solution Pi may not rebind to the same mechanochemical state from which it was released, which could greatly complicate the

interpretation of both muscle fiber and single molecule experiments conducted at high
phosphate concentrations.36,46,47,55
While our experimental results do not specifically address fast skeletal myosin,
the only previous study that used the UFFC to study cytoskeletal motors contains some
data that may support that the stroke occurs first in that isoform as well.71 The
experimental procedures and the interpretation of the data in that previous study did not
aim to address the phosphate release step but did find very similar stroke rates and fast
detachment rates in fast skeletal myosin. This reasoning should help to further support
the idea that Pi release occurs after the stroke in many, if not all myosins. This additional
evidence should affect the understanding and modeling of muscle contraction in the
heart and other muscles. A sound characterization of these rapid mechano-chemical
steps is important for understanding how muscle responds to perturbations, such as
increased levels of solution Pi, which is especially relevant for the ischemic heart.
Besides determining the proper ordering of the working stroke and phosphate
release, there are additional insights into these early states of actomyosin interaction
from our experiments.
The first concerns the properties of the weakly-bound state of actomyosin. This
weakly bound state of myosin has been suggested from muscle fiber and biochemical
experiments,16,53 and is widely accepted in the field. It is characterized by having a very
fast off-rate from actin and can undergo a relatively slow isomerization which places
myosin in a strongly-bound state. This kinetic observation has been linked to structural
studies which associate the weakly-bound state to an open cleft conformation of the
actin-binding site in the myosin head,12 and it is often considered that myosin with
phosphate bound is in the open-cleft, weakly bound state.16 The nomenclature of
“weakly” bound and the idea that the actomyosin interaction site is not fully formed in this

state may have led some to believe this state is unable to support any substantial load. If
this were the case, it would be surprising that the stroke could occur from such a state,
and this type of reasoning may be partially responsible for why some in the field believe
Pi must first be released and the actin binding cleft closed before the stroke. However,
our data show that the weakly bound state can sustain forces of up to 4.5 pN, even if this
state only last for less than a millisecond under these conditions. We observe that a
stroke can occur from this weakly bound state and that such a stroke is capable of
displacing actin against a load. Although thoughtful researchers have recognized that
this is possible,47,168 hopefully our demonstration of the load-bearing nature of this state
and that mechanical work can be performed from this state will help to change the way
some in the field view the “weakly-bound” state.
Secondly, our data show that the working stroke occurs very rapidly (within 1-2
ms of binding) and suggest that the stroke is rapidly reversible. This has been previously
suggested for myosin II151 when under load, and slow reversals of the stroke have been
observed in myosin V under high load,169 but our observations add evidence that this
may occur even in unloaded conditions. Thus, the myosin lever arm may be thought of
having an equilibrium between a pre-stroke and post-stroke state while phosphate is still
bound to the myosin head. Upon phosphate release, it appears that the post-stroke
conformation is “locked in.” This reversibility can make models of myosin’s function in
the muscle much more complex and may explain why it has been possible for some to
produce useful models of muscle function using a cycle in which Pi release precedes or
is partially decoupled from the stroke. The scientists who create such models should
now consider how a rapidly reversible stroke as observed here may improve the
performance of models which place the stroke before Pi release.

This reversibility also raises the question of whether the stroke should be
considered a Brownian ratchet or a true power stroke. The answer to this question may
be more a matter of degree rather than classification, since the pre- and post-stroke
state will always be at some equilibrium with each other based on thermodynamics,
however the amount of bias and the kinetics of the equilibrium are important. If the
kinetics of a stroke reversal are significantly slower than the stroke rate, then this
process may be well described as a power stroke model, since most often the stroke will
occur, and the cycle will proceed without reversing.
However, in our system we observe a reversal rate that is less than an order of
magnitude slower than the stroke rate, indicating that the free energy difference between
these states is not substantial (<3 kT). The data presented here are not able to produce
precise estimates of the reversal rate, and thus it will likely take further studies to fully
settle the question, but results from our study suggest that considering myosin’s working
stroke to be partially due to a Brownian ratchet mechanism may be justified.

5.3. Caveats for the Field
Some of the most widely cited evidence for a model where Pi release occurs before the
stroke comes from structural studies of myosin.12,17,63,65 As discussed in the Introduction
(Section 1.5.4), this conclusion comes from observing the domains and secondary
structural characteristics of various crystal structures and determining when common
features are shared among the structures. For example, when a structure is observed
where Pi is not present (or there is no room for it to be present) in the nucleotide binding
site, but the lever arm is in a pre-stroke state, this is interpreted as evidence that Pi is
released before the stroke. Although structural biology can provide substantial insights
into function, it is not possible to be confident that an observed structural state

corresponds to a biologically relevant state of the protein without additional, functional
evidence. This can be particularly true with myosin structures, as all existing crystal
structures of myosin are not complexed to actin. Actin-binding is well known to affect the
structure of the myosin head,12,37 and it has been recently been shown from cryo-EM
structures and molecular dynamics simulations of actomyosin that actin affects allosteric
communication in the myosin head.14 Our functional studies presented here should help
to interpret the existing structural data by providing information about which observed
structural states are relevant to a cycling myosin.
Our study of the drug OM has provided a direct observation of the decoupling
between biochemistry and mechanics in myosin, which may affect how the field
interprets experiments performed on cardiac and other myosins. Although it has been
previously suggested that decoupling between mechanics and biochemistry may happen
in normal, physiological function,36,170 these suggestions were based on inconclusive
modeling.
While our results cannot fully rule out that some mechano-chemical decoupling
may occur in typical myosin function, we have shown decoupling can play a very
significant role when myosin is perturbed by an external influence. In our study, we saw
decoupling from a small molecule bound between the lever arm and the myosin
head,63,80 but it is also possible that mutations in the myosin could cause a similar
phenomenon. A subset of the myosin field has recently become busy with the study of a
wide variety of myosin mutations that are linked to various cardiomyopathies.92,101,171,172
Typical practice in the field for characterizing a new mutation begins with performing
ATPase or other biochemical assays before moving on to in vitro actin gliding
assays.92,172 It is likely that each of these methods (and possibly both) will provide only a
partial picture of the effects of the mutations. In our example, it took a combination of

biochemistry, motility assays, and single molecule step size and attachment durations to
provide enough information to model the effects of the drug in muscle. This workflow,
including simulations we created to model muscle function from measurable parameters
from single-molecule experiments, should be widely applicable for studying myosin
mutations.

5.4. Future Studies
As discussed above, there are many potential myosin mutations which could be
studied with the workflow presented here. Due to the low-throughput of our experiments,
mutations for which kinetic and motility assays present inconsistencies should be
prioritized. For example, there are reports of a mutation in cardiac myosin (R712L) that
depresses the actin gliding velocity in the in vitro motility assay but has nearly
unchanged kinetics of all key biochemical steps. Even more surprisingly, adding OM to
this myosin can rescue the motility, suggesting that the coupling of biochemistry and
mechanics is disrupted by the mutation and may be restored by the drug.173 Further
study on this and similar mutations using the workflow established here may elucidate
the pathology of some cardiomyopathy mutations.
There is room for additional improvement in the time resolution of the ultra-fast
trapping method by using smaller beads conjugated to the actin filament. The size of the
beads, along with the applied force, sets the velocity of the filament when the actin is not
bound to myosin. With smaller beads and faster velocities, it becomes easier to detect
binding events precisely, allowing short events to be resolved. Also, the Brownian
motion of smaller beads would be less, making it more realistic to quantify the working
stroke and reversals from individual interactions. This could provide quantitative
estimates of the number and rate of stroke reversals that occur under various conditions.

Recently, custom-made microspheres have been designed and produced for optical
trapping,174 including small beads (180 nm in diameter), which are capable of being
loaded with relatively high forces (~10 pN). These beads could effectively double the
time resolution of the experiments, providing significant additional details about myosin’s
short-lived states.
The ultra-fast optical trapping method used in our studies has much potential to
answer similar questions about the weak-binding state, the working stroke, and
phosphate release in other myosin isoforms. Experiments in myosin V would be
particularly informative, as this isoform has some significant kinetic and mechanical
differences from myosin II22 and has had the most evidence presented that its Pi release
step may occur prior to the working stroke.12,17,37,39 Other myosin isoforms such as those
from the relatively slow myosin I family, or the extremely fast myosin XI family would
make an interesting study to see how the kinetics of the weak to strong transition and
the working stroke change as the rates of other steps of the cycle vary. 22
Through continued improvements in the temporal-spatial resolution of single
molecule experiments, the reductionist approach of studying isolated proteins can be
applied to gain new insights into the physiology and pathology of molecular motors.

Appendix A: Analysis of Single Molecule
Data Using Maximum Likelihood Estimation via
MEMLET

This appendix has been adapted from:
MEMLET: An Easy-to-Use Tool for Data Fitting and Model Comparison Using MaximumLikelihood Estimation . Michael S. Woody, John H. Lewis, Michael J. Greenberg, Yale E. Goldman,
& E. Michael Ostap. Biophysical Journal 111, 273–282 (2016).
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6.1. Introduction:
Estimating quantitative characteristics of a biophysical system, such as reaction
rates, ligand affinities, or distance between specific locations within macromolecules
often involves adjusting the parameters of a mathematical model until it best predicts the
relevant experimental data. In experiments on single or small numbers of molecules, the
stochastic nature of the dynamics leads to probabilistic models. The corresponding
probability density functions (PDFs) are typically exponentials, Gaussians, or other
forms, and it is common to consider how complex of a model is warranted by the data,
such as how many exponential components are necessary. The simplest and most
accessible method to fit the model involves binning individual data points to create
histograms, and then using least squares methods to find the optimized parameters of
the PDF. There are important limitations to this approach, however, including the choice
of bin size on the results and the assumption of normally distributed variability among
observations. The number of exponential or Gaussian components necessary to
produce an adequate fit is not easily resolved. Also, when the time scale of the process
being studied approaches the experimental time resolution, the fitting procedure can
severely bias or distort the results, especially in certain cases such as a multiexponential distribution.
An alternative to using least squares methods is Maximum Likelihood Estimation
(MLE),175 which determines the optimum parameters of a given probability distribution
directly from the data without the need for binning or other manipulations (e.g.
calculation of cumulative density functions or survivor curves). Least squares fitting is
actually a special case of MLE that assumes that the variability of the observed data are
normally distributed. MLE makes no assumptions about the distribution of experimental

variability, and it is able to accurately fit parameters from data in which a significant
portion of events are not detected due to experimental detection limits176,177,84. It excels
at fitting datasets which contain multiple dependent variables. Additionally, MLE
methods can be used for reliable global fitting of a common model to datasets from
multiple experimental conditions. Although many scientific computing packages (Origin,
Scientist, MATLAB, etc.) offer some MLE-based fitting tools, the powerful capabilities of
the method for fitting all but the simplest data remain relatively inaccessible for many
users who do not write their own analysis programs. While methods such as Bayesian
estimation also offer advantages for fitting single molecule data, they can be significantly
more complex, requiring users to select an appropriate prior probability distribution
before fitting can occur178. Here we present MEMLET (MATLAB Enabled Maximum
Likelihood Estimation Tool), a simple and powerful MATLAB-based program with a
graphical user interface (GUI) which allows users to fit a selection of common probability
density functions to their data, or to easily enter a custom PDF describing other models.
MEMLET also enables compensation for the experimental limits on the minimum or
maximum detectable event size, comparison of models containing different numbers of
fitted parameters using log-likelihood ratio testing179, and estimation of confidence
intervals using the bootstrap method180,181.

6.2. General Capabilities of MEMLET
MEMLET provides a simple graphic user interface utilizing MATLAB (The
MathWorks, Inc., Natick, MA) that fits data using MLE with the following features:
•

Ability to load data from text files or MATLAB variables

•

Built-in PDFs that are commonly used in data fitting, plus the ability to utilize
user-specified PDFs

•

Options to easily correct for the loss of events above or below a maximum or
minimum detectable value (e.g. instrument dead-time) for built-in or custom
PDFs

•

Significance testing of competing, nested models

•

Determination of confidence intervals of individual parameters by bootstrapping

•

Fitting of datasets with multiple dependent variables

•

Global fitting of multiple datasets from multiple experimental conditions

•

Availability of command-line interface for integration into existing analysis
workflows

•

Availability of MATLAB code or stand-alone executable which avoids the need for
a MATLAB license
The use of each of these features is more fully described in the User’s Guide and

tutorial which accompanies the program.

6.3. Theory:
6.3.1. MLE Algorithm
The MLE method has been well described previously175–177,182. Briefly, the
MLE method seeks to determine the parameters (α1, .., αm) of a given PDF that best
describes a dataset, X. The likelihood (L) of obtaining a particular datum, xi, is simply
the value of the PDF, f(xI , α1 , … , αm ). The joint likelihood (P) for the entire dataset is
the product of the likelihood at each point:

P(X) = ∏i f(xi , α1 , … , αm )

( A.1 )

In practice, this product of many probabilities typically becomes too small for
standard computing environments. This issue is circumvented by maximizing the log of

the joint likelihood. This procedure results in the same set of optimal parameters and
changes the product of the individual likelihoods to a summation:

log(P(X)) = log(∏i f(xi , α1 , … , αm )) = ∑i log(f(xi , α1 , … , αm ))

( A.2 )

The maximum value of this quantity can then be found by minimizing its negative
using a variety of minimization techniques that will find the set of parameters (α1 , … , αm )
most likely to have produced the data.
The actual value of the maximum likelihood (or log of the likelihood) varies
depending on the number of points in the data. This is because every additional data
point reduces the joint probability of the model being an ideal fit to the dataset. Thus,
there is no target likelihood which directly indicates the model’s goodness of fit.
However, the log-likelihood ratio test can be used to compare the likelihoods from
different models fit to the same data (described below).

6.3.2. Fitting Data Subject to Experimental Constraints
Experimental limitations often result in the exclusion of some events from the
dataset. For example, an instrument’s finite sampling rate results in a “dead-time,” where
events shorter than the sampling rate are not detected. In other cases, averaging of the
data over a window can cause the loss of short-lived events. In situations that contain a
dead-time (tmin), the standard form of a PDF will be improperly scaled. This is because,
by definition, the sum of a PDF over its entire domain equals one, but due to the deadtime, there is a range of the domain where no events can be observed (i.e. the
probability of an event with duration less than tmin is zero)176.
Scaling the standard PDF, g(t, 𝛼1 , … , 𝛼𝑚 ), so that it sums to 1 over the actual
experimental range (tmin through infinity, or upper limit of event size, tmax), yields a

renormalized PDF, f(t, tmin, 𝛼1 , … , 𝛼𝑚 ), that is properly normalized over the relevant
range)176,180.
g(t,α1 ,…,αm )

f(t, t min , α1 , … , αm ) =

(A.3 )

R(tmin ,α1 ,…,αm )

R is a renormalization factor given by
∞

R(t min , α1 , … , αm ) = ∫t

min

g(t, α1 , … , αm )dt

( A.4 )

Assuming the PDF g(t, 𝛼1 , … , 𝛼𝑚 ) accurately describes the system being
studied, R gives the proportion of the events that were observed with (1-R) indicating the
proportion of events that were missed because of the instrument dead-time. Note that
the application of the tmin correction is not limited to instrument dead-time, but can be
applied to any limitation that restricts a dataset (e.g., limitations in signal detection,
dynamic range, etc).
A similar procedure can be used to renormalize a PDF if certain events are
excluded or lost because their size is too large to be included by replacing the upper limit
of the integral in Equation 4 with this maximum size. MEMLET also allows users to
specify this maximum detectable event size (tmax), and the program will use the
appropriately scaled PDF for its built-in models.

6.3.3. Likelihood Ratio Testing:
Often when considering multiple models, one wishes to consider whether the
introduction of more free parameters is justified by the data. MLE methods offer a
simple way to determine whether the increase in the goodness-of-fit from using a PDF
with more free variables is statistically justified compared to using a constrained version
of that PDF with fewer free variables. For example, one can statistically test whether a
dataset is better described by the sum of two exponential phases (i.e., unconstrained fit)

or if a single exponential component (i.e., constrained fit) is sufficient. This testing can be
accomplished by examining a test statistic based on the ratio of the log-likelihoods (RLL)
of the constrained fit (LHconst) to the unconstrained fit (LHunconst).
LHconst

RLL = −2 log (LH

unconst

) = 2(log(LHunconst ) − log(LHconst ))

( A.5 )

The RLL value is approximately described by the chi-squared distribution with the
degrees of freedom given by the difference between the number of free parameters in
each model179. This approximation has an error on the order of

1
,
√n

where n is the

number of data points being fit. Thus, for small datasets, this method may exhibit
reduced accuracy179. MEMLET allows the user to specify a constrained PDF to be tested
by inputting which variables should be fixed and their values. The program will generate
a constrained version of the PDF, fit it to the data, and determine the likelihoods for the
unconstrained and constrained fits. A p-value is given representing the probability that
the model with fewer free parameters is sufficient and that the one with more free
parameters is not justified by the improvement in likelihood.

6.3.4. Obtaining Confidence Intervals from the Bootstrap Method:
Estimates of the uncertainties or confidence intervals of parameters obtained by
least squares fitting assumes that the residuals between the data and the fitted function
are normally distributed. MEMLET does not make this assumption, and it is able to
return accurate confidence intervals by using the well-established bootstrap method
176,180,181

.
In brief, synthetic datasets of the same size as the experimental dataset are

generated by randomly selecting values from the experimental dataset with inevitable
duplication. The synthetic dataset is fit via MLE to obtain best-fit parameters. This
process is repeated (~500 – 1000 times), and 95% confidence intervals can be obtained

by examining the distributions of the parameter values estimated from the fits of the
synthetic data. This confidence interval provides information about how well-constrained
the fitted parameters are for the given dataset, and thus also offers some indication of
the appropriateness of the chosen PDF. The distributions of the parameter values from
the bootstrap can be used for further statistical testing, for instance, using Student’s Ttest to determine whether parameters obtained from different data populations are
significantly different.
The reader should be warned that unlike the algorithm used in MEMLET,
MATLAB’s built in MLE-based solver (mle.m) returns confidence intervals for custom
PDFs assuming the residuals are normally distributed, which may not be the case for the
given dataset.

6.3.5. Global Fitting of Multiple Datasets:
In a global fit, multiple datasets (X1, …, Xℓ), each containing nℓ data points xi,j, are fit
to the same PDF with m fitted parameters being shared between datasets
(eg. Α1 , … , αm ) and n fitted parameters varying between datasets
(eg. β1,1 , β1,2 , . . β1,ℓ … , βn,ℓ ). For example, a binding reaction may be performed at
multiple substrate concentrations, changing the on-rate of the reaction, but leaving the
off-rate unchanged. In these cases, series of PDFs are generated, one for each dataset:

f1 (X1 , α1 , … , αm , β1,1 , … , βn,1 ), … , fℓ (Xℓ , α1 , … , αm , β1,ℓ , … , βn,ℓ )

(A.6 )

The sum of the log-likelihoods of each PDF is then evaluated and minimized as
above.
𝑛

ℓ
log(P(X1 , … , Xℓ )) = ∑ℓj=1 ∑i=1
log(fj (xi,j , α1 , … , αm , β1,j , … , βn,j )

(A.7 )

In MEMLET, each data point, regardless of the dataset in which it is contained,
has an equal weight in the fitting of the data.

6.3.6. Fitting Implementation and Method for Finding Global Minima:
MEMLET utilizes the hybrid-simulated annealing algorithm built-in to MATLAB
(simulannealbnd.m) to minimize the log-likelihood (Eq. A.2; 183). The simulated
annealing method has the advantage of being relatively insensitive to the initial usergenerated parameter guesses, making it less likely to get trapped in a local minimum of
the multi-dimensional likelihood surface. Initial parameter guesses are iteratively
perturbed by a random amount and are tested for goodness-of-fit. The limit on the size
of this initial perturbation is set by the “Annealing Temperature” parameter. At each
iteration, if the goodness-of-fit has increased, the size of the random perturbation is
decreased, and the system “cools.” Here, we employ a hybrid method that first uses the
simulated annealing technique to find the approximate location of the global minimum
before switching to a direct search (patternsearch.m by default) or other specified
minimization algorithm to finely resolve the global minimum.

6.4. Results and Examples
Here we present several sets of simulated data showing the advantages of using
MLE for fitting models to datasets as provided in MEMLET. Then we show two examples
of using MEMLET to fit previously published data. While the shortcomings of some of
the procedures that are used in comparison to MEMLET will be obvious to investigators
experienced in model fitting, the examples are provided as a tutorial for those new to the
subject.

6.4.1. Advantages of Using Unbinned Data
The MLE method used by MEMLET offers advantages over least-squares fitting
of binned data, particularly when the number of data points is small. These advantages
can be illustrated considering a 2-exponential process. We performed a simulated
reaction where species S1 and S2 were independently converted to species P with rates
of k1 = 500 s-1 and k2 = 50 s-1 (Scheme A.1). The percentage of P formed from S1 was
defined as 20%, and 250 simulated data points representing the time of appearance of P
were drawn from an exponentially weighted random variable (Figure 6.1).

S1
Scheme A.1

k1= 500 s-1

S2
k2=50 s-1

P

The appearance of P is described by the sum of two exponential distributions,
weighted by the relative amplitudes (A and 1-A) of each pathway (Eq. A.8)184.

𝐴𝑘1 exp(−𝑘1 𝑡) + (1 − 𝐴)𝑘2 exp(−𝑘2 𝑡)

(A.8 )

In the case of single molecule data, the amplitudes (A or (1-A); Eq. A.8) of each
phase of an exponential distribution, give the proportion of detected events that occur
with a given rate (k1 or k2 respectively). The PDF given in Eq. A.8 is properly normalized
by first scaling each exponential function by its rate, before multiplying by the relative
proportion of each phase. This means that the total scaling factor for each exponential is
the rate multiplied by the relative proportion of events (e.g., Ak1). This subtlety in the
scaling of amplitudes is important when comparing the equations used for the fitting of
single-molecule data to the equations used for fitting data curves from ensemble
experiments, such as stopped flow kinetics, where the amplitudes of the exponential
phases are not scaled by their rates. In such cases, the relative amplitude of each

exponential phase gives a direct indication of the number of molecules that have
undergone a transition.

Figure 6.1 MLE fitting outperforms least squares fitting of binned data. A-D: Parameters used for
generating data (histograms) according to equation 8 are shown in black, while the fit to the binned
histograms (red) and the MLE fit (green), which is independent of binning, are plotted on each panel. Inset
of C and D show the same data and fits with the x-axis on a log-scale. E-G: Average fitted value for the two
rates and relative amplitudes, as well as the 95% confidence intervals (error bars/shaded area) obtained
by 1,000 rounds of simulations. The values used to generate the simulated data are shown by the black
dot and black dashed line.

Least squares fitting of Eq. A.8 to histograms containing 7 – 60 bins created from
the simulated dataset show that the number of bins has a considerable effect on the
values of estimated model parameters (Figure 6.1). Plots of best-fit parameters as a
function of number of bins show that the rate (k1) and amplitude (A) of the fast phase are
vastly underestimated when the number of bins is small (<15 bins; Figure 6.1E, G), as
the information about this rate is lost by grouping nearly all the fast events into one or
two bins (Figure 6.1A, B). For the slower rate (k2), increasing the number of bins
decreases the precision of the determined parameter (Figure 6.1F), which is due to
increased stochastic variability in the number of observations in each bin (Figure 6.1C,
D). Least squares fitting of histograms typically overestimates the fast phase (Figure
6.1E). When MEMLET fits the same PDF to the data, it accurately resolves both the fast
and slow phases as well as their relative amplitudes with smaller confidence intervals
(green bar in Figure 6.1 E-G). A tutorial demonstrating how to use MEMLET to perform
this type of fit is given in Figure 6.2.

Figure 6.2 Tutorial 1: Performing a Simple Fit

6.4.2. Fitting of Datasets Limited by Experimental Conditions
Data acquisition in most experiments is limited by a tmin, which can be an
instrument dead time or minimum signal threshold. For example, in fluorescence
imaging experiments, the shortest time a molecular state can be observed will be set by
the frame rate of the camera185–187, while the dead time in an optical trapping experiments
is often limited by the frequency response of the intrinsic thermal noise of the
system71,188. If the magnitudes of the events of interest are on the same order as tmin,
there may be a significant perturbation on the values of the fitted parameters if the
effects of tmin are not considered84.
Such effects of a tmin in the form of an instrument dead-time is demonstrated in
Figure 6.3, where we simulated a 1,000 point dataset representing the duration of time
that molecules remain in state A until they transition to state B (scheme 2) at a rate of 50
s-1.

A

k=50s-1

B

Scheme A.2

The lifetime of the population of A is described by a single exponential
distribution (Figure 6.3A, blue). In the absence of an instrumental dead-time, the
transition rate can be determined from the simulated data by calculating the inverse of
the mean of the durations.
However, when a tmin threshold is imposed by removing all durations shorter than
10 ms, 60% of the events are removed from the analysis (Figure 6.3A, red). Because the
events that are missed are the shortest events, the inverse of the mean duration (33 s-1)
underestimates the true rate of the process. (Figure 6.3A, dashed red line). A faster
rate constant (Figure 6.3B, C blue) or a longer dead-time would result in an even more
substantial underestimation of the rate.

Figure 6.3 Effect of instrument dead-time on determination of best-fit parameters for different fitting
procedures. A: a simulated single exponential dataset shown as histograms for the complete dataset
(blue) and the dataset subjected to tmin = 10 ms (red). B: Trend for a single exponential of the fitted rates
versus the actual rates of the simulated data with tmin = 10 ms imposed for all rates using the inverse
mean method (blue), histogram fits (yellow), cumulative distribution fits (red), and MLE method (green)
with the PDFs used for fitting specified for each method. Five-hundred rounds of fitting unique simulated
datasets yields 90% confidence intervals for each method (shown by shaded areas). The dark shaded
areas and closed symbols show how each method performs when the number of points is held constant
at 1,000 data points, while the light shaded areas and open symbols describe the fit when the number of
fitted points is reduced as the rate increases due to tmin. The difference in between light and dark is
most obvious for the MLE while for the other methods the dark shaded areas appear as lines. C: The
distribution of fitted rates (histograms) compared to simulated rates (black dashed line) from the 500
simulated data sets subjected to tmin = 10 ms used to generate Panel B. For the MLE fits, the labels on the
left y-axis give the counts for the light areas, while the right y-axis labels are the counts for the dark areas.
Other methods share the left axis labels.

Missing events due to a dead-time may lead to a reduction in number of events
in the shortest duration bins (red histogram, Figure 6.3A), which can lead to inaccurate
rates obtained by least squares fitting. Fitting the uncorrected single exponential PDF to
the full, binned dataset using least squares fitting yields a rate of 49.5 s-1 (95%
confidence interval 48.6-50.4) (blue line, Figure 6.3A), while the data subject to the 10
ms dead-time yields a rate of 42.5 s-1 (39.5-45.6) (red line, Figure 6.3A). Notably, the
binned data that are truncated due to tmin can resemble a double-exponential or gamma
PDF, resulting in the application of an inappropriate kinetic model.
Figure 6.3B shows the effect of a 10 ms dead-time on fitted rates obtained via
different methods as a function of the rate constant used to simulate the data (k 1,
Scheme A.2). As the rate constant is increased, more events are missed from the
original 1,000 simulated events, until at a rate of 500s-1 only 6 events remain. Fitting the
standard, uncorrected PDF to histograms using least-squares fitting (yellow, Figure
6.3B, C) will often underestimate the simulated rate when a tmin is present. Adding an
additional fitting variable to account for the amplitude when fitting to a cumulative
distribution function (CDF), helps to increase the accuracy of the fit (red, Figure 6.3B, C),
however this method fails at rates >200 s-1 when tmin is more than twice the mean lifetime
of the events. Use of MEMLET to fit a dead-time-corrected PDF (as described in the
Methods) yields accurate fitting (error <10 %), even when tmin is nearly 4 times larger
than the mean lifetime (green, Figure 6.3B, C). Keeping the number of data points
constant at 1,000, as shown in dark green in Figure 6.3B and Figure 6.3C, allows the
corrected MLE fit to produce very accurate results with small confidence intervals (dark
shaded regions of Figure 6.3B). Assuming that tmin is known, this MLE method requires
fewer free parameters than the cumulative distribution with a free amplitude term. A

tutorial demonstrating how to use MEMLET to fit data subject to a dead-time is given in
Figure 6.4.

Figure 6.4 Tutorial 2: Performing a Fit Subject to a Dead-Time

The effect of tmin on the fit can impact the conclusion of an experiment. For
example, the data shown in Figure 6.3 could represent fits to a dataset produced by an
instrument with a 10 ms dead-time under various experimental conditions that affect the
rate of a studied process. It is clear that as the rate of the reaction increases, the fitted
rates plateau for all tested fitting methods except for the corrected MLE fit, leading to a
possible misinterpretation of the experimental results. While other methods exist that can
correct for tmin in simple cases such as a when the data is best described by a single
exponential function, MEMLET provides a consistent way to account for tmin across a
variety of complex models.
As an aside that would be a footnote if Biophysical Journal allowed it: For the
single exponential example, a very simple method of estimating the time constant is to
subtract tmin from the raw average of the sample durations:
τest =  ti / n - tmin

( A.9 )

where n = number of samples. This relationship gives the same values as the
green symbols in Figure 6.3B. However, it is only useful for a single exponential process
and does not provide confidence intervals or the other features of MEMLET. Performing
such dead-time corrections allows the other methods to perform better than shown in
Figure 6.3, but MLE will still outperform in challenging circumstances, such as when the
number of points is low (Figure 6.5).

Figure 6.5 Data were generated in the same way as in Figure 6.3, but dead-time corrections were used for
all fitting methods. The inverse method was corrected as described in the text by subtracting the deadtime from the mean duration before calculating the inverse value. The fits to the binned data points were
corrected by using the same dead-time corrected PDF used in the MLE fit and ignoring any bins whose
range was less than or included the dead-time. Cumulative distributions were corrected by subtracting a
floating amplitude term from the PDF given in Figure 6.3. The corrected mean method gives the same
result as the MLE method (as expected and described in the main text), however this inverse mean
method is not applicable to data with multiple exponential components. When the number of data points
is kept constant at 1000 (closed symbols and dark shaded areas representing 90% confidence intervals
from 1000 rounds of simulations), the fits all maintain accuracy, but the MLE and mean fits show the
smallest confidence intervals (mean confidence intervals not shown for clarity, but are the same as the
MLE). When the number of points being fit are allowed to decrease with increasing rate due to more
events being shorter than the 10ms dead-time (open symbols and light shaded areas), the MLE (and
mean) fit offers the more accurate fit and lowest confidence intervals, particularly at high rates.

When a process includes transitions to a state via multiple pathways (Scheme
A.1), it is important to know the relative contribution of each of these pathways, which
can be derived from the amplitudes of each exponential component. Estimates of the
amplitudes are highly susceptible to distortion when tmin exists. When the simulated data
from Figure 6.1, which contains two exponential phases, is subjected to a tmin, data
originating from the faster phase are more likely to go unobserved (Figure 6.6A). This
causes the relative amplitude of the faster phase to be underestimated when using leastsquares fitting to a histogram (Figure 6.6B, yellow).

Figure 6.6 Effect of instrument dead-time on multi-component models for different fitting procedures. A:
The empirical cumulative density function (CDF) for the entire simulated dataset from Figure 6.1 (blue),
and the CDF when events shorter than 2 ms are removed (red). Vertical dashed lines show the dead-time,
while horizontal dashed lines show the proportion of events missed. Inset shows a zoomed-in view of the
same plot. B: The performance of histogram fits (yellow), cumulative distribution fits (red), and MLE fits
(green), in estimating the proportion of fast events as a function of increasing tmin. Shaded areas indicate
95% confidence intervals for the fits estimated from 500 rounds of simulations.

Cumulative distributions with an extra free amplitude term yield accurate fits for
very small tmin (<0.5 ms, half of the mean lifetime of the fast phase, Figure 6.6B, red).
However, the tmin corrected MLE fit performed by MEMLET is able to faithfully report the
relative amplitudes of each phase to within 10%, even when tmin is the same size as the
mean lifetime (2ms) of the fastest events (Figure 6.6B, green). The ability of MEMLET
and other methods to accurately fit double exponential functions depends greatly on the
difference between the two rates of the processes, as shown in Figure 6.7.

Figure 6.7 Data sets composed of 1000 points each were simulated by drawing from a double exponential
distribution with k1 = 100 s-1 and varying k2. 50% of events came from the variable rate process, and no
dead time was imposed on the data. 1000 independent datasets were generated and fit using cumulative
distributions, histograms, and MEMLET’s MLE algorithm. (A) The fitted rate for k2 is plotted, along with
90% confidence intervals. The variable rate is difficult to accurately fit when it is 2-fold (50-200 s-1) of k1.
MLE fitting consistently yielded a more accurate rate with lower confidence intervals outside of this 2-fold
range than the other methods tested. (B) Plot of the percentage of 1000 simulations in which the loglikelihood ratio test yields a p-value below 0.05, indicating a double exponential fit is justified over a single
exponential fit. When the value of k2 approaches k1 (100 s-1), the log-likelihood ratio test is unable to
distinguish the two components.

6.4.3. Fitting Data with Multiple Dependent Variables
Fitting data consisting of multiple dependent variables can become difficult when
the relationship between the variables is not simple. When the residuals of a fit are not
normally distributed (e.g. observations of photon counts which follow a Poisson
distribution), it is inappropriate to fit the data using least squares fitting as the
assumptions necessary for least squares fitting are not met 176. As mentioned, the

accuracy of MLE fitting is not dependent on this assumption, and MEMLET can be easily
used in cases where two or more dependent variables are present. A tutorial for using
MEMLET to fit a dataset with two dependent variables is given in Figure 6.8.

Figure 6.8 Tutorial 3: Fitting 2D datasets

When optical trapping experiments are used to study the force dependence of an
association lifetime between two molecules, both the force applied to the molecules and
the duration of a single interaction are recorded24,151,189. In Figure 6.9, MEMLET has
been used to fit a dataset from an optical trap experiment studying the durations of
attachment between myosin 1b and actin189. The experiment reveals durations of
attachments at a wide distribution of forces (Figure 6.9A). The standard deviations of the
grouped data show that at each force, the spread in the durations differs. At forces
below 1.2 pN, the value of the durations is strongly affected by force, while at forces
above 1.2 pN, there is little change in the mean duration as force increases (Figure
6.9B). This suggests the overall rate of dissociation, k, is given by the sum of a forceindependent rate (ki) that dominates at high forces, and a force-dependent rate (kF) that
dominates at lower forces, as shown in Scheme A.3 and Equation A.10.

Attached
kF (F)

ki
Scheme A.3

Detached
k= kF(F) + ki =k0·exp(-F·d/kBT) + ki

(A.10)

where k0 is the rate of the force-dependent transition at zero load, F is the force,
d is the “distance parameter,” which indicates the sensitivity of rate on force, k B is
Boltzmann’s constant, and T is the temperature. The distribution of attachment
durations will be exponentially distributed at this summed rate (ki+kF) at each force, but
the overall distribution of all attachment durations will not be exponentially distributed,
causing the data points to appear very disperse (Figure 6.9A).
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Table 6.1. Results of fitting various models to the data show in Fig 7 in the main text. The Log-likelihood
ratio test can be applied to determine p-values for whether the first equation (One Force dependent
phase and One force independent phase in parallel) is statistically justified over other models. Note: The
independent series PDF can not be written as a simplified version of the parallel PDF, so it’s not strictly
possible to perform the log-likelihood testing to compare the two models. However, from the loglikelihoods and the fitted values, it can be seen that the series PDF fits no better than the Bell Equation,
which is statsically less significant than the parallel fit and has one more degree of freedom. This shows
that the series fit is inferior to the parallel fit for this dataset.

Figure 6.9 MEMLET can determine non-linear relationships between multiple dependent variables. A:
Data points representing acto-myosin attachment duration data from Laakso et al. (blue), with data
grouped by force in 0.5 pN bins with standard deviations (green bars, no binning was used for fitting). The
MLE fit (red) to the PDF in Equation 10 describing Scheme 3 with 90% confidence intervals (grey shaded
area) determined from 500 rounds of bootstrapping. B: The calculated CDF of the data in Panel A grouped
in specified force ranges showing the rate of the process is force dependent at low forces (0-1.2 pN), but
force independent at higher forces (>1.2 pN) as shown in Scheme 3.

MEMLET is capable of fitting this complex model to the data while taking into
account an instrumental dead time (Figure 6.9A, Table 6.1). A simulated dataset of
similar characteristics and the corresponding fit are shown in Figure 6.10 and Tables A.2
and A.3, alongside other possible parameter values, illustrating the program’s ability to
accurately fit this type of complex distribution.

Figure 6.10 Simulated data using the same kinetic model that was used to fit the data in Figure 6.9. 500
simulated datasets of 329 points each were generated using the “One Force dependent phase and One
force independent phase in parallel” PDF from Table 6.1and then were fit using the MLE fitting method.
The simulated parameters are given at the top of each panel. 95% Confidence intervals (grey) were
determined using the results of the 500 independently fit datasets. The program is able to accurately fit
the parameters over a wide range of input parameters, including those similar to the data shown in Figure
7 (Panel B). The fitting performs worst when the distance parameter (d) is very low (Panel C), or very high
(Panels A and E), because in such cases the force range being simulated is either too small or large,
respectively, to show the effect of the force dependent rate. Table 6.2 and Table 6.3 show the
performance of the fits from each case.
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Table 6.2 Parameters of the simulation shown in Figure 6.10 that shows MEMLET is capable of accurately
fitting data similar to that presented in Figure 6.9. Number in parenthesis indicated 95% confidence
intervals. Fits to the data in Figure 6.9 with 95% confidence intervals show in the last row.

d error

ki (s1) sim

ki error

18.3 %
1%
-27.8 %
1.58 %
15.5 %

d (nm)
sim
127
12.7
1.27
12.7
127

-1.84 %
-0.803 %
483 %
0.0101 %
-12.3 %

0.1
0.01
0.001
0.01
0.01

-1.42 %
2.31 %
1500 %
2.96 %
-4.41 %

3.27 %

12.7

0.769 %

0.1

0.347 %

Panel

kf (s1) sim

kf error

A
B
C
D
E

3.55
0.355
0.0355
3.55
0.355

F

0.355

Table 6.3 Values of the simulated parameters from Figure 6.10 and the percent error of the fits from the
simulated values.

6.4.4. Determining Statistical Justification of Additional Fitted Parameters
It is often non-trivial to decide which model is the appropriate choice to describe
a given dataset. The program presented here provides a log-likelihood based method
(described above in Theory: Likelihood Ratio Testing) for quantitatively determining
whether a PDF with more free fitting variables fits significantly better than a constrained
version of that PDF with fewer free parameters. To demonstrate this functionality in
MEMLET, Tutorial 4 (Figure 6.11) shows how to determine if adding an additional
exponential phase to a single exponential distribution is statistically justified in a
simulated dataset. After following the described procedure for statistical testing,
MEMLET provides a p-value giving the probability that the model with fewer fitted
parameters is a statistically better fit over the more complex model when accounting for
the increased number of free parameters (i.e. if p=0.05, there is 95% confidence that the
model with the additional parameters is a statistically better fit). An example of how well
this test can discriminate the two phases of a double exponential distribution as a
function of the difference between the two rates is shown in Figure 6.7.

Figure 6.11 Tutorial 4: Performing Model Testing

This test can be applied to the data presented in Figure 6.9 to determine if the
observed data require a force-dependent term for significance, or if it can be adequately
described by a simpler model function. For the data in Figure 6.9, it was previously
determined using MLE-based methods that the data is well-described by a process that
includes a force dependent process as well as a parallel, force-independent process as
shown in Scheme A.3189. A PDF describing a process with both a force-dependent and
a force-independent process can be input as a custom PDF into the fitting program, and
the log-likelihood testing function can be used to determine that this indeed yields a
better fit to the data than either a single force-dependent or a single force-independent
process (p<10-6, see Table 6.1), and that the free parameters, ki, k0, d, are all statistically
justified.

6.4.5. Global Fitting
In some cases, multiple datasets might be described by distributions that share
some, but not all, of the same parameter values. For example, by changing the value of

an independent variable across experiments, such as the concentration of a solute (ions,
nucleotide, etc.), one rate of a multi-rate process may be changed without affecting the
other rates present. MEMLET is capable of using multiple datasets acquired under
various conditions to fit a given model, letting the user specify which fitting parameters
are shared between the datasets and which vary in different experimental conditions, as
demonstrated by the Global Fitting Tutorial. (Figure 6.12)

Figure 6.12 Tutorial 5: Performing Global Fits

As an example, we apply this procedure to single molecule FRET data from
Chen et al., 190 shown in Figure 6.13, where the FRET value signals the distance
between a fluorophore on a ribosomal subunit (L11) and a fluorophore on a tRNA during
the translation of a peptide sequence190.

Figure 6.13 . Global Fitting in MEMLET improves precision of fitting multiple datasets. Fitting of FRET
efficiency data from Figure 3D of Chen et al. showing two populations of FRET efficiencies in two datasets.
Panels A and B: Each dataset was fit individually with a double Gaussian PDF (dashed red lines, solid lines
show individual Gaussian components). The global fit (yellow) constrained the position and width of both
Gaussian components, while allowing the relative amplitudes to vary between the data sets. Vertical lines
show the fitted position of the high FRET peak for the individual (red) and global (yellow) fits.

The ribosomes were in a PRE-translocation complex waiting for the translocase,
elongation factor G, to bind. As evidenced from time courses of the FRET efficiency
(Figure 3A, B in ref. 190), some of the ribosomes fluctuated between two PREtranslocation structures, termed “classic” and “hybrid”, whereas other ribosomes stably
occupied either the “classic” or “hybrid” PRE state. For both stable and fluctuating
ribosomes, the distributions of FRET efficiencies between two fluorophores were best
described by the sum of two Gaussian distributions, the two components being justified
by the log-likelihood ratio test described above (p-value of 2x10-12 and 0.00319 for the
stable and fluctuating datasets respectively). Are the mean positions of the FRET peaks
the same in both datasets? When fitting the datasets independently (Figure 6.13, red),
the apparent position of the higher FRET peak differs between the stable and fluctuating
ribosomes. This might be due to the high FRET peak containing a small percentage of
events in the stable data (~10%), thereby biasing or reducing the precision of the fitted
peak. The global fitting feature of MEMLET allows the peak positions and widths to be

specified as shared parameters, with only the relative amplitude of each peak being
unique between the datasets. This global model (Figure 6.13, yellow) yields a good fit to
the data, and allows the relative amplitudes of the two FRET values to be accurately
compared between the stable and fluctuating ribosome classes. The log-likelihood ratio
test shows that using the individual fit parameters for each dataset is not statistically
justified (Table 6.4). A simulated dataset with similar parameters (Figure 6.14, Table
6.5) demonstrates that the global fitting implementation is capable of increasing the
accuracy and precision of fitting in such cases when the number of points in a particular
dataset are few. In such situations where multiple component distributions are used,
users are encouraged to perform similar simulations which emulate their experimental
data to ensure their fitted parameters can be reliably determined.

top
bottom

glob
top
glob
bot

A
0.0598
0.2086

Individual Fits
mu1
sig1
mu2
sig2
0.734
0.109
0.332
0.153
0.629
0.116
0.310
0.132
Sum of Individual LL
Global Fit (mu1,sig1,mu2,sig2 shared)

0.1196

0.635

0.143

0.1843

0.635

0.143

0.318

Log-Likelihood
467.603
-77.49
390.113

0.145

467.043

0.318
0.145
Sum of Global LL
2* Ratio of Sum of
Global & Indiv LL
p value for 4 degrees of
freedom

-76.169
390.874
1.522
0.82

Table 6.4 The values of the fits from Figure 6.13 inlcuding the log-likelihoods for both the inidivudual and
global fits, where the amplitude was allow to vary between datasets. The goodness-of-fit of the global fit
compared to the individual fits can be compared using the log-likelihood ratio test by considering both
datasets together. The sums of the log-likelihoods of the two datasets combined can be compared
between the individual and global fits. There is a difference of four degrees of freedom between the
global and inidivdual datasets (10 free fitting variables versus 6). This yields a p-value of 0.82 between the
global and individual fits, indicating that the inidividual fits are not statistically justified over the global fit.

Figure 6.14 Simulated data with the same number of points as the data shown in Figure 6.13. Panel A
shows a simulated dataset with similar values to that of Figure 6.13. Other panels show how the global fit
can improve or match the accuracy of the fitted parameters compared to individual fits for a wide variety
of parameters. Black dashed lines show the simulated peak positions, while the red line shows the peak
positions from individually fitting the top and bottom datasets separately. Yellow lines show the peak
positions when the top and bottom datasets were fit globally with only the amplitude of each of the two
Gaussian components varying between the two datasets. Simulation and fitted parameters are given in
Table A.5.
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Panel B
Individu
Individu
al
al top
bottom
-0.1%
--0.1%
-0.1%
-0.4%
1.3%
1.3%
0.1%
0.0%
0.3%
-3.7%

Panel D
Individ
Individ
ual
ual top botto
m
25.2%
--15.8%
34.8%
28.1%
8.8%
-6.5%
1.1%
8.1%
-2.6%
-9.0%

Global
fit
-0.1%
0.1%
-0.2%
0.0%
0.1%
0.3%

Global
fit
-0.1%
0.3%
2.7%
0.5%
-0.2%
-2.4%

Table 6.5 Simulated values and the percent error of the individual fits to the top and bottom datasets
from each Panel in Figure 6.14 compared to the percent error of the Global fit to each Panel. Panel A most
closely resembles the data shown in Figure 6.13. In Panels A, C, and D, the global fits have a lower error
than the individual fits.

6.5. Conclusion
The provided program offers an easy to use and accessible method for
researchers with a wide range of computational expertise to utilize Maximum Likelihood
Estimation to fit their data. In addition to a simple Graphical User Interface, many of the
program’s functionalities are accessible and can be enhanced by editing and writing
further scripts in MATLAB. The included documentation makes it easy to fit the data to
predefined PDFs, utilize custom PDFs, estimate uncertainties using bootstrapping, and
test whether adding additional parameters to a model is statistically justified. By easily
allowing users to automatically renormalize a PDF to account for the size of their

minimum or maximum detectable event (tmin or tmax), the accuracy of fitting is greatly
improved. For more complex datasets, the ability to perform global fitting and utilize
multidimensional data enables thorough analysis. The program runs in the MATLAB
programming environment, and is also available as a standalone application which only
requires the freely available MATLAB runtime. Both versions of the program, as well as
the associated help files, are currently available on GitHub for download.
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This normalized video was used for analysis in panels C and D. C) The mean intensity in each ROI
in the normalized video shows pseudo-periodic fluctuations in its localized intensity with a

similar period (25 kHz). The fluctuations in the different regions vary in amplitude and phase. D)
The signal that would be created from projecting the recorded images onto either a Quadrant
Photodiode (QPD, blue) or a lateral effect photodiode (LEP, red) were simulated to see if the
variations mainly arose as fringes crossed the quadrant boundary. The force signal varied for
both types of detectors with similar periodicity, but with somewhat different secondary
characteristics. ............................................................................................................................... 44
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reduction in the amplitude of the variations and doubling of their spacing changes the landscape
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AOD variations introduce added noise. E) A comparison of the simulated trap positions with the
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without non-linearities (pink histogram). F) Simulated trap positions under feedback when only
the trap’s potential is present and non-linearities are absent. ..................................................... 46
Figure 2.8 A) Schematic of the optical trap setup including EODs. Dashed blue lines indicate
conjugate planes. L7 is necessary to create a conjugate plane at Picomotor Mirror 1 (PM1) to
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lenses described above and slightly different positions of half waveplates and other lenses. PBS:
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Figure 2.9 A) Characterization of the deflection of the EODs as a function of trap position (green)
shows a uniform detected force signal on the QPD. The corresponding signal using AODs from
Figure 2.5 is shown offset at the same scale. B) An enlarged view of the EOD data from Panel A
shows that there are no detectable “wiggles” in the deflection of the beam by the EOD. C) The
actin dumbbell’s position is shown for the beginning of a single interaction between cardiac
myosin and actin using the EOD-based force-clamp system. Red dashed lines guide the eye to
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it quickly stops at t = 1 ms. There is one clear displacement of ~10 nm at 2 ms and no other large
fluctuations. A similar figure for the AOD-based system is shown in Figure 2.4A without the
initial motion of the filament at a constant velocity ..................................................................... 49
Figure 2.10 UFFC Realtime Drift and EOD slope correction (DSC) system. a) Relative unbound
velocities of one trap under 1.5 pN applied load from multiple sequential traces over 12 minutes
without the real time corrections (red) shows a 20% change in the velocity, while the DSC

system results in <3% change in velocity over the same period. b) Distributions of velocities from
single traces when 1.5 pN of load are applied (traces are from different days). The distribution
without DSC is broader and has a lower unbound velocity (red) than the DSC enabled trace
(blue). c) Approximately 25 ms of raw force signals and position signals when the DSC is engaged
with a force set point of 4.5 pN. An upper and lower pause are indicated. The equations to the
right show the calculations to obtain the values plotted in d). d) Calculated drift and EOD slope
values for both traps over the full 30 second trace of c. e) The estimated real force and position
traces from the data in c with the pauses removed for further analysis. ..................................... 51
Figure 3.1 Myosin Biochemical Model and UFFC Example Traces a) Currently accepted mechanochemical model of acto-myosin interaction. Inset: Two possible models of when phosphate may
be released during myosin’s biochemical cycle. b) Applied forces from the ultra-fast force clamp
feedback system set to apply 3.75 pN of load. Dashed line indicates zero force. c) Position of the
actin filament as reported by the trap position while being subject to the forces applied in b).
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d) and e) The force on and position of the actin filament during a myosin binding event under
hindering (positive) load. f) Expanded section of panel f showing the binding (red triangle) and
dissociation (blue triangle) can be distinguished by the change in slope of the position trace. g)
Further expanded view of f) showing a displacement (green triangle) of approximately 10 nm
occurring within about 1 ms of actin binding (red triangle). ......................................................... 57
Figure 3.2 Kinetics of actomyosin dissociation under load. a) Cumulative distributions functions
of actomyosin attachment durations at 1 uM ATP under assisting loads (solid lines) on a semi-log
plot. Best fits from the loglikelihood ratio test are shown for each data set (dashed lines). Lowload data from non-feedback experiments shown in grey with a single exponential fit. Inset
shows the same data on a linear scale. b-e) Comparison of cumulative distribution functions for
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phosphate (dark solid lines). f) Fitted rates from the multiexponential function which describe
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fitted rates (ks), red the fastest rates (kf), and green the intermediate rate (kint) when three rates
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Figure 3.3 Fits to attachment durations. a) Data from Figure 2a plotted with other potential fits,
showing that for forces >2.25 pN a triple exponential fit was required. b) The amplitudes
(relative fraction) of each fitted rate kf (Af, red), kint(Aint, green), and ks(As, blue) for data with 0
(dark bars) and 10 mM (light bars) added Pi. c) Plot of the corrected cumulative distribution
functions for 0 mM Pi and hindering loads taking into account that events are missed by the
experimental deadtime (see Methods). Dashes lines show fits to the data and extrapolate back

to the graph origin (not shown). d) Similar plot to b, but showing the corrected amplitudes
based on the experimental deadtime. The fast amplitude (red) is considerably larger for each
force than in panel b because the majority of the events that are missed detached at this fastest
rate. Error bars are 68% confidence intervals from 500 rounds of bootstrapping for all panels.. 62
Figure 3.4 Force dependence of fast and intermediate detachments at 0 mM Pi and 1M ATP. a)
Bell equation fits for kf were performed separately for assisting (negative) and hindering loads
(positive). For assisting loads k0 = 579 s-1, d=-1.47 nm, and for hindering loads k0 = 354 s-1, d=2.54 nm. b) The fit for ki was performed on positive and negative data but excluded the point at
-4.5 pN. k0 = 256 s-1, d=-1.18 nm. ................................................................................................... 63
Figure 3.5 Kinetics of detachment at saturating ATP (1mM MgATP). a) Fitted detachment rates kf
(red), kint(green), and ks(blue) shown for 1 M ATP (closed circles, same data as in Fig. 2f) and 1
mM ATP (open diamonds). Zero load rates (black) are from the non-feedback experiments. The
kf does not vary at higher ATP concentration, while ks is faster and force dependent. b) ks at
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resisting loads ................................................................................................................................ 64
Figure 3.6 Visualization of the myosin working stroke dynamics under hindering load. a) Example
traces of the position of the actin filament (as reported by the leading trap position) during
individual acto-myosin interactions under 3.75 pN of hindering load. Red triangles indicate
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function of applied load with a linear fit, giving an estimate of the stiffness of the myosin lever
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Figure 3.7 Quantification of total observed displacement from ensembles as a function of the
minimum event duration included in the ensembles (e.g. the data points at x=10 ms indicates
the average displacement when only events that are longer than 10 ms are included in the
ensemble average). Displacement is normalized to the largest displacement observed for that
force. As more events are excluded (increasing x-axis), the total observed displacement rises,
until it nearly reaches it maximum when x=15 ms. This result is justification of why events longer
than 15 ms were analyzed separately. .......................................................................................... 66
Figure 3.8 Kinetics of the initial working stroke displacement. a) and b) Ensembles averages from
events longer than 25 ms with the size of the initial displacements normalized. a) without added

Pi and b) with 10 mM added Pi for 1.5 pN to 3.75 pN hindering loads. c) Quantification of the
observed stroke rate (kstroke, diamonds) from the 20% to 80% rise-time of the signals in a) and b).
The rates kf from Figure 2f are plotted as red circles for comparison with the stroke rates ........ 67
Figure 3.9 Limitations in quantifying 4.5pN initial stroke rates. a). In the absence of phosphate,
the normalized 4.5pN data shows noise characteristics which makes it difficult to reliably use the
20-80% rise time measurement, but this method was most reliable for the other forces studied.
An exponential function (red) fit to the data from 0.18 ms to 1 ms gives a rate of the stroke,
kstroke = 4740 s-1, as compared to the rate from the 20-80% rise time of 3600 s-1 (Figure 3.8c). b)
With 10 mM added Pi, the total stroke is very small and thus the noise in the normalized trace is
quite large, making quantification difficult. An exponential fit from 0.2 ms to 0.63 ms (red) gives
a kstroke = 3490 s-1, similar to the estimated 3570 s-1 from the 20-80% rise time (Figure 3.8c). ..... 68
Figure 3.10 Possible effects of free Pi on displacements. a) Schematic for the working stroke
occurring before Pi release and the expected effect of Pi of causing increased and delayed stroke
reversals. b) Schematic of Pi release occurring before the working stroke and the expected
effect of solution Pi on idealized displacement traces predicting a delay in the working stroke
from Pi being able to rebind and then dissociate again from a pre-stroke state. ......................... 69
Figure 3.11 Effect of added Pi on reversals of the working stroke displacement. a) Example
traces of displacements in individual interactions under 3pN of load with 10 mM Pi present with
possible stroke reversals (open green triangles) highlighted. b) Ensemble averages of events
longer than 25 ms at 1.5 pN (blue), 3 pN (red), and 4.5 pN (green) with 0 (light colored lines) and
10 mM added Pi (dark lines). Data at the various forces are offset by 2 nm for readability. c)
Expanded view of the boxed region in b) showing the initial stroke and dip. Triangles indicate the
detected maximum initial displacement, and circles indicate the location and timing of the
maximum ‘dip’ in the signal as described in the Methods using a moving average. d)
Quantification of the relative total displacement for events longer than 25ms with 10mM added
Pi compared to that with no added Pi. d) Quantification of the relative size of the dip for 10 mM
vs 0 mM added Pi. e) Comparison of the time between the maximum initial displacement and
minimum of the dip for no added Pi (blue) and 10 mM added Pi (red). g) Simulated ensembles
averages from the model described in the text and methods with Pi release occurring after the
working stroke. h) Expanded view of the boxed region in g) showing the simulated dip in the
displacement. Inset shows a simplified view of the working stroke-first model used in
simulations. .................................................................................................................................... 70
Figure 3.12 Simulations of the effect of free phosphate on ensembles averages. The scheme in a)
shows the rates and pathways used in the simulations of the ensembles shown in Fig. 3.11 g,h in
the main text. When a rate of 100 s-1 was used for rebinding of myosin-ADP-Pi to actin (small
black up arrow near red), the estimated biochemically measured Pi release rate is 18 s-1, in
agreement with the literature (see Supplementary Note 1).68,77 b) and c) Examples of 8 (out of
3000) individual traces simulated using the above pathway with added Gaussian noise to aid
visualization. Averages of these (and other) traces are shown in the main text Fig. 3.11 g and h.
b) Traces simulated with no Pi rebinding and c) simulated with Pi rebinding at 400 per second,
showing more reversals of the stroke, especially those occurring later in the cycle. ................... 71

Figure 3.13 Proposed model with short-lived, weakly-bound attachments directly preceding the
working stroke, which is followed by phosphate release and potential phosphate rebinding.
Ranges of rates are estimates of the rate at zero load (lowest value) to 4.5 pN of hindering load
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Figure 3.14 Simulations of the initial ensemble displacement for single (blue) vs. multistep (red,
yellow, green) processes occurring between actin binding and the working stroke compared to
the observed data for 3pN (black). Only the single process at 5000 s-1 (blue) or a multistep
process with one rate being ≥10,000 s-1 (red and yellow) exhibit a similar rapid displacement like
that observed (black), indicating that if two processes occur after binding but before the stroke
is completed, one of them must be extremely fast. ...................................................................... 75
Figure 4.1 Biochemical Cycle of Cardiac Myosin . Omecamtiv Mecarbil has been shown to
increase the rate of phosphate release (step 5) and bias the ATP hydrolysis step (step 3) towards
the post-hydrolysis M·ADP·Pi state, which is proposed to cause myosin to enter the strong
binding states (red underline) more rapidly. Other biochemical steps have been previously
shown through stop-flow biochemical experiments to be nearly unchanged by the presence of
OM. Inset: Example optical trapping trace of the position (median filtered with 0.4 ms window)
of an actin filament during one interaction with a single myosin molecule reproduced from
Figure 4.2b. The step size and attachment duration of these interactions can be measured as
shown. ............................................................................................................................................ 88
Figure 4.2 The Effect of OM on Myosin Working Stroke Size (a) Example trace of the position of
one bead during several interactions of cardiac myosin with actin in the absence of OM (blue).
The covariance of the two beads’ positions is shown in black and was used to determine when a
binding event occurred, as indicated by the dark horizontal lines above the position trace. (b) An
expanded section of the data inside the dashed box in (a), where two clear interactions can be
visualized. (c) and (d) Example trace similar to that in (a) and (b), but with 10 M OM present.
The interactions are more difficult to distinguish in the position trace (red) but are clear from
the covariance (black). Position traces in (a)-(d) are median filtered with a 0.4 ms window. (e)
Binding events were synchronized at their starts and averaged forward in time to show the
average stroke size observed in the presence of OM ranging from 0 to 10 M. Average stroke
size decreases with increasing OM concentration. (f) The average observed stroke size was
decreased by OM in a dose dependent manner. Error bars give the standard deviation of the
mean step sizes from each molecule observed. N-values are presented in Table 4.1. ................. 93
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Figure 4.6 Actin Attachment Durations as a Function of OM Concentration. (a) Cumulative
distributions of the actomyosin attachment durations (solid lines) at 4 mM MgATP. Without
OM, the attachment durations are well described by a single exponential distribution (dotted
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observed attachment duration (black) at 4 mM MgATP. Black error bars show the standard
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at ka, (black), or at the OM-associated rate (kb, red) from the durations global fit as a function of
OM concentration. (d) Observed step size linearly correlates with the fraction of events which
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step from each molecule studied. (e) Detachment rates at 10 M OM as a function of MgATP
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concentrations. Rate kb (red) was only observed in the presence of the drug and was
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Figure 4.7 Distributions and Fits of the Kinetics of Detachment at Saturating [ATP]. Cumulative
density functions are shown for each OM concentration at saturating MgATP concentration on a
semi-log scale (black). MLE Fits to a single exponential distribution only provide a good fit for
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(red) provide a much better fit. The global double exponential distribution (blue) forces all the of
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Figure 4.8 Distributions and Fits of the Kinetics of Detachment at Sub-saturating [ATP].
Cumulative density distributions (black) of attachment durations at sub-saturating ATP
concentrations for 0 and 10 M OM (left and right columns respectively) on a semi-log axis.
Note the x-axis is scaled differently for the 200 nM MgATP data (a and b). Single exponential
distributions fit well to the data without OM (log-likelihood ratio test119 for double exponential
yielded p = 0.29, 0.44, and 0.43 for 200 nm, 1 M, and 10 M MgATP respectively), but double
exponential distributions are required to describe the 10 M OM data, especially at 200 nM and
10 M MgATP (log-likelihood ratio test119 for double exponential yielded p < 1e-15, = 0.023, and
= 1.26e-12, for 200 nm, 1 M, and 10 M MgATP respectively). At 1 M MgATP, the rate of ATP
induced dissociation (5 per second) and OM-associated dissociation (10 per second) are so close,
they become difficult to distinguish visually. The number of observations is given in Table 4.1.
..................................................................................................................................................... 101
Figure 4.9 Dissociation of Myosin from Actin from Nucleotide-free or ADP-bound States. (a)
Normalized fluorescence transient increases of pyrene actin during the dissociation of rigor
(nucleotide-free or apo) myosin from pyrene actin in the absence of OM (blue curve) and in the
presence of 10 µM OM (red curve) as obtained from stopped-flow biochemical experiments. The
data were fitted by a single exponential rise plus a constant slope (necessary likely due to the
long duration of the experiment, black). The rate of detachment, was very slow, as expected
(0.0054 s-1), and was unchanged by OM. (b) We also observed the rate of dissociation of M-ADP

from pyrene actin (blue, see Methods), which was faster than rigor, but still very slow (0.015 s-1)
and also nearly unchanged by the presence of OM (red, 0.012 s-1). See Table 4.4 for all rates.104
Figure 4.10 Force Dependence of Detachment is Reduced by OM. (a) and (b) Example traces of
force on the motor bead (blue, red) with the trap’s isometric feedback system engaged. Events,
as detected by covariance, are indicated by dark lines above the force traces. (a) In the absence
of OM (blue), forces are predominantly in the positive direction (myosin is under resisting load)
(b) In the presence of 10 M OM (red), forces are generated in both directions. (c) The
observed detachment rates in the absence of 0 OM (blue) and at 10 M OM (red) as a function
of applied load are shown as circles at the average force and rate of 20 events sorted by force.
Green and yellow lines show the detachment rate calculated from Equation 1 and parameters
from the MLE fit in the absence of and presence of 10 M OM, respectively, with 95%
confidence intervals shown as shaded grey areas. Data are composed of 665 and 583 binding
events from 3 and 4 molecules for the absence of OM and 10 M OM respectively. (d) Distance
parameter estimates for the control (no OM) and 10 M OM data from all observed molecules
(closed circles) are shown with 95% confidence intervals from bootstrapping and the estimated
distance parameters from individual molecules (open circles). .................................................. 106
Figure 4.11 Simulations of OM’s Effect on in vitro Actin Gliding Velocity and Isometric Force of
Muscle Preparations. (a) Summary of parameters used in models in panels (b)-(e). (b)
Comparison of gliding filament velocity for the protein used in this study (open triangles) and
from Swenson et al.91 (closed circles) to simulated data from the various model parameter sets
(colored lines as in (a)). The Stroke Eliminated, Prolonged Time of Attachment (SEPTA) Model
(red), with parameters from the single molecule measurements, fully accounts for the observed
marked decrease in vitro velocity as a function of OM concentration. Motility error bars are
standard deviations of velocities from individual filaments (n of filaments= 92 - 6709). (c)
Comparison of simulated, normalized, isometric forces at an intermediate calcium concentration
(15% activation, lines colored as in (a)) and results from Nagy et. al11 who reported a bellshaped force response of permeabilized myocardial trabeculae as a function of OM (black
circles). The SEPTA model (red) shows a similar biphasic shape. (d) Active force data reproduced
from Nagy et. al. as a function of pCa (-log [Ca2+]) at 0, 100 nM and 1 M OM. (e) Simulated
isometric force at 0 OM (grey line), and using the SEPTA model at 100 nM (red dashed line) and
1 M OM (red, solid line) for comparison with the experimental data in (d). The SEPTA model
recapitulates the leftward shift in the pCa-tension curve (calcium sensitization) and decreased
force production at fully activating [Ca2+] .................................................................................. 109
Figure 4.12 Motility Rate and Isometric Force Simulations with Alternative Models ................. 110
Figure 4.13 Model of OM’s Effect on Cardiac Myosin. 1) OM increases the rate of entry into
strong binding as previously measured by phosphate release rates, but the force generating
power stroke is inhibited. 2) Myosin remains strongly bound to actin (red bar), contributing to
increased thin filament activation at intermediate calcium concentrations. 3) OM disrupts the
typical pathway of myosin, causing it to pass through an ADP or apo (nucleotide-free) state with
its lever arm still in the pre-power stroke position. 4) Myosin detaches from actin without
needing to bind ATP. ATP binding must occur before the cycle can start again. ........................ 113

Figure 4.14 Isometric Force as a Fraction of Myosin Bound to OM. The (a) normalized and (b)
non-normalized isometric force developed at pCa 6.4-5.8 in simulations utilizing the SEPTA
parameters from the table in Figure 4.11A plotted as a function of the fraction of myosin bound
to OM. The bell-shaped response to force reaches a maximum between 15-35% of myosin
bound to OM. In the simulations, pCa 6.4, 6.2, 6.0, and 5.8 correspond to 14%, 25%, 40%, and
63% of full activation respectively in the absence of OM. .......................................................... 116
Figure A.1 MLE fitting outperforms least squares fitting of binned data. A-D: Parameters used for
generating data (histograms) according to equation 8 are shown in black, while the fit to the
binned histograms (red) and the MLE fit (green), which is independent of binning, are plotted on
each panel. Inset of C and D show the same data and fits with the x-axis on a log-scale. E-G:
Average fitted value for the two rates and relative amplitudes, as well as the 95% confidence
intervals (error bars/shaded area) obtained by 1,000 rounds of simulations. The values used to
generate the simulated data are shown by the black dot and black dashed line. ...................... 148
Figure A.2 Tutorial 1: Performing a Simple Fit ............................................................................. 149
Figure A.3 Effect of instrument dead-time on determination of best-fit parameters for different
fitting procedures. A: a simulated single exponential dataset shown as histograms for the
complete dataset (blue) and the dataset subjected to tmin = 10 ms (red). B: Trend for a single
exponential of the fitted rates versus the actual rates of the simulated data with tmin = 10 ms
imposed for all rates using the inverse mean method (blue), histogram fits (yellow), cumulative
distribution fits (red), and MLE method (green) with the PDFs used for fitting specified for each
method. Five-hundred rounds of fitting unique simulated datasets yields 90% confidence
intervals for each method (shown by shaded areas). The dark shaded areas and closed symbols
show how each method performs when the number of points is held constant at 1,000 data
points, while the light shaded areas and open symbols describe the fit when the number of
fitted points is reduced as the rate increases due to tmin. The difference in between light and
dark is most obvious for the MLE while for the other methods the dark shaded areas appear as
lines. C: The distribution of fitted rates (histograms) compared to simulated rates (black dashed
line) from the 500 simulated data sets subjected to tmin = 10 ms used to generate Panel B. For
the MLE fits, the labels on the left y-axis give the counts for the light areas, while the right y-axis
labels are the counts for the dark areas. Other methods share the left axis labels. ................... 151
Figure A.4 Tutorial 2: Performing a Fit Subject to a Dead-Time .................................................. 153
Figure A.5 Data were generated in the same way as in Figure A.3, but dead-time corrections
were used for all fitting methods. The inverse method was corrected as described in the text by
subtracting the dead-time from the mean duration before calculating the inverse value. The fits
to the binned data points were corrected by using the same dead-time corrected PDF used in
the MLE fit and ignoring any bins whose range was less than or included the dead-time.
Cumulative distributions were corrected by subtracting a floating amplitude term from the PDF
given in Figure A.3. The corrected mean method gives the same result as the MLE method (as
expected and described in the main text), however this inverse mean method is not applicable
to data with multiple exponential components. When the number of data points is kept
constant at 1000 (closed symbols and dark shaded areas representing 90% confidence intervals
from 1000 rounds of simulations), the fits all maintain accuracy, but the MLE and mean fits show

the smallest confidence intervals (mean confidence intervals not shown for clarity, but are the
same as the MLE). When the number of points being fit are allowed to decrease with increasing
rate due to more events being shorter than the 10ms dead-time (open symbols and light shaded
areas), the MLE (and mean) fit offers the more accurate fit and lowest confidence intervals,
particularly at high rates. ............................................................................................................. 154
Figure A.6 Effect of instrument dead-time on multi-component models for different fitting
procedures. A: The empirical cumulative density function (CDF) for the entire simulated dataset
from Figure A.1 (blue), and the CDF when events shorter than 2 ms are removed (red). Vertical
dashed lines show the dead-time, while horizontal dashed lines show the proportion of events
missed. Inset shows a zoomed-in view of the same plot. B: The performance of histogram fits
(yellow), cumulative distribution fits (red), and MLE fits (green), in estimating the proportion of
fast events as a function of increasing tmin. Shaded areas indicate 95% confidence intervals for
the fits estimated from 500 rounds of simulations. .................................................................... 155
Figure A.7 Data sets composed of 1000 points each were simulated by drawing from a double
exponential distribution with k1 = 100 s-1 and varying k2. 50% of events came from the variable
rate process, and no dead time was imposed on the data. 1000 independent datasets were
generated and fit using cumulative distributions, histograms, and MEMLET’s MLE algorithm. (A)
The fitted rate for k2 is plotted, along with 90% confidence intervals. The variable rate is difficult
to accurately fit when it is 2-fold (50-200 s-1) of k1. MLE fitting consistently yielded a more
accurate rate with lower confidence intervals outside of this 2-fold range than the other
methods tested. (B) Plot of the percentage of 1000 simulations in which the log-likelihood ratio
test yields a p-value below 0.05, indicating a double exponential fit is justified over a single
exponential fit. When the value of k2 approaches k1 (100 s-1), the log-likelihood ratio test is
unable to distinguish the two components. ................................................................................ 156
Figure A.8 Tutorial 3: Fitting 2D datasets .................................................................................... 157
Figure A.9 MEMLET can determine non-linear relationships between multiple dependent
variables. A: Data points representing acto-myosin attachment duration data from Laakso et al.
(blue), with data grouped by force in 0.5 pN bins with standard deviations (green bars, no
binning was used for fitting). The MLE fit (red) to the PDF in Equation 10 describing Scheme 3
with 90% confidence intervals (grey shaded area) determined from 500 rounds of
bootstrapping. B: The calculated CDF of the data in Panel A grouped in specified force ranges
showing the rate of the process is force dependent at low forces (0-1.2 pN), but force
independent at higher forces (>1.2 pN) as shown in Scheme 3. ................................................. 159
Figure A.10 Simulated data using the same kinetic model that was used to fit the data in Figure
A.9. 500 simulated datasets of 329 points each were generated using the “One Force dependent
phase and One force independent phase in parallel” PDF from Table A.1and then were fit using
the MLE fitting method. The simulated parameters are given at the top of each panel. 95%
Confidence intervals (grey) were determined using the results of the 500 independently fit
datasets. The program is able to accurately fit the parameters over a wide range of input
parameters, including those similar to the data shown in Figure 7 (Panel B). The fitting performs
worst when the distance parameter (d) is very low (Panel C), or very high (Panels A and E),
because in such cases the force range being simulated is either too small or large, respectively,

to show the effect of the force dependent rate. Table A.2 and Table A.3 show the performance
of the fits from each case. ........................................................................................................... 160
Figure A.11 Tutorial 4: Performing Model Testing ...................................................................... 162
Figure A.12 Tutorial 5: Performing Global Fits............................................................................. 163
Figure A.13 . Global Fitting in MEMLET improves precision of fitting multiple datasets. Fitting of
FRET efficiency data from Figure 3D of Chen et al. showing two populations of FRET efficiencies
in two datasets. Panels A and B: Each dataset was fit individually with a double Gaussian PDF
(dashed red lines, solid lines show individual Gaussian components). The global fit (yellow)
constrained the position and width of both Gaussian components, while allowing the relative
amplitudes to vary between the data sets. Vertical lines show the fitted position of the high
FRET peak for the individual (red) and global (yellow) fits. ......................................................... 164
Figure A.14 Simulated data with the same number of points as the data shown in Figure A.13.
Panel A shows a simulated dataset with similar values to that of Figure A.13. Other panels show
how the global fit can improve or match the accuracy of the fitted parameters compared to
individual fits for a wide variety of parameters. Black dashed lines show the simulated peak
positions, while the red line shows the peak positions from individually fitting the top and
bottom datasets separately. Yellow lines show the peak positions when the top and bottom
datasets were fit globally with only the amplitude of each of the two Gaussian components
varying between the two datasets. Simulation and fitted parameters are given in Table A.5. .. 166
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